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The skeletal muscle is one of the largest organs in the body, and it has great 
adaptive potential in response to physiological stressors. A marked example of 
muscle adaptation occurs in the mitochondria following exercise training. The 
biogenesis of mitochondria and the clearance of damaged mitochondria can 
promote healthy muscle. This turnover can prevent imbalances in metabolism, 
which can predispose individuals to the development of obesity, diabetes, 
cardiovascular disease, and accelerated aging (Joseph et al, 2012; Patti et al, 
2003). Endurance exercise training has the potential to enhance metabolic 
characteristics in the skeletal muscle, including mitochondrial biogenesis and 
glucose transporter 4 (GLUT4) expression (Holloszy, 2008). The mechanisms 
underlying such adaptations remain to be elucidated, although such adaptations 
have been investigated for several decades. Peroxisome proliferator-activated 
receptor gamma coactivator 1 alpha (PGC-1α) has been implicated as a master 
regulator of mitochondrial biogenesis via its interaction with nuclear respiratory 
factor 2 (NRF-2/GA-binding protein-A) and nuclear respiratory factor 1 (NRF1). 
Both PGC-1α and NRF-1 activate the mitochondrial transcription factor A 
(Tfam), which is responsible for transcribing nuclear-encoded mitochondrial 
genes, as well as proteins involved in mitochondrial DNA (mtDNA) 
transcription, translation, and repair. The PGC-1α mRNA and protein expression 
levels are increased by acute endurance exercise and endurance exercise training 
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(Russell et al., 2003; Taylor et al., 2005), thus suggesting that PGC-1α is a 
potential regulator of metabolic adaptations with endurance exercise.  
Mammalian sirtuins, such as sirtuin 1 (SIRT1), are members of a conserved 
family of NAD
+ 
(Nicotinamide adenine dinucleotide)-dependent deacetylases 
and ADP (adenosine diphosphate)-ribosyltransferase, which are involved in 
numerous fundamental cellular processes, including gene silencing, DNA 
(deoxyribo nucleic acid) repair, and metabolic regulation. SIRT1 promotes 
mitochondrial biogenesis via the deacetylation of PGC-1α. Another important 
metabolic sensor, AMP-activated protein kinase (AMPK), also activates PGC-1α. 
The expression and activity of SIRT1 in rat skeletal muscle (Ferrara et al., 2008) 
have been observed to increase with endurance exercise. Similar to AMPK, 
SIRT1 is widely associated with energy metabolism, thus implicating 
mitochondrial function, and activators of these enzymes could enhance 
mitochondrial biogenesis and endurance capacity. Collectively, these findings 
suggest the possibility that the metabolic adaptations resulting from endurance 
exercise training result, at least partly, through increased PGC-1α protein 
expression through AMPK pathways. The NAD
+
-dependent histone deacetylase 
SIRT1 is also activated by acute endurance exercise (Suwa et al., 2008). Thus, it 
has been proposed that AMPK activates SIRT1 indirectly by increasing the 
intracellular levels of its co-substrate, NAD
+
.  
In both mammalian cells and yeast, the regulation of mitochondrial 
biogenesis clearly involves the cAMP (cyclic adenosine monophosphate) 
signaling pathway. Indeed, it has been shown that treatment of human 
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preadipocytes with forskolin, which leads to an overactivation of the cAMP 
pathway, increased mitochondrial DNA copy number (Bogacka et al., 2005). 
Protein kinase A (PKA), a well studied cAMP downstream effector is also 
known as cAMP-dependent enzyme because it gets activated only if cAMP is 
present. Once PKA is activated, it phosphorylates a number of other proteins 
including cAMP response element binding protein (CREB) and liver kinase B1 
(LKB-1) which induction PGC-1α to regulated mitochondria biogenesis (Than et 
al., 2011; Veeranki et al., 2011). Previous study shown evidence that exercise 
included swimming and running increased cAMP on skeletal muscle and 
myocardium (Palmer, 1988). This evidence together strong suggested that 
exercise increased mitochondrial biogenesis through its ability to increase cAMP. 
In This present study we examined effect of curcumin treatment on cAMP level 
and downstream target of PKA included phosphorylation CREB and LKB-1 
which involved on mitochondrial biogenesis. 
Several polyphenols have been shown to activate cAMP, therefore, currently 
being intensively investigated as potential inducers of mitochondrial biogenesis 
through the deacetylation-mediated activation of PGC-1α (Chowanadisai et al., 
2010; Park et al., 2012). The polyphenols curcumin are components of Curcuma 
longa L, a compound with medicinal properties, and turmeric, a popular culinary 
spice in both vegetarian and non-vegetarian foods. A previous study had shown 
that the anti-oxidant activities of curcumin were more potent than those of 
another polyphenol, resveratrol (Aftab et al., 2010). Furthermore, the long-term 
effects of dietary curcumin on various markers of mitochondrial biogenesis have 
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also been investigated. Five-month dietary supplementation of curcumin has 
been shown to up-regulate PGC-1α protein expression in senescence-accelerated 
mouse-prone 8 (SAMP8), a fast-aging mouse strain, thereby improving 
mitochondrial membrane potential (MMP) and ATP levels and restoring 
mitochondrial fusion in the brain (Eckert et al., 2013). However, the effects of 
curcumin on the skeletal muscle and its underlying mechanisms in the regulation 
of mitochondrial biogenesis are yet to be elucidated.  
In the present study, we have investigated the mechanisms by which 
curcumin affects mitochondrial biogenesis in rats. We predicted that treatment 
with curcumin will have effects on the induction of mitochondrial biogenesis, 
and combined with endurance training (eTR), curcumin treatment addictive or 
synergistically to enhance eTR-induced mitochondrial biogenesis. The primary 
purpose of the present study was to determine the effects of curcumin treatment 
combined with 24 days of eTR on regulation of mitochondrial biogenesis in 
skeletal muscles (m. gastrocnemius [Gas] and m. soleus [Sol]). In the present 
study, we provide the evidence of the efficacy of curcumin treatment and eTR on 
increasing mitochondrial biogenesis in skeletal muscle. We hypothesized that 





II.  Previous Research 
 
1. Mitochondrial Structure and Function 
Mitochondria are abundantly present in mammalian cells. Their fraction 
variation from tissue to tissue, ranging from < 1% (volume) in white blood cells 
to 35% in heart muscle cells (Wiesner, 1997). The mitochondria in skeletal 
muscle are divided into two morphologically different sub-fractions that are 
regionally distinct in the muscle fiber. These are subsarcolemmal (SS) 
mitochondria that lie directly beneath the sarcolemmal membrane and the 
intermyofibrillar (IMF) mitochondria that are located in close contact with the 
myofibrils. The mitochondria are equipped with double membranes, creating the 
intermembrane space between the outer and inner membranes as well as the 
inner matrix compartment, where most of the metabolic processes take place. 
The inner membrane is highly folded, forming so-called cristae, to accommodate 
its large surface area. Embedded in the inner mitochondrial membrane contains 
the five complexes that make up the respiratory chain where oxidative 
phosphorylation takes place.  
Mitochondria are the main site of ATP synthesis, using the free energy of 
the oxidation of metabolic fuels with oxygen. The matrix space which containing 
the enzymes of the citrate cycle and beta-oxidation, enclosed by an inner 
membrane containing the 4 complexes of the electron transport chain, ATP 
synthase and specific carriers for metabolites. Mitochondria also have a 
relatively permeable outer membrane and an intermembrane space. ATP 
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synthesis (oxidative phosphorylation) is critically dependent on the structural 
integrity of the mitochondrion. Electrons from substrate oxidations feed into the 
electron transport chain at complex I or complex II, and then successively flow 
to complex III, complex IV and finally to oxygen. Complexes I, III and IV are 
redox pumps and electron transport causes extrusion of protons from the matrix 
generating an electrochemical proton gradient (proton motive force) across the 
inner membrane. Protons return to the matrix through ATP synthase driving the 
synthesis of ATP. The stoichiometry of proton extrusion and the yield of ATP 
are still uncertain. Mitochondria have genetic continuity and are inherited 
maternally. They possess a small amount of DNA which codes for some, but not 
all, of the subunits of complexes I, III, IV of ATP synthase. mtDNA also codes 
for mitochondrial ribosomal and messenger RNAs involved in the synthesis of 
mitochondrially coded subunits. All other mitochondrial peptides are synthesised 
on cytosolic ribosomes and are imported and targeted to their specific 
intramitochondrial locations, often after proteolytic removal of leader sequences 
(Sherratt, 1991). 
 
2. Mitochondrial Biogenesis 
A. Definitions 
Mitochondrial biogenesis can be defined as the growth and division of pre-
existing mitochondria. Due to their ancient bacterial origin, mitochondria have 
their own genome and a capacity for autoreplication. Mitochondrial proteins are 
encoded by the nuclear and the mitochondrial genomes. The double-strand 
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circular mitochondrial DNA (mtDNA) is ~16.5 kb in vertebrates and contains 37 
genes encoding 13 subunits of the electron transport chain (ETC) complexes I, II, 
III, IV, and V, 22 transfer RNAs, and 2 ribosomal RNAs necessary for the 
translation. Correct mitochondrial biogenesis relies on the spatiotemporally 
coordinated synthesis and import of 1000 proteins encoded by the nuclear 
genome, of which some are assembled with proteins encoded by mitochondrial 
DNA within newly synthesized phospholipid membranes of the inner and outer 
mitochondrial membranes. In addition, mitochondrial DNA replication and 
mitochondrial fusion and fission mechanisms must also be coordinated. All of 
these processes have to be tightly regulated in order to meet the tissue 
requirements. Mitochondrial biogenesis is triggered by environmental stresses 
such as exercise, cold exposure, caloric restriction and oxidative stress, cell 
division and renewal, and differentiation. The biogenesis of mitochondria is 
accompanied by variations in mitochondrial size, number, and mass. The 
discovery that alterations in mitochondrial biogenesis contribute to cardiac 
pathologies such as the hypertrophied or failing heart have increased the interest 
of the scientific community in this process and its regulation. 
 
B. Protein Import into Mitochondria 
Because the majority of mitochondrial proteins are encoded in the nucleus, a 
mechanism for the targeting, import, and correct assembly exists to ensure proper 
mitochondrial function and shape (Baker et al., 2007; Hood et al., 2003). Following 
activation of the nuclear genome, mRNAs are translated in the cytosol to precursor 
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proteins having signals for targeting to specific mitochondrial compartments. These 
proteins are escorted by molecular chaperones, unfolded, and imported into 
mitochondria via the translocase of the outer membrane complex (TOM). After 
transfer across the outer membrane, certain precursors are directed through the 
import machinery of the inner membrane complex (TIM) into the mitochondrial 
matrix in a membrane potential-dependent manner. Subsequently, these precursors 
are cleaved of their import sequences and are refolded by intramitochondrial 
proteins. A majority of mitochondrial protein precursors, however, do not contain 
typical N-terminal targeting signals but instead contain targeting information 
withintheir mature sequences. Other mechanisms ensure proper assembly and 
processing of the different subunits in the mitochondrial complexes of the 
respiratory chain at the inner membrane or in the matrix. These processes are an 
integral part of mitochondrial biogenesis. 
 
C. Mitochondrial Fusion and Fission 
Mitochondria in the cells of most tissues are tubular, and dynamic changes 
in morphology are driven by fission,fusion, and translocation (Bereiter, 1990). 
The ability to undergo fission/fusion enables mitochondria to divide and helps 
ensure proper organization of the mitochondrial network during biogenesis. 
Mitochondrial fission is driven by dynamin-related proteins 1 and optic atrophy 
1 (DRP1and OPA1), while mitochondrial fusion is controlled by mitofusins 
(Mfn1 and 2). Mitofusins are highly expressed in heart and skeletal muscle, and 
their expression is induced during myogenesis and physical exercise (Bach et al., 
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2003; Soriano et al., 2006). In addition to the control of the mitochondrial 
network, Mfn2 also stimulates the mitochondrial oxidation of substrates, cell 
respiration, and mitochondrial membrane potential, suggesting that this protein 
may play an important role in mitochondrial metabolism, and as a consequence, 
in energy balance. OPA1, by contrast, is involved in the remodelling of cristae. 
Mfn and DRP1 expression increases in parallel with mitochondrial content and 
exercise capacity in human skeletal muscle (Garnier et al., 2005) , suggesting 
that fusion/fission processes are an integral part of mitochondrial biogenesis.  
 
D. Factor Regulating Mitochondria Biogenesis 
a. DNA-Binding Transcription Factors Nuclear Respiratory Factor-1, 
Regulator of OXPHOS and mtDNA Replication/Transcription Factors  
NRF-1 was identified as a transcription factor binding to a conserved 
regulatory site of the cytochrome c promoter. NRF-1 binding sites are 
evolutionarily conserved in the proximal promoters of many mitochondrial genes  
(Gollnick et al., 1972). Accordingly, NRF-1 activates the expression of 
OXPHOS (oxidative phosphorylation) components, mitochondrial transporters, 
and mitochondrial ribosomal proteins. In addition, NRF-1 regulates expression 
of Tfam, Tfb1m, and Tfb2m and thereby coordinates the increased expression of 
nuclear mitochondrial genes with increases in mtDNA replication and expression 
(Gollnick et al., 1972). NRF-1 may also affect expression of mitochondrial and 
metabolic genes via indirect mechanisms, e.g., by inducing expression of the 
transcription factor MEF2A (Myocyte-specific enhancer factor 2A), which 
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activates COX (cytochrome c oxidase) genes, GLU4, and PGC-1α  (Baar et al., 
2002). Silencing of NRF-1 leads to a significant suppression of mitochondrial 
target genes, suggesting that endogenous NRF-1 is constitutively active and 
important for the basal expression of mitochondrial targets ((Meirhaeghe et al., 
2003; Ventura-Clapier et al., 2008). Nevertheless, NRF-1 activity can also be 
regulated by phosphorylation and/or interactions with PGC-1α, PGC-1β, PRC 
(PGC-related coactivator), and cyclin D1. Phosphorylation of NRF-1 occurs 
upon exposure of quiescent fibroblasts to serum (which correlates with induction 
of Cycs) and exposure of hepatoma cells to oxidants (which leads to an NRF-1-
dependent induction of Tfam). Depending on the context, phosphorylation 
affects NRF-1 translocation to the nucleus, DNA binding, and/or transcriptional 
activity (Gollnick et al., 1972). Physical interactions of the PGC-1 family 
members with NRF-1 enhance NRF-1-dependent gene expression (Bergeron et 
al., 2001; Puigserver et al., 1998). Many signals known to induce mitochondrial 
biogenesis or respiratory function also induce NRF-1 expression, suggesting that 
NRF-1 is part of the energy-sensing pathway in mammalian cells. In vivo, NRF-
1 expression in muscle is induced by exercise in rat (Narkar et al., 2008). Finally, 
NRF-1 expression was induced in the muscle of rats fed with a creatine analog 
that activates AMP-activated protein kinase (AMPK) and induces adaptations 
similar to those induced by exercise training (Nisoli et al., 2003). All together, 
two major signals have emerged as regulators of NRF-1 expression: increases in 
Ca
2+
 and activation of AMPK. Whether these signals regulate NRF-1 activity 
directly, and not simply NRF-1 expression, is not yet known. In support of a role 
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for NRF-1 as a critical transcription factor for expression of mitochondrial genes, 
NRF-1 null animals show early embryonic lethality, and NRF-1
−/−
 blastocysts 
have reduced mtDNA content and mitochondrial membrane potential (Rodgers 
et al., 2005). Although NRF-1 seems necessary for mitochondrial biogenesis, its 
expression alone is not sufficient to drive this program. Transgenic 
overexpression of NRF-1 in muscle increases expression of select NRF-1 targets 
but does not enhance respiratory capacity, suggesting that activation of parallel 
transcription pathways must complement NRF-1 during exercise-induced muscle 
mitochondrial biogenesis (Lagouge et al., 2006). 
 
b. Mitochondrial Transcription Factor A (TFAM)  
The first mitochondrial transcription factor described was TFAM (Fisher et 
al., 1985), a nuclear encoded protein that is translocated to the mitochondria 
where it exerts its effects by binding to mtDNA. TFAM is a member of the high-
mobility group (HMG) of proteins. It has the ability to bind, unwind and bend 
DNA without sequence specificity, but show higher affinity for LSP and HSP. 
C-terminal deletion of TFAM resulted in loss of specific DNA binding and 
transcription activation of the protein. The vital role of TFAM during 
development and maintenance of the organism is shown by the lethality of 
homozygous TFAM knock-out in both mice (Larsson et al., 1998). Homozygous 
TFAM knock-out mice die between embryonic days 8.5-10.5. The mutant 
embryos lack mtDNA, and display severe respiratory chain deficiency with 
massive accumulation of morphologically abnormal mitochondria, as well as 
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delayed neutral development and defective heart. The biological regulatory 
function is further demonstrated by that TFAM level varies with the level of 
mtDNA in human cell (Larsson et al., 1994). Completely about mitochondrial 
biogenesis mechanism included factors which involve in regulating 
mitochondrial biogenesis has showed in Figure II-1. 
 
3. Transcription Cascade of Mitochondrial Biogenesis 
A. PGC-1α (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 
1 Alpha) 
Mitochondria are composed of 1,500 proteins, which are encoded by both 
the nuclear and mitochondrial DNA (mtDNA). The mtDNA encodes only 13 of 
these polypeptides, which are subunits of the mitochondrial ETC. It also encodes 
for two rRNA genes and 22 tRNA genes required for mitochondrial protein 
synthesis. All other mitochondrial proteins are encoded by the nuclear DNA. 
Consequently, the process of mitochondrial biogenesis requires coordination 
between these two genomes. This coordination is regulated primarily by the 
PGC-1 family of transcriptional coactivators, which work by activating 
transcription factors. However, they do not interact directly with DNA. As 
described below, they bind to several different transcription factors that bind 
DNA. PGC-1α coactivators also interact with a histone acetyltransferase 
complex that consists of cAMP response element binding protein/p300 that 





Figure II-1.   The mitochondrial life cycle (Carter et al., 2015). 
Under steady-state conditions, mitochondrial turnover occurs through a 
combination of organelle synthesis and degradation. Binding of transcriptional 
coactivators, such as PGC-1α, to transcription factors (TFs) results in the 
expression of nuclear genes encoding mitochondrial proteins (NUGEMPs; 1) 
and production of multiple mRNAs (2). These mRNAs are exported from the 
nucleus and translated into protein in the cytosol (3). With the assistance of 
chaperones, proteins destined for the mitochondria will be directed to the 
protein import machinery (PIM) for import into the organelle (4). Once inside, 
the proteins are directed to the appropriate mitochondrial compartment, and the 
organelle can expand to contain more ETC machinery. Tfam is a matrix-
destined protein that binds mtDNA (5) to regulate transcription and mtDNA 
replication (6). Two adjacent organelles can be tethered and fused together 
through the fusion proteins (Mfn1/2 and Opa1) as an additional mechanism for 
organelle expansion (7). Healthy mitochondria consume oxygen (8) and 
produce ATP (9) in the electron transport chain (ETC), in accordance with the 
cellular demand. When a portion of the mitochondrial network becomes 
damaged, fission proteins (Fis1, Mff, and Drp1) can be recruited to the 
dysfunctional site to cleave off the damaged portion (10). Typically, 
dysfunctional mitochondria are recognized through an increase in ROS 
emission and lower membrane potential (11). Once the damaged 
mitochondrion is separated from the network, it can be flagged for mitophagic 
degradation by ubiquitination of outer membrane proteins and binding of p62, 
LC3II, and NIX (12). Lipidated LC3II will initiate autophagosome formation 
to surround the organelle (12). Once fully encapsulated, the autophagosome 
(13) is directed to the lysosome. Fusion of the autophagosome with the 
lysosome results in the degradation of the organelle by proteolytic enzymes to 
its basic constituents (14).   
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associated protein/vitamin D receptor-interacting protein (TRAP/DRIP) mediator 
complex in order to activate DNA transcription. In addition to regulating 
mitochondrial biogenesis, the PGC-1 α coactivators are involved in modulating 
other metabolic pathways including fatty acid oxidation (FAO), lipogenesis, 
gluconeogenesis, and thermogenesis. The PGC-1α  family initiates mitochondrial 
biogenesis by activating transcription factors that regulate the expression of 
nuclear DNA encoded mitochondrial proteins (Ventura et al., 2008). These 
transcription factors include the nuclear respiratory factor 1 and 2 (NRF-1 and 
NRF-2) and the estrogen related receptor alpha (ERRα). The activation of these 
transcription factors increases the expression of many mitochondrial proteins, 
including the mitochondrial transcription factor A (Tfam) (Bergeron et al., 
2001) .  
Tfam is essential for mtDNA replication, transcription, and maintenance. 
Therefore, by regulating Tfam levels, the PGC-1α coactivators are able to 
influence the expression of proteins encoded by the mtDNA. The proteins 
encoded by the nuclear DNA are imported into the mitochondria where some 
will combine with proteins encoded by the mtDNA to form the multi subunit 
complexes of the mitochondrial OXPHOS system. Therefore, the PGC-1α family 
regulates mitochondrial biogenesis by coordinating the expression of 
mitochondrial proteins encoded by both the nuclear and mitochondrial genomes 
(Figure II-2). Although PGC-1α acts mainly in the nucleus more recently, 








Figure II-2. PGC-1α coactivators are master regulators of mitochondrial 
biogenesis (Jornayvaz et al., 2010). 
PGC-1α coactivators regulate mitochondrial biogenesis by 
coordinating the expression of mitochondrial proteins encoded by 
both the nuclear and mitochondrial genome. To accomplish this, 
they activate transcription factors such as NRF-1/2 and ERRa, 
thereby increasing the expression of nuclear DNA-encoded 
mitochondrial proteins. These mitochondrial proteins are then 
imported into the mitochondria. One such protein is TFAM, which 
when upregulated, leads to increased mtDNA replication and 
increased expression of mtDNA-encoded proteins. These 




protein deacetylase sirtuin 1 (SIRT1), another pivotal regulator of mitochondrial  
biogenesis, are located in the mitochondria. This is an interesting model as 
before this study, these proteins were thought to function only in the nucleus. 
Using fluorescent microscopy, the authors showed that PGC-1α and SIRT1 did 
not only colocalize with the nuclear Hoechst stain but also with cytochrome c, a 
mitochondrial protein used to label the mitochondrial network (Aquilano et al., 
2010; Dillon et al., 2012). In addition, they showed Tfam interacts with PGC-1α 
and SIRT1 in the mitochondria to form multiprotein complexes  (Aquilano et al., 
2010). Moreover, they found that the mtDNA D-loop region was present in 
crosslinked mitochondria immunoprecipitated with anti-PGC-1α and that PGC-
1α and SIRT1 were present in nucleoid (a poorly defined structure containing 
mtDNA and proteins) enriched mitochondrial fractions (Aquilano et al., 2010).  
Studies performed in mammalian cells and mouse models have highlighted 
the importance of the PGC-1 family in the regulation of mitochondrial 
biogenesis. The overexpression of PGC-1α  in C2C12 muscle cells, cardiac 
myocytes, and primary rat neurons was shown to increase mitochondrial density, 
the expression of nuclear and mitochondrial genes and mitochondrial function  
(Lehman et al., 2000; St-Pierre et al., 2003). Also, increased PGC-1α expression 
in mouse heart and skeletal muscle triggers an increase in mitochondrial 
biogenesis (Russell et al., 2004; Wenz et al., 2009). Accordingly, the ablation of 
PGC-1α in mouse skeletal muscle and heart leads to decreased expression of 
most nuclear and mitochondria encoded genes, decreased mitochondrial enzyme 
activity and mitochondria content (Adhihetty et al., 2009). These studies 
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demonstrate that PGC-1α play pivotal roles in regulating mitochondrial 
biogenesis and function. 
 
B. AMPK  (5' Adenosine Monophosphate-Activated Protein Kinase) 
AMPK is a major regulator of mitochondrial biogenesis which regulates 
intracellular energy metabolism in response to acute energy crises (Hardie, 2007). 
β-GPA (β-guanadinopropionic acid) is a creatine analogue acting as a chronic 
pharmacological activator of AMPK. Indeed, β-GPA mimics exercise training 
and leads to reductions in the intramuscular ATP/AMP ratio and 
phosphocreatine concentrations, which in turn activates skeletal muscle AMPK. 
Rats fed for 8 weeks with β-GPA had a chronic skeletal muscle AMPK 
activation, which resulted in increases in NRF-1-binding activity, δ-ALAS 
mRNA expression, cytochrome c protein expression and mitochondrial content, 
thus demonstrating that AMPK activation promotes mitochondrial biogenesis 
through PGC-1α and the NRFs (Bergeron et al., 2001). To further examine the 
role of AMPK in mitochondrial biogenesis, transgenic mice overexpressing a 
DN (dominant-negative) mutant of AMPK in muscle (DN-AMPK) were treated 
with β-GPA. This treatment had no effect on AMPK activity or mitochondrial 
content in DN-AMPK mice, but induced an activation of muscle AMPK and 
mitochondrial biogenesis in wild-type mice. Furthermore, this AMPK 
inactivation abrogated the β-GPA-induced expression of PGC-1α and CaMKIV 
(calcium/calmodulin-dependent protein kinase IV) (Zong et al., 2002). 
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Pharmacological activation of skeletal muscle AMPK enhances 
mitochondrial biogenesis, an effect shown to be dependent largely on expression 
of the AMPK α2 subunit (Jorgensen et al., 2007) and peroxisome proliferator-
activated receptor γ co-activator-1α (PGC-1α) (Leick et al., 2009). The 
overexpression of constitutively active skeletal muscle AMPK also increases 
PGC-1α and mitochondrial function, further supporting a critical role for this 
pathway in regulating mitochondrial biogenesis (Garcia-Roves et al., 2008). 
Consistent with these findings, mice lacking AMPK β (O'Neill et al., 2011) or 
liver kinase B1 (LKB-1) (Jeppesen et al., 2013; Tanner et al., 2013) have 
reduced muscle mitochondrial contents. Many studies have investigated the 
mechanisms by which AMPK may regulate mitochondrial biogenesis, and this 
has been shown to involve both direct phosphorylation and acetylation (via 
sirtuin 1) of PGC-1α (O'Neill et al., 2013). However, with exercise, mice lacking 
PGC-1α  (Adhihetty et al., 2009) or sirtuin 1 have normal increases in 
mitochondrial biogenesis (Philp et al., 2011). Interestingly, in LKB-1 muscle 
null mice, exercise training does not increase components of the mitochondrial 
electron transport chain (Tanner et al., 2013). Taken together, these data 
demonstrate that by sensing the energy status of the muscle cell, AMPK is a key 
regulator of mitochondrial biogenesis. 
 
C. SIRT1 (Sirtuin 1) 
Evidence was shown that PGC-1α was in fact a deacetylation target of 
SIRT1 and that acetylation regulated PGC-1α activity (Sack et al., 2012; Nemoto 
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et al., 2005; Rodgers et al., 2005). There are at least 13 lysine residues on PGC-
1α that appear to be reversibly acetylated (Rodgers et al., 2005). SIRT1 appears 
to be the predominant in vitro and in vivo regulator of PGC-1α deacetylation. In 
particular, in skeletal muscle, fasting was shown to lead to a SIRT1-dependent 
deacetylation of PGC-1α, and this deacetylation appeared to be required for 
PGC-1α-dependent gene expression, including gene products required for 
effective mitochondrial biogenesis (Gerhart-Hines et al., 2007). The above 
studies suggest that mitochondrial biogenesis might be regulated by tissue 
energetic status and that the sirtuins would represent important energy sensors in 
this homeostatic loop. Indeed, the notion that PGC-1α acetylation and function, 
and by extension mitochondrial activity, are regulated in a nutrient-dependent 
fashion by SIRT1 is appealing. Nonetheless, the concept that SIRT1 is in turn 
responding to nutrient-sensitive changes in basal NAD levels, although often 
invoked, has until recently had little experimental support. The difficulty in 
proving the supposition is that measurement and manipulation of NAD levels in 
various subcellular compartments is experimentally challenging. One recent 
approach is to carefully examine mice with a deletion of a major NAD-
consuming enzyme, poly (ADP-ribose) polymerase-1 (PARP-1). These mice 
appear to have elevated NAD levels along with increased SIRT1 activity (Bai et 
al., 2011). Another recent report suggested that adiponectin, a secreted adipokine, 
could regulate intracellular NAD levels. Again, in these studies the addition of 
adiponectin to cells appeared to increase mitochondrial content through a SIRT1- 
and PGC-1α-dependent pathway. These results might be particularly important 
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because metabolic diseases are often associated with low adiponectin levels 
(Hotta et al., 2000), as well as with mitochondrial dysfunction (Petersen et al., 
2004), although the link between these two observations were previously 
unknown. The generation of new mitochondria through a SIRT1 / PGC-1α-
regulated pathway is complemented by another important connection between 
SIRT1 and the mitochondria. In particular, it would appear that SIRT1 is an 
important regulator of removing damaged mitochondria through the process of 
autophagy (Lee et al., 2008). Evidence suggests that SIRT1 can stimulate 
autophagy and that SIRT1
−/−
 tissues appear to accumulate abnormal-appearing 
mitochondria, consistent with what is seen in autophagy-deficient tissues (Lee et 
al., 2008). 
The molecular basis for how SIRT1 stimulates autophagy is not clear. There 
is evidence that key molecules required for autophagy including Atg5 and Atg7 
are direct targets of sirtuin-dependent deacetylation  (Lee et al., 2008). In 
addition, the FoxO family of transcription factors, known targets of SIRT1 
deacetylation as well as regulators of autophagy, has also been implicated 
(Hariharan et al., 2010). Nonetheless, although details remain to be elucidated, 
the notion that SIRT1 can regulate both the creation of new mitochondria as well 
as the removal of old mitochondria suggests a role for sirtuins in overall 
mitochondrial flux and in the maintenance of what may be viewed as “youthful” 
mitochondria in the cell. There is also evidence that a recently described 
extracellular, circulating form of the enzyme nicotinamide 
phosphoribosyltransferase (Nampt) may be an important in vivo mediator of 
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insulin secretion (Revollo et al., 2007). The Nampt enzyme is a key enzyme in 
NAD biosynthesis and is responsible for the conversion of nicotinamide to 
nicotinamide mononucleotide, a metabolite that can in turn be converted directly 
to NAD. Again, these observations highlight the potential function of SIRT1 in 
linking metabolites such as NAD to the maintenance of overall metabolic 
homeostasis.  
 
D. cAMP  (Cyclic Adenosine Monophosphate) 
Cyclic AMP is generated from ATP via adenylyl cyclases (ACs) and 
degraded via phosphodiesterases (PDEs). The cAMP generated by adenylyl 
cyclases is tightly regulated by phosphodiesterases (PDE), which catabolize 
cAMP into 5′ AMP. There are 11 known PDE families; some are specific for 
cAMP (PDEs 4, 7, 8), others for cGMP (PDEs 5, 6, 9), whereas the remainder 
(PDEs 1–3, 10, 11) catabolize both cAMP and cGMP. Each of the PDE families 
includes multiple isoforms with distinct enzymatic characteristics, modes of 
regulation, expression patterns, and distribution throughout the cell. Cyclic AMP 
effector molecules contribute to the complexity and specificity of cAMP 
signaling. PKA, a well studied cAMP downstream effector, is a tetrameric 
enzyme consisting of two catalytic domains (C) and two regulatory domains (R). 
In mammals, there are three known isoforms of catalytic subunits (Cα, Cβ, Cγ) 
and four isoforms of regulatory subunits (RIα, RIβ, RIIα, RIIβ). cAMP binding 
to R releases active C subunits, which phosphorylate key substrates (Kim et al., 
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2005). A structurally diverse group of proteins called A kinase anchoring 
proteins (AKAPs) direct PKA to distinct subcellular sites (Diviani et al., 2011). 
 
E. CREB (cAMP Response Element Binding Protein) 
The signal transduction pathway leading to expression of nuclear genes 
encoding mitochondrial proteins is believed to be regulated by CREB-dependent 
transcription of PGC-1α, a co-activator of these genes and master regulator of 
mitochondrial biogenesis (Conkright et al., 2003). An important mechanism of 
CREB activation of PGC-1α in this pathway is the activation and nuclear 
translocation of CRTC, a family of CREB co-activators that are known to 
respond to metabolic stress mediated through cAMP- dependent protein kinase 
(PKA) or AMP-activated protein kinase (AMPK) (Wang et al., 2009). The 
cAMP response element-binding protein (CREB) is a ubiquitous transcription 
factor that regulates the transcription of cAMP response element-regulated genes. 
It belongs to the CREB/ATF1 (Cyclic AMP-dependent transcription factor ATF-
1) family of cAMP/Ca2+ responsive transcription factors. PKA phosphorylation 
activates CREB. Nuclear CREB regulates PGC-1α, the master regulator of 
mitochondrial biogenesis (Chowanadisai et al., 2010). Blocking CREB or PGC-
1α in mouse hepatocytes inhibited mitochondrial biogenesis induced by 
pyrroloquinoline quinone (PQQ), a redox cofactor and antioxidant compound. In 
addition to its nuclear roles, CREB is also found bound to the mitochondrial 
DNA (Cammarota et al., 1999). In brain, mitochondrial CREB regulates 
mitochondrial gene expression and neuronal survival (Lee et al., 2005). CREB is 
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thought to be transported to the mitochondria via chaperone molecules, such as 
Hsp70 (70 kilodalton heat shock proteins). CREB uptake was promoted by the 
mitochondrial membrane potential and by TOM complex, responsible for the 
translocation of the proteins from the cytoplasm into the mitochondria. Once 
inside mitochondria, CREB interacts with cAMP response elements (CREs) in 
the mitochondrial DNA, thereby regulating expression of mitochondrial 
components of the electron transport chain. It appears to bind directly to the D-
loop of mitochondrial DNA. Mitochondrial CREB phosphorylation was shown 
to regulate expression of mitochondrial DNA-encoded proteins, such as ND1 
(NADH dehydrogenase 1), ND6 (NADH dehydrogenase 6), and COX-III 
(cytochrome c oxidase subunit III / ATP6 Adenosine Triphosphate Synthase 
Subunit 6). Based on experiments with either wild-type or Ser133 mutant 
mitochondrially targeted CREB, It was proposed that CREB can be 
phosphorylated by PKA within mitochondria (Ryu et al., 2005).  
 
F. LKB-1 (Liver Kinase B1) 
Liver kinase B1 (LKB-1) was discovered only 12 years ago, as a serine–
threonine kinase that is mutated in Peutz-Jeghers Syndrome. Initially, studies to 
identify the function of LKB-1 were difficult, as its sequence gave few clues as 
to its activity. Overall it had little similarity to other protein kinases. However, 
studies in cell lines including HeLa S3 and G361 melanoma cells, which lack 
endogenous LKB-1, provided insights into LKB-1’s role as a tumor suppressor, 
including early evidence of its role in stress and damage responses. More 
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recently, LKB-1 has been appreciated to be a signaling protein, integrating 
cellular energy sensing with growth and proliferation, functioning both in the 
nucleus and the cytoplasm. It is ubiquitously expressed throughout the body, and 
functions as a heterotrimer with STRAD (sterile-20-related adaptor) and MO25 
(mouse protein-25) in cells. LKB-1 is post-translationally modified by kinases in 
several signaling pathways including cAMP–PKA (Alexander and Walker., 
2011). Despite the fact that it is constitutively active in cells, it has also been 
noted that LKB-1 catalytic activity is enhanced when STRAD and MO25 are 
present in the complex.  
AMP-activated protein kinase (AMPK) is one of the best characterized 
substrates of LKB-1. LKB-1 has now been shown to be one of the primary 
kinases that phosphorylates AMPK. AMPK activation by agonists such as 5-
aminoimidazole-4-carboxamide ribonucleoside (AICAR), metformin or 
phenformin or in response to stress is absent in LKB-1-deficient cells (Hawley et 
al., 2003), identifying LKB-1 as an obligatory AMPK kinase in this setting. 
Activation of AMPK by AICAR occurs via mono-phosphorylation of AICAR to 
its active form, ZMP which can mimic the effect of AMP on AMPK, i.e., 
allosteric activation and enhancement of phosphorylation by upstream kinase(s). 
In addition to LKB-1, the calmodulin-dependent protein kinases CaMKKα and 
CaMKKβ also function as kinases for Thr 172 of AMPK. This activation 
pathway is calcium-responsive, does not require an increase in AMP, and is 
thought to be particularly important for endocrine hormone regulation, for 
example adiponectin activation of AMPK in vascular endothelial cells. CaM-
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kinases are most highly expressed in neural tissue, where they play a role in 







4. Exercise Induces Mitochondrial Biogenesis 
Endurance exercise has a number of health benefits, including improvements 
in muscle metabolism, cardiovascular function, and increased exercise tolerance. 
The increase in endurance is a result of greater oxygen delivery and extraction by 
the exercising muscle. Oxygen extraction is a result of an improved capillary-to-
fiber ratio, as well as a higher mitochondrial content within muscle. The increase 
in mitochondrial content is a well-established adaptation within the exercised 
muscle, but the molecular mechanisms underlying this change in muscle 
phenotype still remains to be clarified. This increase in mitochondrial content 
which occurs as a result of regular exercise is referred to as mitochondrial 
biogenesis.  
 
A. The Role of PGC-1α as a Regulator of Exercise Induces Mitochondrial 
Biogenesis 
PPARγ coactivator-1α (PGC-1α) is the ‘master regulator’ of mitochondrial 
biogenesis because of its ability to induce mitochondrial biogenesis in a variety 
of experimental models. For example, the overexpression of PGC-1α in skeletal 
muscle of transgenic mice is sufficient to coordinate a host of muscle adaptations 
reminiscent of endurance exercise training, including increased mitochondrial 
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content, increased proportion of Type I muscle fibers, and a corresponding 
increase in muscle fatigue resistance. PGC-1α binds to and coactivates DNA-
binding transcription factors, thus augmenting their activity. The primary targets 
of PGC-1α are the nuclear respiratory factors, NRF-1 and NRF-2. PGC-1α 
increases the expression of both these transcription factors, and coactivates NRF-
1-mediated transcription. NRF-1 and/or NRF-2 binding sites are found in the 
promoter regions of several nuclear genes encoding mitochondrial proteins, 
including cytochrome c, components  electron transport chain complexes, 
mitochondrial import proteins, heme biosynthesis proteins, and the 
mitochondrial transcription factors Tfam. Thus, working through NRF-1, PGC-
1α coordinates the bi-genomic regulation of mitochondrial biogenesis. The 
expression of PGC-1α is regulated by altered patterns of physical activity. In 
response to a single bout of exercise, PGC-1α mRNA and protein are 
significantly elevated in mice and rats, and humans (Hood and Saleem, 2007). 
Increase in gene expression is evident as early as 2 h post-exercise. Although 
exercise elicits numerous systemic changes in the body, the exercise-induced 
PGC-1α upregulation appears to be independent of these factors. Evidence for 
this comes from the fact that contractile activity alone (i.e. no humoral influence) 
is sufficient to increase PGC-1α expression. Together, these studies point to 





B. Calcium and AMP Kinase Signaling to Exercise Increase Mitochondrial 
Biogenesis 
a. Ca2+ Signaling and Exercise 
In skeletal muscle, Ca
2+
 acts as an essential regulatory and signaling 
molecule. Gene expression of respiratory proteins in skeletal muscle has been 
linked to intracellular Ca
2+
 signaling mediated by Ca
2+
-dependent regulatory 
enzymes, namely calcineurin, Ca
2+
/calmodulin-dependent protein kinase 
(CaMK) and protein kinase C (PKC). The strongest evidence favoring Ca
2+
-
mediated alterations in mitochondrial biogenesis come from studies with 
CaMKIV isoform overexpression. Transgenic mice possessing a constitutively 
active CaMKIV exhibited increased muscle PGC-1α expression, mitochondrial 
biogenesis, and an up-regulation of mitochondrial gene expression (Wu et al., 
2002). CaMK increases PGC-1α promoter activity through the activation of 
cAMP response element binding protein (CREB) (Handschin et al., 2003). 
Electrical stimulation of skeletal muscle in mice activates the PGC-1α promoter, 
and this effect is abolished when CREB is mutated (Akimoto et al., 2004). These 
studies point to CREB in altering PGC-1α transcription in response to multiple 
exercise-induced signals. Surprisingly, the response of CaMKIV knockout mice 
to endurance training, including an upregulation of PGC-1α, is indistinguishable 
from that of wildtype (WT) mice. Thus, other CaMK isoforms, more abundantly 
expressed in muscle, may be important for the exercise-induced upregulation of 




b. AMPK Activation with Exercise 
5′-AMP activated protein kinase (AMPK) is an energy-sensing enzyme that 
responds to cellular conditions associated with energy depletion. AMPK has 
been shown to be activated by exercise in both animals and humans. The enzyme 
is a heterotrimer that consists of a catalytic α subunit and two regulatory subunits, 
β and γ. The signaling cascade that involves AMPK phosphorylation and 
activation is the result of a reduction in the ATP/ADP ratio, and a concurrent 
elevation in AMP due to myokinase activity, such as that which occurs during 
contractile activity. AMPK is allosterically activated by AMP up to 10-fold 
(Carling et al., 1987) and is antagonized by ATP which competes for the same 
binding site (Corton et al., 1995). AMPK can also be phosphorylated and 
activated by one or more upstream protein kinases that create a more than 100-
fold activation. Activation of AMPK also occurs with 5-aminoimidazole-4-
carboxamide riboside (AICAR) treatment. AICAR is taken up by cells and 
phosphorylated by cellular adenosine kinase to ZMP, an analog of AMP. 
Pharmacological activation of AMPK by AICAR increases PGC-1α mRNA 
(Terada et al., 2002) and protein (Irrcher et al., 2003). This upregulation of PGC-
1α transcription and translation is accompanied by the increased DNA binding 
activity of NRF-1. As noted above, NRF-1 is a transcriptional regulator of 
proteins involved in mitochondrial biogenesis. In addition, chronic activation of 
AMPK using AICAR in resting rats has resulted in increases in mitochondrial 
enzymes such as δ-aminolevulinic synthase, cytochrome c, citrate synthase and 
malate dehydrogenase in skeletal muscle (Winder et al., 1985). Thus, AMPK 
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activation is another important regulator of mitochondrial biogenesis under 
conditions of energy deprivation in muscle cells. 
 
c. SIRT1 Activation with Exercise  
Silent information regulator 2 is an oxidized form of nicotinamide adenine 
dinucleotide (NAD
+
)-dependent histone deacetylase that is required for longevity 
in Caenorhabditis elegans and Saccharomyces cerevisiae in response to energy 
restriction. In mammals, the silent information regulator 2 ortholog, SIRT1 
functionally interacts and deacetylates several proteins. SIRT1 also deacetylates 
and functionally activates PGC-1α. SIRT1 is required for PGC-1α–induced up-
regulation of mitochondrial biogenesis in skeletal muscle cells. SIRT1 plays a 
role in muscle gene expression in the modulation of the cytosolic NAD
+
-to-
NADH (reduced form of nicotinamide adenine dinucleotide) ratio. Because the 
cytosolic NAD
+
-to-NADH ratio changes during muscle contractio, it is possible 
that SIRT1 contributes to skeletal muscle adaptations with endurance exercise 
(Suwa et al, 2008). It is therefore very likely that increased SIRT1 protein 
expression by endurance exercise results in elevated SIRT1 deacetylase activity 
as well as causing an allosteric effect of an increased cytosolic NAD
+
-to-NADH 
ratio and then at least in part contributes to the metabolic adaptations by 
activating the PGC-1α in skeletal muscle (Suwa et al., 2008).  
Completely how mechanism exercise / contractile activity induces 


















Figure II-3. Contractile activity-induced mitochondrial biogenesis (Ljubicic et al., 2010). 
 (1) A single bout of contractile activity results in the activation of multiple downstream 
signaling molecules and kinases. Elevations in intracellular calcium are associated with 
the subsequent activation of calcium/calmodulin-dependent protein kinase (CaMK). The 
production of reactive oxygen species (ROS) and activation of mitogen-activated protein 
kinases (MAPK) and AMP kinase (AMPK) also constitute the diverse array of signaling 
pathways that are elevated by contractile activity. (2) These multiple signaling cascades 
induce the binding of transcription factors to the promoter region of PPAR gamma 
coactivator-1α (PGC-1α) and elicit its transcription. PGC-1α, auto-regulates its own 
transcription and (3) binds to the promoter region of its target genes such as nuclear 
respiratory factor 1 and 2 (NRF-1, NRF-2) and stimulates their expression. (4) NRF-1 
trans-activates nuclear genes encoding mitochondrial-destined proteins such as 
mitochondrial transcription factor A (TFAM). (5) These mitochondrial-destined proteins 
are transcribed in the nucleus and exported into the cytoplasm where the mRNA 
transcripts can be stabilized or destabilized by the binding of RNA-binding proteins 
(RBP) to the 3′ untranslated region (UTR) of the mRNA. (6) Upon translation, many 
mitochondrial proteins are synthesized as precursor proteins with cleavable N-terminal 
pre-sequences. These are imported by the protein import machinery which consists of 
the translocases of the outer membrane (TOM) and translocases of the inner membrane 
(TIM) complexes. Once imported, the precursor protein is processed to produce the 
mature form. (7) TFAM, a mitochondrial DNA (mtDNA) transcription factor, can 
induce the expression of mtDNA-encoded proteins which together with nuclear DNA-
transcribed proteins, are assembled to form multisubunit complexes that become part of 
the electron transport chain (ETC).  
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5. Role of Polyphenol Induces Mitochondrial Biogenesis 
A. Polyphenol 
Over the past 10 years, researchers and food manufacturers have become 
increasingly interested in polyphenols. The chief reason for this interest is the 
recognition of the antioxidant properties of polyphenols, their great abundance in 
our diet, and their probable role in the prevention of various diseases associated 
with oxidative stress, such as cancer and cardiovascular and neurodegenerative 
diseases. Furthermore, polyphenols, which constitute the active substances found 
in many medicinal plants, modulate the activity of a wide range of enzymes and 
cell receptors (Manach et al., 2004; Middleton et al., 2000). Several thousand 
molecules having a polyphenol structure (ie, several hydroxyl groups on 
aromatic rings) have been identified in higher plants, and several hundred are 
found in edible plants. These molecules are secondary metabolites of plants and 
are generally involved in defense against ultraviolet radiation or aggression by 
pathogens. These compounds may be classified into different groups as a 
function of the number of phenol rings that they contain and of the structural 
elements that bind these rings to one another. Distinctions are thus made between 
the phenolic acids, flavonoids, stilbenes, and lignans (Figure II-4). The 
flavonoids, which share a common structure consisting of 2 aromatic rings (A 
and B) that are bound together by 3 carbon atoms that form an oxygenated 
heterocycle (ring C), may themselves be divided into 6 subclasses as a function 













anthocyanidins, and flavanols (catechins and proanthocyanidins) (Fig.II-5). In 
addition to this diversity, polyphenols may be associated with various 
carbohydrates and organic acids and with one another. 
 
B. Mechanism Polyphenol Increase Mitochondrial Biogenesis 
a. Polyphenols Increase Sirtuins to Regulated Mitochondrial Biogenesis 
Sirtuin1 is thought to play a role in regulation of mitochondrial biogenesis. It has 
been demonstrated in vitro, that polyphenolics, particularly resveratrol, can 
enhance the activity of the recombinant human sirtuin coded by SIRT1, 
apparently by a conformational change to the enzyme. Resveratrol at 10 M also 
extended the lifespan of yeast from ~23 to ~37 generations (Howitz et al., 2003). 
Chemical derivatives of resveratrol appear to be even more effective (Yang et al., 
2007), suggesting that these compounds in some way decrease the DNA damage 
associated with aging. These enzyme-activation results have been questioned by 
subsequent studies on the grounds that resveratrol required highly supra-
physiological concentrations (a 3-fold activation at 20 M) and a non-
physiological substrate to have a measurable effect (Grubisha et al., 2005; 
Kaeberlein et al., 2005). Observations that the plasma concentration of 
resveratrol from a realistic dose is in the nanomolar range and that it exists in 
vivo almost entirely as conjugates, rather than as free resveratrol (Goldberg et al., 
2003) cast further doubt on sirtuin activation as a key mechanism in vivo. It 










of mitochondrial biogenesis stimulation by polyphenols in vivo. Furthermore, 
Park et al. (2012) has showed evidence that resveratrol mediated mitochondrial 
biogenesis through AMPK-SIRT-PGC-1α pathway with it ability inhibiting PDE 
and increase cAMP level in skeletal muscle (Figure II-6). 
 
b. Polyphenol Decrease ROS to Regulated Mitochondrial Biogenesis 
It is well-established that inhibitors of the ETC increase ROS (Reactive 
oxygen species) generation. It has been shown, in vitro, that flavonoids can 
inhibit specific mitochondrial functions, including NADH oxidase (Hodnick et al, 
1986), F1-ATPase (Gledhill et al., 2007) and the membrane permeability 
transition (Santos et al, 1998). Other in vitro studies found that polyphenols 
inhibited overall mitochondrial respiration (Hodnick et al., 1987) and the closely 
related rate of ATP generation (Dorta et al., 2005). The former study also 
detected a burst of ROS generation associated with the inhibition of respiration. 
A wide range of compounds was tested in these studies, to the extent that 
structure-activity relationships were established. The two best classes of 
compound appeared to be stilbenes (e.g., resveratrol) and flavonols (e.g., 
quercetin). These findings suggest that polyphenols, if they were able to access 
the mitochondriain vivo, could directly but transiently increase ROS generation, 












Figure II-6.  Proposed model of how polyphenol resveratrol mimics calorie 





c. Polyphenol Inhibit PDE Activity and Induces cAMP Signaling to Increase 
Mitochondrial Biogenesis 
Resveratrol inhibits PDE activity and induces cAMP signaling via Epac1, 
which activates PLCε, resulting in Ca2+ release via the Ryr2 Ca2+ channel and, 
ultimately, the activation of the CamKKβ-AMPK pathway. CR increases cAMP 
levels by increasing glucagon and catecholamine levels, which activate AC 
activity and cAMP production. AMPK increases mitochondrial biogenesis and 
function by increasing PGC-1α expression, NAD+ levels, and SIRT1 activity. An 
additional pathway that may contribute to resveratrol action is indicated with 
dotted lines Resveratrol, a polyphenol in red wine, has been reported as a calorie 
restriction mimetic with potential antiaging and antidiabetogenic properties. Park 
et al. (2012) was reported that the metabolic effects of resveratrol result from 
competitive inhibition of cAMP-degrading phosphodiesterases, leading to 
elevated cAMP levels.  Furthermore, this study was indicated that resveratrol 
inhibits PDE4 in order to increase cAMP and finally through AMPK-SIRT1-
PGC-1α pathway regulated mitochondrial biogenesis (Figure II-6). Similar with 
that study Dallas et al. (2008) also indicated that polyphenol SINETROL have 
ability to inhibit PDE in human body fat adipocytes to show strong lipolytic 
effect mediated by cAMP-PDE inhibitor. This result together seems look like 
that polyphenol have ability to regulated mitochondrial biogenesis with inhibit 





C. Effect of Polyphenol Curcumin in Skeletal Muscle 
a.  Curcumin 
Turmeric is a spice stemming from the rhizomes belonging to a ginger 
family (Zingiberaceae) component called Curcuma longa. Described as 
horizontal underground stems with shoots and leaves, rhizomes are notable for 
their vibrant yellow colour. This colouris largely derived from fat-soluble 
polyphenolic pigments called curcuminoids). The yellow pigment segregated 
from from the rhizomes of Curcuma longais termed curcumin, or turmeric, as it 
is the natural phenol curcuminoid. The structure of curcumin was established in 
the year 1910 and it was originally isolated almost two hundred years ago. The 
main constituent of turmeric (a spice) is curcumin, which is similar to aspirin (a 
renowned carcinogenesis prevention chemical) in its chemical makeup. The 
dietary phytochemical curcumin (chemical structure shown in Figure II-7) has a 
long his history of medicinal use in India and Southeast Asia for a wide variety 
of medical condition. The safe consumption of curcumin is easily confirmed by 
the fact that for hundreds of years it has frequently been part of the diet of people 
in a number of countries. Curcumin was reported to have antitumor, antioxidant, 
antiarthritic  and anti-inflammatory properties. Docking studies of these were 
performed using GOLD and AutoDock into a few well validated targets of 
anticancer therapy (COX-2, PhenolsulphoTransferases, Matrix 
metalloproteinases (MMPs), P450 and TNF-alpha) has showed a good 








Figure II-7.  Turmeric, curcumin and its chemical structure (Shetty et al., 2014) 
(a) The root of turmeric. (b) Crystallized powder of curcumin. 
Curcumin is thought to be the main active ingredient derived from 
the root of turmeric. (c) The enol and keto forms of curcumin are 
common structures of the drug. The enol form is more energetically 












Figure II-8.  Binding mode of BDC (bis-Demethoxycurcumin) (Girija et al., 
2010)  
Binding mode of BDC (bis-Demethoxycurcumin) (shown in Green 
Molecular Surface model) to MMPs (Left). Binding mode of BDC 
in the active site (top view) of MMPs along with interacting amino 
acids(Right) from their respective regions of active site.  
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indicating these derivatives are potent procarcinogen activating enzyme 
inhibitors  (Figure II-8).  Curcumin, a  hydrophobic   natural  product,  comprises 
two phenolic rings. Each ring is replaced with methoxy ether functionality in the 
ortho-position and attached to each other by an aliphatic unsaturated heptene 
linker in the para-position with an α, β diketonic functionality on carbon-3 and -5. 
The electrophilic α, β-unsaturated carbonyl groups are capable of reacting with a 
nucleophile such as glutathione (Scapagnini et al., 2002). Results from a number 
of studies suggest that the diketone functionality is able to go through reversible 
tautomerization between enolic- and ketonic-forms (Payton et al., 2007). 
Commercial curcumin characteristically comprises three main curcuminoids: 
curcumin (~77%), demethoxy curcumin (~17%) and bis-demethoxycurcumin 
(~3%) (Figure II-7). Curcumin is radiant yellow in colour at pH 2.5 to 7 and 
evolves to red at pH ≥7. Whether in solid or soluble form, curcumin goes 
through photo degradation upon exposure to light. Curcumin has a melting point 
of 183
o
C, a molecular formula of C21H20O6, and a molecular weight of 368.37 
g/mol. It is not as soluble in water as in organic solvents such as dimethyl 
sulfoxide, ethanol, methanol and acetone.  
 
b.  Effect of Curcumin to Increase Mitochondrial Biogenesis 
Curcumin may surpass other bioactive components with regard to potential, 
but because of its low bioavailability its usefulness and attainable blood levels 
associated to its consumption is laced withdoubt (Kidd, 2009).  A previous study 
had shown that the anti-oxidant activities of curcumin were more potent than 
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those of another polyphenol, resveratrol (Aftab et al., 2010). Furthermore, the 
long-term effects of dietary curcumin on various markers of mitochondrial 
biogenesis have also been investigated. Five-month dietary supplementation of 
curcumin has been shown to up-regulate PGC-1α protein expression in 
senescence-accelerated mouse-prone 8 (SAMP8), a fast-aging mouse strain, 
thereby improving mitochondrial membrane potential (MMP) and ATP levels 
and restoring mitochondrial fusion in the brain (Eckert et al, 2013). However, the 
effects of curcumin on the skeletal muscle and its underlying mechanisms in the 




III. Research Design and Structure 
 
Muscle adaptation occurs in the mitochondria following exercise training. 
Endurance exercise training has the potential to enhance metabolic 
characteristics in the skeletal muscle, including mitochondrial biogenesis. 
Several polyphenols have been shown to activate cAMP, and are currently under 
intense investigation as potential inducers of mitochondrial biogenesis. The anti-
oxidant activities of curcumin have been reported to be more potent than those of 
another well-studied polyphenol, resveratrol and the long-term effects of dietary 
curcumin on various markers of mitochondrial biogenesis have been investigated. 
The effects of curcumin on the regulation of mitochondrial biogenesis in skeletal 
muscle however, have yet to be elucidated. The primary purpose of the present 
study was to determine the combined effects of curcumin treatment together with 
24 days of eTR on the regulation of mitochondrial biogenesis in skeletal muscles 
(Gas and Sol). We predicted that treatment with curcumin combined with 
endurance training (eTR), may additively or synergistically enhance the effect of 
exercise. In the order to clarify this hypothesis, present study aimed to examine 
the effects of combination of endurance training (eTR) and curcumin treatment 
on the expression of AMPK, SIRT1, PGC-1α, and OXPHOS subunits, 
mitochondrial DNA copy number, and CS activity in rat skeletal muscle. 
Furthermore, the present study also examined the effect of exercise and curcumin 
treatment  on  the  levels  of  cAMP  and  downstream  targets  of PKA including 
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phosphorylated CREB and LKB-1. The schematic schedule for present 
experiments shown on diagram at Figure III-1. 
 
1. Effect of Curcumin Treatment on Mitochondrial Marker (Experiment I) 
Previous studies have showed evidence that endurance exercise have ability 
to increase mitochondrial biogenesis in skeletal muscle. Curcumin have been 
investigated can increase mitochondrial biogenesis in brain and liver. However, 
effect curcumin treatment itself and together with endurance exercise have not 
yet elucidated. On the experiment I, we used multiple parameters to determine 
whether mitochondrial biogenesis occurring in the curcumin treatment in skeletal 
muscle including mitochondrial marker COX-IV and OXPHOS sub unit 
expression. Furthermore we also examined mitochondrial DNA copy number 
and Citrate Synthase (CS) activity. 
 
2. Mechanism Pathway How Curcumin Treatment Regulated Mitochondrial 
Biogenesis (Experiment II) 
PGC-1α has been extensively described as a master regulator of 
mitochondrial biogenesis. Two metabolic sensors, AMPK and SIRT1 have been 
described to directly affect PGC-1α activity through phosphorylation and 
deacetylation, respectively. To determine how mechanism pathway curcumin 
treatment increases mitochondrial biogenesis, we examined curcumin treatment 
on AMPK-SIRT1-PGC-1α pathway included phosphorylation AMPK, SIRT1 




Figure III-1. Content of the present study.  
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3. Effect of Curcumin Treatment on cAMP Level in Skeletal Muscle  
(Experiment III) 
In both mammalian cells and yeast, the regulation of mitochondrial 
biogenesis clearly involves the cAMP signaling pathway. In the experiment III, 
our purpose is to examine the direct target of curcumin treatment to increase 
mitochondrial biogenesis. To clarify this purpose, we examined curcumin 
treatment on cAMP level on gastrocnemius.  
 
4. Effect of Curcumin Treatment on cAMP - PKA Pathway (Experiment IV) 
Protein kinase A (PKA), also known as cAMP-dependent enzyme, is a 
well-studied, downstream effector of cAMP and is activated only in the presence 
of cAMP. To determine whether cAMP needed or involve on curcumin 
treatment induces mitochondrial biogenesis, we used PKA inhibitor (H89) to 
determine this effect. Furthermore, we examined downstream target of PKA 








It is well established that exercise training induces an increase in muscle 
mitochondria, resulting in fatigue resistance and enhanced endurance 
performance (Holloszy, 1967). One of the main adaptations of skeletal muscle to 
endurance training is an increase in oxidative capacity by stimulation of 
mitochondrial biogenesis. Oxidative phosphorylation is the main source of 
energy, in the form of ATP, during active steady state in most types of muscle 
fibres at exercise. During transition from rest to work, the increased ATP 
demand must be matched by an elevated ATP supply in order to prevent fast 
complete exhaustion of ATP, which would lead to termination of exercise and 
possibly to muscle-cell death. In subsequent steps, exercise leads to the induction 
of proteins that control the transcriptional regulation of the OXPHOS system and 
the transcription and replication of mitochondrial DNA (Canto et al., 2007). This 
present experiment we examined whether curcumin treatment itself and 
curcumin treatment together with endurance exercise increase mitochondrial 
marker COX-IV, OXPHOS subunit expression, mitochondrial DNA copy 
number and CS mitochondrial enzyme activity. Our hypothesis said that 
curcumin itself increase mitochondrial biogenesis marker and augment 






All procedures performed in the present study were approved by the Ethics 
Committee on Animal Experimentation of Kanazawa University (Protocol: AP-
10187). Ten-week-old male Wistar rats (body weight, 282–375 g) were used for 
the experiments. The animals were housed in an air-conditioned room and 
exposed to a 12-h light-dark photoperiod. A standard diet (Oriental Yeast, Tokyo, 
Japan) and water were provided ad libitum. The animals were randomly divided 
into six groups: control without eTR group, curcumin 50 mg/kg-BW/day without 
eTR, curcumin 100 mg/kg-BW/day without eTR, control with eTR group, 
curcumin 50 mg/kg-BW/day with eTR, and curcumin 100 mg/kg-BW/day with 
eTR. Low doses of curcumin (50 mg/kg-BW/day) or high doses of curcumin 
(100 mg/kg-BW/day) were dissolved in dimethyl sulfoxide (DMSO). All 
animals were intraperitoneally injected once daily for twenty-eight days with 
DMSO solution containing curcumin or the same volume of DMSO (vehicle 
alone).  
 
B. Endurance Exercise Training 
The endurance exercise training (eTR) group rats swam 2 h/day in four 30-
min bouts separated by 5 min of rest. After the first 30-min bout, a weight equal 
to 2% of body weight was tied to the body of the rats. The rats swam with the 
weight attached for the remaining three exercise bouts. All rats swam in a barrel 
filled to a depth of 50 cm. The swimming area was 190 cm
2
/rat (Kawanaka et al., 
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1985). The rats performed the above swimming protocol once a day for 24 days 
(6 days/week × 4 weeks). 
 
C. Sample Preparation 
Animals were anesthetized after one hour last endurance exercise session 
with 50 mg of pentobarbital sodium per 100 g of body weight. For biochemical 
studies, two calf muscles (m. gastrocnemius [Gas] and the m. soleus [Sol]) were 
quickly isolated; the tissues were washed in ice-cold saline, separated from the 
connective tissues and nerves, and then frozen in liquid nitrogen. Nuclear 
proteins were isolated using a modified version of the protocol established by 
Blough (Blough et al., 1999). Approximately 40 mg of muscle was homogenized 
in 500 μl of ice-cold buffer A (250 mM sucrose, 10 mM NaCl, 3 mM MgCl2, 1 
mmol/l dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride (PMSF), and 
2 μl/40 mg tissue protease inhibitor cocktail) on ice for ~30 s. The homogenate 
was then centrifuged (Centrifuge 5415R, Eppendorf, Germany) for 5 min at 500 
g at 4°C. The supernatant, representing a crude fraction, was used as the total 
tissue fraction in the immunoblots. The remaining pellet was resuspended in 500 
μl of ice-cold buffer B (50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM 
DTT, 50 mM NaF, 5 mM Na pyrophosphate, 50 mM MgCl2, 10% glycerol, 1% 
Triton X-100, 1 mM PMSF, and 2 μl/40 mg tissue protease inhibitor cocktail) 
and placed on ice for 10 min, with occasional mixing. The resuspended pellet 
was spun in a centrifuge for 5 min at 3000 g at 4°C. The supernatant, 
representing the nuclear fraction, was extracted and stored.  
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D. Western Blotting 
Western blotting analysis was performed as previously described (Furuichi 
et al, 2010). Briefly, equal protein amounts of samples were loaded onto SDS-
PAGE (SDS-polyacrylamide gel electrophoresis) gels 12.5% (COX-IV and Total 
OXPHOS) and the proteins were transferred onto a polyvinylidene difluoride 
membrane (PVDF; polyvinylidene difluoride membrane, ATTO, Japan). The 
membrane was incubated in Tris-buffered saline (TBS) buffer (150 mm NaCl, 
25 mm Tris-HCl, pH 7.4) containing 0.1% Tween-20 for 10 min at room 
temperature.  The membrane was then incubated on 4% blocking buffer on room 
temperature for 1 hour. The membrane was then incubated with mouse 
monoclonal antibody to COX-IV (1:1000 dilution, #: ab14744-GR125134-4, 
Abcam, Cambridge, England), Total OXPHOS Rodent WB antibody Cocktail 
(1:1500 dilution, #: MS604-G2830, Abcam, Cambridge, England), Mouse 
monoclonal antibody to β-actin (1:1000 dilution, #: ab8226-GR110198-3, 
Abcam, Cambridge, England), Mouse monoclonal to GAPDH (1:1000 dilution, 
#: ab8245-GR168547-1, Abcam, Cambridge, England) antibodies at 4°C for 
overnight and rinsed with TBS-T 3 times. It was then reacted with HRP (HRP; 
horseradish peroxidase-conjugated) Anti-rabbit IgG, HRP-linked Whole Ab 
donkey (Peroxidase-Linked Secondary Antibodies, GE healthcare, England) or 
Anti-mouse IgG HRP-linked Whole Ab donkey (Peroxidase-Linked Secondary 
Antibodies, GE healthcare, England) and signals were visualized by the 
enhanced chemiluminescence detection method using the ECL Plus Western 
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blotting detection system (GE Healthcare, USA). The signal intensity was 
quantified using imaging software (Image J, version 1.46, NIH, Maryland, USA).  
 
E. Mitochondrial DNA Copy Number 
Genomic DNA was extracted using a spin column. Briefly, muscle tissue 
was treated with proteinase K (20 μl)( Qiagen, Netherland), followed by addition 
of SDS (200 μl) to lyse the cells. The homogenized solution was incubated at 
56°C and 100% ethanol (200 μl) was added to precipitate the DNA. The mixture 
was applied to a QIAamp spin column, and after two washes with buffer (500 μl), 
genomic DNA was eluted with elution buffer (200 μl). The final DNA 
concentration was determined by UV spectrophotometry at 260 and 280 nm. The 
mitochondrial (mt) copy number was estimated by quantitative real-time PCR 
(ABI 7300 Real Time PCR System; Foster City, CA) from the relative amounts 
of nuclear and mtDNA. (mt:nuclear DNA) which reflects the concentration of 
mitochondria per cell in the tissue. The mt.DNA forward primer used was (5’ to 
3’) CCCTAAAACCCGCC ACATCT and the reverse primer was 
GAGCGATGGTGAGAGC TAAGGT. For nuclear DNA, the forward primer 
was CGAGTCGTCTTT CTCCTGATGAT and the reverse primer was 
TTCTGGATTCCAA TGCTTCGA. Quantification was performed in a total 
reaction volume of 20 μl containing: 2X SYBR Tli RNaseH Plus (10 μl) (Takara 
Bio, Japan) each primer (0.8 μl), 50X ROX Reference Dye II (0.4 μl) (Takara 
Bio, Japan) sample DNA (2 μl), and water (6 μl). Amplification and detection 
were performed in a 7300 real time PCR (Applied Biosystem) system. PCR was 
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initiated with 95°C denaturation followed by an enzyme activation step for 30 s 
followed by 40 cycles of 95°C denaturation for 5 s, and annealing and elongation 
for 30 s at 60°C. Samples were assayed in duplicate. Data analysis was based on 
measurement of the cycle threshold (CT), and the difference in CT values was 
used as a measure of relative abundance: CT(nDNA) −CT(mt.DNA) or ΔCT, a 
quantitative measure of the mitochondrial genome. Results were expressed as the 
copy number of mtDNA per cell, 2 × 2
−ΔCT
, which is a unitless ratio. 
 
F. Citrate Synthase Activity 
Skeletal muscle (20 mg) was homogenized on ice in 0.1 M Tris buffer 
containing 0.1% Triton X-100, pH 8.0. Citrate synthase (CS) activity was 
determined spectrophotometrically according to the method described by Srere 
(Srere, 1969). The homogenates were frozen and thawed thrice to disrupt the 
mitochondria to expose the CS and the assay was performed in a total volume of 
900 μl: 100 mM Tris buffer (pH 8.0), 1 mM 5,5-dithiobis (2-nitrobenzoate) 
(DTNB), 3 mM acetyl-CoA, 5 mM oxaloacetate (OAA), and 100 μl of muscle 
homogenate. The principle of the assay is to initiate the reaction of acetyl-CoA 
with OAA and link the release of free CoA-SH to a colorimetric reagent, DTNB. 
All measurements were performed in duplicate at 30°C and read used 
spectrophotometri (Lambda25, Perkin Elmer, USA) on 412 nm. CS activity was 
normalized to the total protein content and was expressed as micromoles per 




G.  Statistical Analysis 
Two-way analysis of variance (ANOVA) as used to assess the main effect of 
exercise (non-eTR vs. eTR groups) and curcumin (non-curcumin vs. curcumin 
groups) and the exercise x curcumin interaction. The Tukey-Kramer post-hoc 
test was used for analysis to identify of difference between low dose and high 
dose curcumin groups. All data were expressed as mean ± standard deviation 
(SD). The level of significance was established at P < 0.05. 
 
3. Result 
A. Effect of Curcumin Treatment on Body Weight Gain. 
Descriptive data for body weight are presented in Table IV-1. Two-way 
ANOVA indicated that eTR decrease weight gain compare non-eTR (F = 45.91, 
P < 0.001). Furthermore rats with curcumin treatment also decreased the weight 
gain compare non-curcumin group (F = 15.85, P < 0.001) and no interaction 
between two factor (F = 3.90, P > 0.05). Post-hoc test indicated that only high 
dose curcumin treatment significant different than DMSO (P < 0.05) These 
results indicated that curcumin additive eTR effect to reduce body weight gain. 
 
B.  Curcumin Treatment with eTR Enhances Expression of The Mitochondrial 
Markers COX-IV and OXPHOS Subunit 
Owing to the complementary effects of curcumin and eTR on AMPK 
phosphorylation, SIRT1 expression, NAD
+
/NADH ratio, and deacetylation of 
PGC-1α, we hypothesized a potentially additive or synergistic effect of the two 
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parameters on mitochondrial biogenesis. We assessed the mitochondrial content 
in skeletal muscle by measuring the expression level of cytochrome c oxidase 
subunit IV (COX-IV). Figure IV-1 and IV-2 show the change in the COX IV 
protein expression in skeletal muscle after 28 days of treatment with eTR or 
curcumin treatment. Two-way ANOVA showed significant effect for eTR in Gas 
and Sol (F = 173.03 for Gas, 150.75 for Sol, P < 0.001) and curcumin treatment 
(F = 36.94 for Gas, 20.77 for Sol, P < 0.001) and no interaction between two 
factor (n.s.). Furthermore, post-hoc test analysis indicated that both doses of 
curcumin significant different than DMSO (P < 0.05) and high dose and low 
dose were significant different (P < 0.05). The results of four representative 
oxidative phosphorylation (OXPHOS) subunits by two-way ANOVA analysis 
demonstrated that eTR upregulated the protein levels, in both Gas and Sol 
(Figure IV-3A & C, IV-4A & C, P < 0.001) but was not showed for Complex V: 
ATP synthase subunit-α (Figure IV-3B and IV-4B, n.s.). Furthermore, in both 
Gas and Sol, curcumin treatment increase Complex I subunit NDUFB8 (F = 
16.92 for Gas, 131.71 for Sol, P < 0.001) and no interaction between two factor 
(n.s.), Complex II subunit 30 kDa (F = 10.59 for Gas, 13.68 for Sol, P < 0.001) 
and no interaction between two factor (n.s.), and Complex III subunit Core 2 (F 
= 35.33 for Gas, 60.229 for Sol, P < 0.001) and no interaction between two 
factor (n.s.), whereas levels of Complex V: ATP synthase subunit-α was not 
increased in Gas and Sol (n.s.). Addition, post-hoc analysis indicated that high 
dose curcumin significant different than low dose (P < 0.05) to increase 









 Body Weight 
GROUPS Before Exercise (g)     After Exercise  
                                       28 days (g) 
DMSO       352.3 ± 9.6 399.2 ± 13.6      46.8 ± 5.8 
CD 50  341.5 ± 32.3 380.8 ± 31.2  39.3 ± 32.8 
CD 100  387.3 ± 14.2 420.2 ± 13.6 32.8 ± 5.2 
DMSO + eTR      330.1 ± 35.6 359.3 ± 35.7 29.3 ± 4.5 
CD 50 + eTR 331.2 ± 26,6 364.7 ± 26.1 33.5 ± 5.5 
CD 100 + eTR 335.8 ± 18.7 359.3 ± 13.2 21.5 ± 6.1 
 
 
Table IV-1.  Descriptive data for body weight  
Value are mean ± SD (n = 6 in each group) DMSO = control 
without endurance exercise. CD 50 = curcumin 50 mg/kg-BW/day 
in DMSO. CD 100 = curcumin 100 mg/kg-BW/day in DMSO. 
DMSO + eTR = control with endurance exercise. CD 50 = 
curcumin 50 mg/kg-BW/day in DMSO + endurance exercise. CD 
100 = curcumin 100 mg/kg-BW/day in DMSO + endurance 
exercise. Two-way ANOVA revealed main effect for eTR (P < 
0.001) and curcumin treatment (P < 0.001) no interaction between 
two factor for body weight gain after 28 day eTR and curcumin 
treatment. Post-hoc analysis revealed that compared to DMSO 
group, only high doses curcumin were showed significant 















Figure IV-1.  Effect of curcumin treatment increases COX-IV protein 
expression in gastrocnemius. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for COX-IV in Gas and no 
interaction between two factor (P > 0.05). Post-hoc analysis 
revealed that compared to DMSO group, both doses curcumin 











Figure IV-2.  Effect of curcumin treatment increases COX-IV protein 
expression in Soleus. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for COX-IV in Sol and no 
interaction between two factor (P > 0.05). Post-hoc analysis 
revealed that compared to DMSO group, both doses curcumin 






Figure IV-3.  Effect of curcumin treatment increases total OXPHOS subunits 
expression in Gastrocnemius. 
Value are mean ± SD (n = 6 in each group) DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for OXPHOS subunit Complex I, 
II and III (A, C) and no interaction between two factor (P > 0.05) 
but not in Complex V (B) in Gas. Post-hoc analysis revealed that 
compared to DMSO group, both doses curcumin increases total 




Figure IV-4.  Effect of curcumin treatment increases total OXPHOS subunits 
expression in Soleus. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for OXPHOS subunit Complex I, 
II and III (A, C) and no interaction between two factor (P > 0.05) 
but not in Complex V (B) in Sol. Post-hoc analysis revealed that 
compared to DMSO group, both doses curcumin increase total 
OXPHOS subunits I, II and III ( P < 0.05) in Sol. 
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In conclusion, these results indicated that high-dose curcumin treatment in 
conjunction with eTR increased the expression of COX-IV and OXPHOS 
subunits in skeletal muscle and curcumin and eTR were found to act additively.  
 
C. Curcumin Treatment Together with eTR enhances the Mitochondrial DNA 
Copy  Number and CS Activity 
The relative amount of mtDNA in skeletal muscle was determined by RT-
PCR. An increase in mtDNA copy number relative to nuclear DNA is one of the 
best molecular markers of mitochondrial biogenesis (Medeiros, 2008). Two way 
ANOVA demonstrated that eTR significantly increased the mtDNA copy 
number in both Gas and Sol compared to non eTR (Figure. IV-5, F = 593.82 for 
Gas, 145.94 for Sol, P < 0.001), curcumin treatment increased mtDNA copy 
number compared to that by the control only DMSO (Figure IV-5, F = 43.46 for 
Gas, 14.05 for Sol, P < 0.001) and no interaction between two factor (n.s). 
Furthermore, post-hoc test analysis indicated that both doses curcumin 
significant different than DMSO group (P < 0.05) in Gas but in Sol only high 
dose significant different than DMSO (P < 0.05). In addition,, eTR increased CS 
enzyme activity in Gas and Sol (Figure IV-6, F = 652.69 for Gas, 152.09 for Sol, 
P < 0.001) and this was observed also with curcumin treatment where the CS 
activity increased in both Gas and Sol (Figure IV-6, F = 42.34 for Gas, 38.04 for 
Sol, P < 0.001) no interaction between two factor (n.s.). Meanwhile, post-hoc 
analysis result indicated that only high dose curcumin significant different than 








Figure IV-5.  Effect of curcumin treatment increases mitochondrial DNA copy 
number in skeletal muscle. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for mitochondrial DNA copy 
number in Gas and Sol no interaction between two factor (n.s.). 
Post-hoc analysis revealed that compared to DMSO group, both 
doses curcumin increases mitochondrial copy number in Gas (P < 









Figure IV-6.  Effect of curcumin treatment increases citrate synthase (CS) 
activity in skeletal muscle. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for CS activity in Gas and Sol, no 
interaction between two factor (n.s.). Post-hoc analysis revealed 
that compared to DMSO group, high dose curcumin increases CS 




indicate that high-dose curcumin treatment and eTR additively increases the 
mitochondrial DNA copy number and CS activity in skeletal muscle. 
 
4.  Discussion 
Mitochondrial biogenesis is influenced by environmental stress such as 
exercise, caloric restriction, low temperature, oxidative stress, cell division and 
renewal and differentiation. Mitochondrial biogenesis is accompanied not only 
by variations in number, but also in size and mass. The process of mitochondrial 
biogenesis is complex and requires gene products from both the mitochondrial 
and the nuclear genomes. For example, complex IV in the respiratory chain, 
named cytochrome c oxidase complex IV subunit IV (COX-IV). It is well 
established that physical activity increases mitochondrial content (Baar et al, 
2002). These early studies in animals suggested 6-week-old rats subjected to 
exercise 5 days per week for 3 months showed an increase in skeletal muscle 
cytochrome c concentration, as well as increased activities of key mitochondrial 
enzymes and OXPHOS (oxidative phosphorylation) (Holloszy, 1967). Similar 
with this study, our result showed that 28 day swimming exercise increase 
mitochondrial marker COX-IV and total OXPHOS subunits. Previous research 
suggested that the polyphenol resveratrol combined with exercise could regulate 
mitochondria biogenesis through its antioxidant activity (Menzies et al., 2013). 
Based on that evidence, we suggested that curcumin treatment have ability to 
increase mitochondrial marker included COX-IV and total OXPHOS subunits in 
skeletal muscle.  Indeed, our result showed that curcumin treatment increase 
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COX-IV and total OXPHOS subunits and curcumin additive endurance exercise 
induces COX-IV and total OXPHOS subunits in gastrocnemius and soleus. 
Regulation of mtDNA copy number is essential for maintaining cellular energy 
requirements. High-energy requiring cells, such as muscle, require large 
quantities of ATP and maintain high numbers of mtDNA copy.
 
MtDNA 
replication and transcription are tightly coupled such that the expression of the 
mtDNA genes, and hence the generation of ATP through OXPHOS, requires 
continuous replication of mtDNA (Dickinson et al., 2013). Maximal citrate 
synthase activity (CS) is routinely used as a marker of aerobic capacity and 
mitochondrial density in skeletal muscle. Exercise training has resulted in 
increases in CS ranging from 0 to 100% (Holloszy et al., 1970). Similar with that 
evidence our result showed that endurance training and curcumin treatment 
increase mitochondrial copy number and CS activity in skeletal muscle.  
 
5.  Summary 
These results indicate that high-dose curcumin treatment and eTR additively 
increases the expression of mitochondria marker COX-IV and total OXPHOS 
subunit, the mitochondrial DNA copy number and CS activity in gastrocnemius 




V. Mechanism Pathway How Curcumin Treatment Regulated 
Mitochondrial Biogenesis 
 
1.  Purpose 
PGC-1α activity is influenced by various post-translational modifications. 
AMP-activated protein kinase phosphorylate PGC-1α, modifying its stability and 
activity (Li et al., 2011). Besides these phosphorylation sites, PGC-1α contains 
multiple distinct acetylation sites. PGC-1α deacetylation has been demonstrated 
to occur via SIRT1 in vitro as well as in vivo during exercise  induced increase 
in SIRT1 activity has been described in skeletal muscle (Gurd, 2011)  and can be 
mimicked by polyphenol resveratrol (Lagouge et al., 2006) . Recently, a reduced 
PGC-1α acetylation was described after a single session of exercise  (Canto et al., 
2009). In addition, the mechanisms underlying the interaction between PGC-1α 
deacetylation by SIRT1 and PGC-1α phosphorylation by AMPK have been 
investigated in detail (Canto et al., 2009). 
The purpose of present experiment to determine how the mechanism molecule 
pathway which involve in mitochondrial biogenesis. We examine the effect of 
curcumin treatment itself and curcumin treatment together with endurance 
exercise in both doses to phosphorylation AMPK, NAD+/NAH ratio and 
deacetylation of PGC-1α on skeletal muscle. We suggested that curcumin 
treatment increase and additively endurance exercise induces mitochondrial 




2.  Methods 
A.  Sample Preparation for Western Blotting 
Animals were anesthetized after one hour last endurance exercise session 
with 50 mg of pentobarbital sodium per 100 g of body weight. For biochemical 
studies, two calf muscles (m. gastrocnemius [Gas] and the m. soleus [Sol]) were 
quickly isolated; the tissues were washed in ice-cold saline, separated from the 
connective tissues and nerves, and then frozen in liquid nitrogen. Nuclear 
proteins were isolated using a modified version of the protocol established by 
Blough (Blough et al., 1999). Approximately 40 mg of muscle was homogenized 
in 500 μl of ice-cold buffer A (250 mM sucrose, 10 mM NaCl, 3 mM MgCl2, 1 
mmol/l dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride (PMSF), and 
2 μl/40 mg tissue protease inhibitor cocktail) on ice for ~30 s. The homogenate 
was then centrifuged (Centrifuge 5415R, Eppendorf, Germany) for 5 min at 500 
g at 4°C. The supernatant, representing a crude fraction, was used as the total 
(whole) tissue fraction in the immunoblots whereas the pellet used for nuclear 
tissue fraction. Supernatant centrifuged for 30 min at 10.000 g at 4
0
C following 
with second centrifuge for 30 min at 1.000 g at 4
0
C and used supernatant as 
cytosol fraction. The remaining pellet for nuclear fraction was resuspended in 
500 μl of ice-cold buffer B (50 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 
mM DTT, 50 mM NaF, 5 mM Na pyrophosphate, 50 mM MgCl2, 10% glycerol, 
1% Triton X-100, 1 mM PMSF, and 2 μl/40 mg tissue protease inhibitor 
cocktail) and placed on ice for 10 min, with occasional mixing. The resuspended 
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pellet was spun in a centrifuge for 5 min at 3000 g at 4°C. The supernatant, 
representing the nuclear fraction, was extracted and stored 
 
B.  Western Blotting 
Western blotting analysis was performed as previously described (Furuichi 
et al, 2010). Briefly, equal protein amounts of samples were loaded onto SDS-
PAGE (SDS-polyacrylamide gel electrophoresis) gels 10% (p-AMPKα, t-
AMPKα), 7.5% (SIRT1, PGC-1α, Acetylated-lysine) and the proteins were 
transferred onto a polyvinylidene difluoride membrane (PVDF; polyvinylidene 
difluoride membrane, ATTO, Japan). The membrane was incubated in Tris-
buffered saline (TBS) buffer (150 mm NaCl, 25 mm Tris-HCl, pH 7.4) 
containing 0.1% Tween-20 for 10 min at room temperature.  The membrane was 
then incubated on 4% blocking buffer on room temperature for 1 hour. The 
membrane was then incubated with Rabbit polyclonal antibody to Phospho-
AMPKα (Thr 172) (1:1000 dilution, #: 2535S-16, Cell Signaling Technology, 
Danvers, MA, USA), Rabbit polyclonal to AMPKα (1:1000 dilution, #: 26035-6, 
Cell Signaling Technology, Danvers, MA, USA), Rabbit polyclonal to SIRT1 
(1:1000 dilution, #: 13181-1-AP-00014457, Proteintech, Chicago, IL, USA), 
Mouse monoclonal to PGC-1α (1:500 dilution, #: KP9803-D00151286, 
Calbiochem, San Diego, CA, USA), Rabbit polyclonal to acetylated–lysine 
(1:1000 dilution, #: 94415-11, Cell Signaling Technology, Danvers, MA, USA), 
anti-β-actin (1:1000 dilution, #: ab8226-GR110198-3, Abcam, Cambridge, 
England) and Rabbit polyclonal antibody to lamin A/C (1:1000 dilution,  #: SC-
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20681-D0142, Santa Cruz Biotechnology, CA, USA) antibodies at 4°C for 
overnight and rinsed with TBS-T three times. It was then reacted with HRP 
(HRP; horseradish peroxidase-conjugated) Anti-rabbit IgG, HRP-linked Whole 
Ab donkey (Peroxidase-Linked Secondary Antibodies, GE healthcare, England) 
or Anti-mouse IgG HRP-linked Whole Ab donkey (Peroxidase-Linked 
Secondary Antibodies, GE healthcare, England) and signals were visualized by 
the enhanced chemiluminescence detection method using the ECL Plus Western 
blotting detection system (GE Healthcare, USA). The signal intensity was 
quantified using imaging software (Image J, version 1.46, USA).  
 
C.  Immunoprecipitation 
The nuclear fraction was obtained using the same procedure as western 
blotting. In this preparation, buffer D (20 mM Tris-HCl [pH 7.4], 50 mM NaCl, 
250 mM sucrose, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM DTT, 4 mg/l 
leupeptin, 50 mg/l trypsin inhibitor, 0.1 mM benzamidine, and 0.5 mM PMSF) 
was used instead of buffers A and C. The nuclear fraction of protein was divided 
into 1-ml PBS aliquots. Dynabeads (Invitrogen, CA, USA) were added to the 
samples, and the samples were subsequently incubated at 4°C for 1 h. The 
Dynabeads were collected using magnets, and normal mouse immunoglobulin G 
(nIgG; Santa Cruz, USA) was added to the supernatants and incubated at 4°C 
overnight. Samples were centrifuged at 7000 g at 4°C for 30 s, and aliquots of 
this supernatant were reacted with primary antibodies against PGC-1α and 
mouse nIgG at 4°C overnight. Dynabeads were then added and incubated at 4°C 
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for 2 h. The pellet was collected using magnets and washed with PBS. The final 
pellet from the immunoprecipitation (IP) was analyzed using SDS-PAGE and 







/NADH ratio was assessed using an NAD
+
/NADH 
assay kit (K337-100, Biovision, USA) according to the manufacturer’s 
instructions. Briefly, tissues were lysed with 400 µl of NADH/NAD extraction 
buffer by freezing/thawing. Extracts were vortexed for 10 s and centrifuged at 
16,000 g for 5 min. Supernatants containing NAD
+
 and NADH were transferred 
into a new microcentrifuge tube. To determine the concentration of NADH, the 




(tNAD) and NADH samples were mixed with an NAD cycling enzyme, which 
converts NAD
+
 to NADH at room temperature for 5 min, and incubated with an 
NADH developing agent at RT for 1 h. The amount of NADH was determined 
by the absorbance at 450 nm at spectrophotometry (Infinite 200 PRO, Tecan, 
USA). NAD
+
 concentration were calculated by subtracting the NADH 
concentration from the tNAD value. 
 
E.  Statistical Analysis 
Two-way analysis of variance (ANOVA) as used to assess the main effect of 
exercise (non-eTR vs. eTR groups) and curcumin (non-curcumin vs. curcumin 
groups) and the exercise x curcumin interaction. The Tukey-Kramer post-hoc 
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test was used for analysis to identify of difference between low dose and high 
dose curcumin groups. All data were expressed as mean ± standard deviation 
(SD). The level of significance was established at P < 0.05. 
 
3.  Result 
A.  Curcumin Treatment with eTR Increases Phosphorylation of AMPK  
In accordance with previous study reports, two way ANOVA demonstrated 
that administration of curcumin enhanced the phosphorylation of the Thr
172
 
residue of the AMPKα catalytic subunit in Gas and Sol (Figure V-1 and V-2, F = 
100.51 for Gas, 17.99 for Sol, P < 0.001). However, in both Gas and Sol, eTR 
treatment enhanced the increase in AMPK phosphorylation (Figure V-1 and V-2, 
F = 383.29 for Gas, 125.96 for Sol, P < 0.001) and no interaction between two 
factor (n.s.). Meanwhile, post-hoc analysis showed that both doses curcumin 
significant different with DMSO (Figure V-1 and V-2, P < 0.05) and low dose 
was different than high dose (P < 0.05) to increase phosphorylation AMPK in 
Gas and Sol (Figure V-1 and V-2, P < 0.05). This result suggests that curcumin 
activates AMPK phosphorylation in skeletal muscles and that the effect is in 
addition to the response to eTR. 
 
B.  Curcumin Treatment with eTR Increases NAD
+
/NADH Ratio and SIRT1 
Expression 
In accordance with this approach, two way ANOVA demonstrate that eTR 
increased the cellular NAD
+









Figure V-1.  Effect of curcumin treatment increases phosphorylation of AMPK 
(Thr 172) in gastrocnemius. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two 
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for phosphorylation of AMPK in 
Gas, no interaction between two factor (n.s.). Post-hoc analysis 
revealed that compared to DMSO group, both doses curcumin 










Figure V-2.  Effect of curcumin treatment increases phosphorylation of AMPK 
(Thr 172) in soleus. 
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two 
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for phosphorylation of AMPK in 
Sol, no interaction between two factor (n.s.). Post-hoc analysis 
revealed that compared to DMSO group, both doses curcumin 




= 243.73 for Gas, 587.07 for Sol, P < 0.001). Furthermore, curcumin treatment 
increased the cellular NAD
+
/NADH ratio in Gas and Sol (Figure V-3 and V-4, F 
= 39.74 for Gas, 50.97 for Sol, P < 0.001) and no interaction between two factors 
(n.s.). However, curcumin treatment increased the expression of the SIRT1 
protein only in Gas (Figure V-5, F = 14.32, P < 0.001) but was not showed in Sol 
(Figure V-6, n.s.) and eTR increased SIRT1 protein expression in both muscle 
types (Gas and Sol) (Figure V-5 and V-6, F = 75.97 for Gas, 53.65 for Sol, P < 
0.001) and no interaction between two factors (n.s.). Meanwhile, post-hoc 
analysis showed that both doses of curcumin significant different than DMSO to 
increase NAD
+
/NADH ratio in both skeletal muscle (Figure V-3 and V-4, P < 
0.05). On the other hand, only high dose curcumin showed different than DMSO 
to increase SIRT1 protein expression in Gas (Figure V-5, P < 0.05). These 
results indicate that high dose curcumin increases the expression of SIRT1 in 
skeletal muscle via an increase in the cellular NAD
+
/NADH ratio and that this is 
additive to the effect of eTR. 
 
C.  Curcumin Treatment with eTR Decrease Acetylation of PGC-1α 
We therefore examined the deacetylation of PGC-1α in skeletal muscle. As 
shown in Figure V-7 and V-8, two way ANOVA determined that curcumin 
treatment, decreased the acetylation of PGC-1α in Gas and Sol (F = 26.03, 14.09 
respectively, P < 0.001). However eTR decreased the acetylation of PGC-1α in 










Figure V-3.  Effect of curcumin treatment increases NAD
+
/NADH ratio in 
gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for NAD
+
/NADH ratio in Gas, no 
interaction between two factor (n.s.). Post-hoc analysis revealed 
that compared to DMSO group, both doses curcumin increase 
NAD
+











Figure V-4.  Effect of curcumin treatment increases NAD
+
/NADH ratio in 
soleus.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for NAD
+
/NADH ratio in Sol, no 
interaction between two factor (n.s.). Post-hoc analysis revealed 
that compared to DMSO group, both doses curcumin increase 
NAD
+













Figure V-5.  Effect of curcumin treatment increases SIRT1 expression in 
gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for SIRT1 expression in Gas, no 
interaction between two factor (n.s.). Post-hoc analysis revealed 
that compared to DMSO group, only high dose curcumin increase 










Figure V-6.  Effect of curcumin treatment increases SIRT1 expression in 
soleus.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) for SIRT1 




0.001) and no interaction between two factor (n.s.). Furthermore, post-hoc 
analysis showed that low dose and high dose curcumin significant different than 
DMSO in Gas and Sol (Figure V-7 and V-8, P < 0.05) but was not different 
between low dose and high dose treatment (n.s.). This result together indicating 
that curcumin induced PGC-1α deacetylation in skeletal muscles in an additive 
manner to the effect produced by eTR. 
 
4.  Discussion  
AMPK is a critical regulator of mitochondrial biogenesis in response to 
energy deprivation and previous studies have reported that its expression 
increases after exercise (Sakamoto et al., 2005; Stein et al., 2000). Furthermore, 
previous studies found that curcumin increases the phosphorylation of AMPK in 
skeletal muscle (Na et al., 2011). NAD
+
 and NADH, are coenzymes required for 
the generation of ATP by mitochondria. SIRT1 is dependent on NAD
+
 as a 
substrate and has therefore been proposed as a key regulator of the adaptation to 
acute and chronic exercise in the mitochondria of skeletal muscle (Gurd, 2011). 
Activation of PGC-1α is important both for the determination of mitochondrial 
content and the induction of mitochondrial biogenesis in skeletal muscle. 
Previous research has demonstrated that deacetylation of PGC-1α by SIRT1 is 
important for skeletal muscle function and the induction of mitochondrial 
biogenesis in response to exercise (Gurd, 2011). 








Figure V-7.  Effect of curcumin treatment decreases acetylation of PGC-1α in 
gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for  decrease acetylation of PGC-
1α in Gas, no interaction between two factor (n.s.). Post-hoc 
analysis revealed that compared to DMSO group, both doses 










Figure V-8.  Effect of curcumin treatment decreases acetylation of PGC-1α in 
soleus.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 
100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-
way ANOVA revealed main effect for eTR (P < 0.001) and 
curcumin treatment (P < 0.001) for  decrease acetylation of PGC-
1α in Sol, no interaction between two factor (n.s.). Post-hoc 
analysis revealed that compared to DMSO group, both doses 




indicators of insulin sensitivity and enhanced mitochondrial respiration in wild-
type mice, which requires AMPK activation and may involve SIRT1-dependent 
PGC-1α deacetylation (Li et al., 2011). Similar with previous result our result 
showed evidence that 28 day swimming exercise increase mitochondrial 
biogenesis (result of experiment I) through increase phosphorylation AMPK, 
NAD+/NADH ratio, SIRT1 expression and deacetylation of PGC-1α (result of 
experiment II) in skeletal muscle.  
It has been reported that feeding mice polyphenol resveratrol activates 
AMPK and SIRT1 in skeletal muscle leading to deacetylation and activation of 
PGC-1α, increased mitochondrial biogenesis, and improved running endurance 
(Lagouge et al., 2006). Based on that study, we suggested that polyphenol 
curcumin capable induces mitochondrial biogenesis through AMPK-SIRT1-
PGC1α pathway. Indeed, our result showed that curcumin additively endurance 
exercise induces phosphorylation AMPK, NAD+/NADH ratio, SIRT1 
expression and deacetylation of PGC-1α. 
 
5.  Summary 
This result suggests that curcumin activates AMPK phosphorylation in 
skeletal muscles and that the effect is in addition to the response to eTR. 
Furthermore, these results also indicate that curcumin increases the expression of 
SIRT1 in skeletal muscles via an increase in the cellular NAD
+
/NADH ratio and 
that this is additive to the effect of eTR. Parallel with above result this present 
result indicating that curcumin induced PGC-1α deacetylation in skeletal muscles 
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in an additive manner to the effect produced by eTR alone. This result together 
suggested that curcumin treatment additively endurance exercise to induce 




VI. Effect of Curcumin Treatment on cAMP Level in skeletal muscle 
(Experiment III) 
 
1.  Purpose 
The result of previous experiments (I and II) have showed evidence that 
curcumin itself increase and additively endurance exercise induces mitochondrial 
biogenesis through AMPK-SIRT1-PGC-1α pathway in rat skeletal muscle. 
However, the direct target of curcumin to increase mitochondrial biogenesis 
remains unknown. In both mammalian cells and yeast, the regulation of 
mitochondrial biogenesis clearly involves the cAMP signaling pathway. Indeed, 
it has been shown that treatment of human preadipocytes with forskolin, which 
leads to an overactivation of the cAMP pathway, increased the copy number of 
mitochondrial DNA  (Bogacka et al., 2005). Furthermore, cAMP will quickly 
hydrolyze to 5’AMP by enzyme Phosphodiesterase (PDE). Previous studies have 
provided evidence that exercise, including swimming and running increase 
cAMP levels in skeletal muscle and myocardium (Palmer, 1988) and the 
mitochondrial biogenesis seen after exercise may be attributable to this increase. 
The purpose of this present experiment to determine whether curcumin 
treatment have ability to increase cAMP which involve in regulated 
mitochondrial biogenesis manner examine curcumin treatment to cAMP level in 
m. gastrocnemius. Our hypothesis said that curcumin treatment increases cAMP 





2.  Methods 
A.  Animals and Exercise Training 
Ten-week-old male Wistar rats (body weight, 282–375 g) were used for the 
experiments. The animals were randomly divided into 4 groups (six rats every 
groups):  control without eTR group, curcumin 100 mg/kg-BW/day without eTR, 
control with eTR group, and curcumin 100 mg/kg-BW/day with eTR. All 
animals were intraperitoneally injected once daily for three days with DMSO 
solution containing curcumin or the same volume of DMSO (vehicle alone).  
The exercise training group rats swam 2 h/day in four 30-min bouts 
separated by 5 min of rest. After the first 30-min bout, a weight equal to 2% of 
body weight was tied to the body of the rats. The rats swam with the weight 
attached for the remaining three exercise bouts. All rats swam in a barrel filled to 
a depth of 50 cm. The swimming area was 190 cm
2
/rat (Kawanaka et al., 1985). 
The rats performed the above swimming protocol once a day for three days. 
 
B.  cAMP Direct Immunoassay Kit 
Levels of cAMP in cell extracts were measured with the cAMP Direct 
Immunoassay Kit (ab65355, Abcam, UK) following the manufacturer's 
instructions. Briefly, add 50 μl of the acetylated Standard cAMP and test samples 
from to the Protein G coated 96-well plate. This step following add 10 μl of the 
reconstituted cAMP antibody per well to the standard cAMP and sample wells 
except the well with 0_B pmol cAMP for background reading). Incubate for 1 
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hour at room temperature with gentle agitation.Wash 5 times with 200 μl 1X 
Assay Buffer each wash.Completely empty the wells by tapping the plateon a 
new papertowel after each wash. After making sure there is no liquid left behind, 
add 100 μl of HRP developer and develop for 1 hour at room temperature with 
agitation. Finally, stop the reaction by adding 100 μl of 1M HCl (not provided) 
to each well (sample color should change from blue to yellow) and read the plate 
at OD 450 nm by spectrophotometry (Infinite 200 PRO, Tecan, USA). 
 
C.  Statistical Analysis 
Two-way analysis of variance (ANOVA) as used to assess the main effect of 
exercise (non-eTR vs. eTR groups) and curcumin (non-curcumin vs. curcumin 
groups) and the exercise x curcumin interaction. The Tukey-Kramer post-hoc 
test was used for analysis to identify of difference between low dose and high 
dose curcumin groups. All data were expressed as mean ± standard deviation 
(SD). The level of significance was established at P < 0.05. 
 
3.  Result 
A.  Curcumin Treatment and Exercise Increases cAMP level  
We therefore hypothesized that curcumin by itself and in combination with 
exercise, would increase the levels of cAMP in skeletal muscle. Curcumin 
indeed increased cAMP levels (Figure. VI-1, F = 81.78 P < 0.001). Furthermore, 












Figure VI-1.  Effect of curcumin treatment increases cAMP level in 
gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
100 = curcumin 100 mg/kg-BW/day in DMSO. Ex = exercise. 
Two-way ANOVA revealed main effect for exercise (P < 0.001) 
and curcumin treatment (P < 0.001) for cAMP level in Gas, no 
interaction between two factor (n.s.). Post-hoc analysis revealed 
that compared to DMSO group, curcumin increase cAMP level in 







F = 211.26, P < 0.001) and no interaction between two factor (F = 0.29, P > 
0.05).  
 
4.  Discussion  
In both mammalian cells and yeast, the regulation of mitochondrial 
biogenesis clearly involves the cAMP (cyclic adenosine monophosphate) 
signaling pathway. Indeed, it has been shown that treatment of human 
preadipocytes with forskolin, which leads to an overactivation of the cAMP 
pathway, increased mitochondrial DNA copy number (Bogacka et al., 2005). 
The cAMP generated by adenylyl cyclases is tightly regulated by 
phosphodiesterases (PDE), which catabolize cAMP into 5′ AMP. It is well 
known that exercise increases the levels of cAMP (Ohyama et al, 2015) and 
curcumin has also been reported to have this effect as measured by inhibition of 
endothelial cell phosphodiesterase (PDE) (Abusnina et al, 2009). Our result 
showed that curcumin treatment (100 mg/kg-BW/day) increases cAMP level on 
gastrocnemius and when curcumin combined with exercise it seem look like that 
curcumin additively exercise effect to induce cAMP level in skeletal muscle.  
  
5. Summary 
This result suggested that curcumin treatment have ability to increase cAMP 




VII. Effect of Curcumin Treatment on cAMP – PKA pathway 
 
1.  Purpose 
Protein kinase  A (PKA), a well-studied cAMP downstream effector is also 
known as cAMP-dependent enzyme because it gets activated only if cAMP is 
present. Once PKA is activated, it phosphorylates a number of other proteins 
including cAMP response element binding protein (CREB) (Than et al., 2011) 
and liver kinase B1 (LKB1) (Veeranki et al., 2011) which induction PGC-1α to 
regulated mitochondria biogenesis. Previous study showed that PKA inhibitor 
(H89) inhibited mitochondrial biogenesis in brain which indicated that PKA-
CREB plays a critical role in mitochondrial biogenesis in brain (Sheng et al., 
2012). 
The purpose of this present experiment to examine the downstream target of 
PKA included phosphorylation CREB and LKB-1 to determine whether cAMP 
needed in curcumin treatment induces mitochondrial biogenesis in skeletal 
muscle by used PKA inhibitor (H89). Our hypothesis suggested that curcumin 
increase the downstream target of PKA included phosphorylation CREB and 
LKB-1 and PKA inhibitor (H89) abolished this effect. 
 
2.  Methods 
A.  Animals 
Ten-week-old male Wistar rats (body weight, 282–375 g) were used for the 
experiments. The animals were randomly divided into 6 groups: control 
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(DSMSO only) without exercise group, curcumin 100 mg/kg-BW/day without 
exercise, H89 (PKA inhibitor) 20 mg/kg-BW/ day without exercise, H89 + 
curcumin 100 mg/kg-BW/day without exercise, control (DMSO only) with 
exercise group, and curcumin 100 mg/kg-BW/day with exercise, H89 (PKA 
inhibitor) 20 mg/kg-BW/ day with exercise, H89 + curcumin 100 mg/kg-BW/day 
with exercise. All animals were intraperitoneally injected once daily for three 
days with DMSO solution containing curcumin, H89 or the same volume of 
DMSO (vehicle alone). Meanwhile, Exercise training protocol same with 
previous methods in this present study. 
 
B.  Western Blotting 
Western blotting analysis was performed as previously described (Furuichi 
et al, 2010). Briefly, equal protein amounts of samples were loaded onto SDS-
PAGE (SDS-polyacrylamide gel electrophoresis) gels 10% (p-LKB-1, t-LKB-1, 
p-CREB, t-CREB) and the proteins were transferred onto a polyvinylidene 
difluoride membrane (PVDF; polyvinylidene difluoride membrane, ATTO, 
Japan). The membrane was incubated in Tris-buffered saline (TBS) buffer 
(150 mm NaCl, 25 mm Tris-HCl, pH 7.4) containing 0.1% Tween-20 for 10 min 
at room temperature.  The membrane was then incubated on 4% blocking buffer 
on room temperature for 1 hour. The membrane was then incubated with Rabbit 
polyclonal to Phospho LKB-1 (S 428) (1:500 dilution, #: ab63473-GR91843-2, 
Abcam, Cambridge, England), Rabbit polyclonal to LKB-1 (1:500 dilution, #: 
ab58786-GR146310-3, Abcam, Cambridge, England), Mouse monoclonal to 
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CREB (Phospho S133) (1:500 dilution, #: ab173780-GR316230-2, Abcam, 
Cambridge, England), Rabbit polyclonal to CREB + CREM (1:500 dilution, #: 
ab5803-GR156230-3, Abcam, Cambridge, England), Mouse monoclonal 
antibody to β-actin (1:1000 dilution, #: ab8226-GR110198-3, Abcam, 
Cambridge, England), Mouse monoclonal to GAPDH (1:1000 dilution, #: 
ab8245-GR168547-1, Abcam, Cambridge, England), and Rabbit polyclonal 
antibody to lamin A/C (1:1000 dilution,  #: SC-20681-D0142, Santa Cruz 
Biotechnology, CA, USA) antibodies at 4°C for overnight and rinsed with TBS-
T three times. It was then reacted with HRP (HRP; horseradish peroxidase-
conjugated) Anti-rabbit IgG, HRP-linked Whole Ab donkey (Peroxidase-Linked 
Secondary Antibodies, GE healthcare, England) or Anti-mouse IgG HRP-linked 
Whole Ab donkey (Peroxidase-Linked Secondary Antibodies, GE healthcare, 
England) and signals were visualized by the enhanced chemiluminescence 
detection method using the ECL Plus Western blotting detection system (GE 
Healthcare, USA). The signal intensity was quantified using imaging software 
(Image J, version 1.46, USA). 
 
C.   Immunoprecipitation 
The nuclear fraction was obtained using the same procedure as western 
blotting. In this preparation, buffer D (20 mM Tris-HCl [pH 7.4], 50 mM NaCl, 
250 mM sucrose, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM DTT, 4 mg/l 
leupeptin, 50 mg/l trypsin inhibitor, 0.1 mM benzamidine, and 0.5 mM PMSF) 
was used instead of buffers A and C. The nuclear fraction of protein was divided 
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into 1-ml PBS aliquots. Dynabeads (Invitrogen, CA, USA) were added to the 
samples, and the samples were subsequently incubated at 4°C for 1 h. The 
Dynabeads were collected using magnets, and normal mouse immunoglobulin G 
(nIgG; Santa Cruz, USA) was added to the supernatants and incubated at 4°C 
overnight. Samples were centrifuged at 7000 g at 4°C for 30 s, and aliquots of 
this supernatant were reacted with primary antibodies against PGC-1α and 
mouse nIgG at 4°C overnight. Dynabeads were then added and incubated at 4°C 
for 2 h. The pellet was collected using magnets and washed with PBS. The final 
pellet from the immunoprecipitation (IP) was analyzed using SDS-PAGE and 
immunoblotting with western blotting method. 
 
D.  Statistical Analysis 
All data were expressed as mean ± standard deviation (SD). Variables 
among groups were compared using one-way ANOVA, and a Tukey-Kramer 
post-hoc test was performed if the ANOVA indicated a significant difference. 
The level of significance was established at P < 0.05. 
 
3.  Result 
A.  Curcumin Treatment and Exercise Increase Phosphorylation LKB-1   
We determined the downstream target proteins of cAMP-dependent protein 
kinase (PKA) by using the PKA inhibitor H89. Our results showed that curcumin 
increased the phosphorylation of LKB-1 in group without exercise in Gas 
(Figure VII-1, 1,6 ± 0.85  for curcumin without exercise vs. 1.0 ± 0.26 for 
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DMSO without exercise, P < 0.05) and H89 abolished this effect (Figure VII-1, 
0.78 ± 0.2, P < 0.05). Furthermore, curcumin augments exercise effect to 
increases phosphorylation of LKB-1 in Gas (Figure VII-1, 2.85 ± 0.22 for 
curcumin with exercise vs. 2.39 ± 0.45 for DMSO with exercise, P < 0.05) and 
H89 abolished this effect (Figure VII-1, 1.17 ± 0.54, P < 0.05). These results 
suggested that curcumin increases the phosphorylation of LKB1 in skeletal 
muscle in addition to the effect of exercise.  
 
B.  Curcumin Treatment and Exercise Increase Phosphorylation of CREB 
In order to determine the parallel downstream target proteins of cAMP-
dependent protein kinase (PKA). We examine effect curcumin and exercise to 
increase phosphorylation of cAMP response element binding protein (CREB) by 
using the PKA inhibitor H89. Our results showed that curcumin increased the 
phosphorylation of CREB in group without exercise in Gas (Figure VII-2, 1.37 ± 
0.91  for curcumin without exercise vs. 1.0 ± 0.13 for DMSO without exercise, P 
< 0.05) and H89 abolished this effect (Figure VII-2, 0.44 ± 0.7, P < 0.05). 
Furthermore, curcumin augments exercise effect to increase phosphorylation of 
CREB in Gas (Figure VII-2, 2.11 ± 0.22 for curcumin with exercise vs. 1.76 ± 
0.67 for DMSO with exercise, P < 0.05) and H89 abolished this effect (Figure 









Figure VII-1.  Effect of curcumin treatment increases phosphorylation of LKB-1 
(Ser 428) in Gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
100 = curcumin 100 mg/kg-BW/day in DMSO. *: significant 
difference from DMSO without exercise group (P < 0.05). #: 
significant difference from DMSO + exercise group (P < 0.05). †: 
significant different from curcumin without exercise (P < 0.05). ‡: 










Figure VII-2.  Effect of curcumin treatment increases phosphorylation of CREB 
(S-133) in Gastrocnemius.  
Value are mean ± SD (n = 6 in each group). DMSO = control. CD 
100 = curcumin 100 mg/kg-BW/day in DMSO. *: significant 
difference from DMSO without exercise group (P < 0.05). #: 
significant difference from DMSO + exercise group (P < 0.05). †: 
significant different from curcumin without exercise (P < 0.05). ‡: 









the phosphorylation  of  CREB in skeletal muscle in addition to the effect of 
exercise. 
 
C.  Curcumin Treatment and Exercise Increase Phosphorylation of AMPK, 
COX-IV protein expression and Decrease Acetylation PGC-1α 
We continuing to examine the downstream target from CREB and LKB-1 
included phosphorylation AMPK, acetylation of PGC-1α and COX-IV 
expression in order to found out effect curcumin regulated mitochondrial 
biogenesis through cAMP - PKA pathway.  Indeed, one-way ANOVA showed 
that curcumin together with exercise increases phosphorylation of AMPK in gas 
(Figure VII-3, 1.83 ± 0.24 for curcumin with exercise vs. 1.00 ± 0.94 for DMSO 
without exercise, P < 0.05) and H89 abolished this effect (Figure VII-3, 0.75 ± 
0.12, P < 0.05). Addition, curcumin together with exercise also increases COX-
IV expression (Figure VII-5, 2.4 ± 0.44 for curcumin with exercise vs. 1.00 ± 
0.92 for DMSO without exercise, P < 0.05) and H89 abolished this effect (Figure 
VII-5, 0.97 ± 0.209, P < 0.05). Whether, curcumin together with exercise 
decrease acetylation of PGC-1α in Gas (Figure VII-4, 0.41 ± 0.53 for curcumin 
with exercise vs. 1.00 ± 0.26 for DMSO without exercise, P < 0.05). 
 
4.  Discussion 
Protein kinase A (PKA), a well studied cAMP downstream effector is also 
known as cAMP-dependent enzyme because it gets activated only if cAMP is 






Figure VII-3.  Effect of curcumin treatment increases phosphorylation of AMPK 
(Thr-172) in gastrocnemius.  
Value are mean ± SD ( n= 6 in each group). DMSO = control 
without exercise. CD 100 = curcumin 100 mg/kg-BW/day in 
DMSO. *: significant difference from DMSO without exercise 
group (P < 0.05). #: significant difference from DMSO + exercise 
group (P < 0.05). †: significant different from curcumin without 











Figure VII-4.  Effect of curcumin treatment decreases acetylation of PGC-1α in 
gastrocnemius.  
Value are mean ± SD ( n= 6 in each group). DMSO = control 
without exercise. CD 100 = curcumin 100 mg/kg-BW/day in 
DMSO. *: significant difference from DMSO without exercise 











Figure VII-5.  Effect of curcumin treatment increases COX-IV protein 
expression in gastrocnemius.  
Value are mean ± SD ( n= 6 in each group). DMSO = control 
without exercise. CD 100 = curcumin 100 mg/kg-BW/day in 
DMSO. *: significant difference from DMSO without exercise 
group (P < 0.05). #: significant difference from DMSO + exercise 
group (P < 0.05). †: significant different from curcumin without 










including cAMP response element binding protein (CREB) and liver kinase B1 
(LKB-1) which induction PGC-1α to regulated mitochondria biogenesis  (Than 
et al, 2011 and Veeranki et al, 2011). Previous study shown evidence that 
exercise included swimming and running increased cAMP on skeletal muscle 
and myocardium (Palmer, 1988). This evidence together strong suggested that 
exercise increased mitochondrial biogenesis through its ability to increase cAMP. 
Our result showed evidence that curcumin together with exercise increase 
phosphorylation LKB-1 and CREB. On the other hands, H89 abolished this 
effect. This result together indicates that cAMP is needed to regulate 
mitochondrial biogenesis in skeletal muscle and is in accordance with the results 
of a previous study, which showed that curcumin increased the phosphorylation 
of CREB in the brain (Nam et al., 2014) and of LKB-1 in skeletal muscle (Na et 
al., 2011). We continuing to examine downstream target from CREB and LKB-1 
included phosphorylation of AMPK, acetylation of PGC-1α and COX-IV 
expression and indeed exercise and curcumin increase phosphorylation of 
AMPK, COX-IV expression and decrease acetylation of PGC-1α and H89 seem 
look like abolished this effect. Previous study showed evidence that LKB-1 
induces phosphorylation of AMPK in skeletal muscle (Na et al., 2011) and 
following by induces PGC-1α to regulated mitochondria biogenesis. On the other 
hand, previous study has showed that CREB induces mitochondrial biogenesis 





5.  Summary 
These results suggest that curcumin increases the levels of cAMP as well as 
the phosphorylation of LKB-1, CREB, AMPK in skeletal muscle in addition to 
the effect of exercise.   
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VIII. Overall Discussion 
 
The physiological significance of mitochondrial biogenesis is enhancement 
of cellular oxidative phosphorylation, which improves the endurance of the 
organism. Pathways that regulate mitochondrial biogenesis have recently 
emerged as potential metabolic targets. Previous studies presented evidence that 
curcumin could induce mitochondrial biogenesis in the liver and brain (Kuo et al., 
2012a; Liu et al., 2014).  
 
1.   Curcumin Treatment and Endurance Exercise Increase Mitochondrial 
Marker in Skeletal Muscle 
Our data support the finding that curcumin upregulates the expression of 
mitochondrial markers COX-IV (Figure IV-1 and IV-2), and OXPHOS sub unit 
(Figure IV-3 and IV-4) as well as increases the mtDNA copy number (Figure IV-
5) and CS activity (Figure IV-6). Furthermore, we demonstrated that eTR 
increases in the expression of COX-IV (Figure IV-1 and IV-2), OXPHOS 
subunit (Figure IV-3 and IV-4), mitochondrial DNA copy number (Figure IV-5), 
and CS activity (Figure IV-6) as predicted. To our knowledge, this study is the 
first to demonstrate increased mitochondrial biogenesis in rat skeletal muscle 
stimulated by a combination of curcumin and exercise. The effect of curcumin 
appeared weaker in Sol than that in Gas and this maybe owing to differences in 
the pattern of recruitment of rat skeletal muscle during swimming (Roy et al., 
1985). In addition, a previous study concluded that PGC-1α and mitochondria 
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content the fibers differ between species and that type IIa fibers, rather than type 
I fibers, are most represented in rodent skeletal muscle (Gouspillou et al., 2014). 
Previous research suggested that the polyphenol resveratrol combined with 
exercise could regulate mitochondria biogenesis through its antioxidant activity 
(Menzies et al., 2013). In fact, the increased mitochondrial capacity stimulated 
by physical exercise was actually ROS-dependent, and ROS generated in 
muscles during exhaustive activity was the stimulus that triggered mitochondrial 
biogenesis (Viña et al., 2009). Curcumin, however, is a more powerful 
antioxidant than other polyphenols including resveratrol (Aftab et al., 2010) and 
biomedical investigations of curcumin have provided evidence for a wide range 
of molecular and cellular activities, mostly related to redox reactions and signal 
transduction (Hatcher et al., 2008). We therefore speculated that the bioactivity 
of curcumin in skeletal muscles would be superior to that of resveratrol and 
directed through the regulation of mitochondrial biogenesis. In this study, 
curcumin treatment increased the levels of markers of mitochondrial biogenesis 
in skeletal muscle  in a similar fashion to combination treatment with endurance 
training, suggesting that curcumin treatment together with exercise plays a role 
in the regulation of mitochondrial biogenesis in skeletal muscle. 
 
2.  Curcumin Treatment and Endurance Training Regulated Mitochondria 




Exercise is known to induce mitochondrial biogenesis in skeletal muscles 
and improve performance by increasing oxidative capacity (Hood., 1985; 
Williams et al., 1986) for which the enzyme AMPK serves as a metabolic sensor. 
Structurally, mammalian AMPK is a heterotrimer of three subunits: one catalytic 
(α) and two regulatory (β and γ) subunits (Cheung et al., 2000; Stapleton et al., 
1997). In skeletal muscles, exercise can elevate the cellular [AMP]/[ATP] ratio 
in cells (Chen et al., 2003), thereby activating AMPK (Hardie et al., 1998; 
Hardie et al., 2001; Zong et al., 2002), which is a critical regulator of 
mitochondrial biogenesis in response to energy deprivation (Zong et al., 2002). 
A previous study demonstrated that curcumin treatment could increase the 
phosphorylation of AMPK and alleviate insulin resistance in skeletal muscles 
(Na et al., 2011). In adipocytes of C57/BL mice fed a high-fat diet, curcumin 
was shown to increase the phosphorylation of AMPK (Ejaz et al., 2009) 
suggesting that the AMPK pathway might be a target for curcumin in regulating 
mitochondrial biogenesis in skeletal muscles. Indeed, our results demonstrated 
that high doses of curcumin induced the phosphorylation of AMPK in Gas and 
Sol (Figure 4A, B). In addition, in accordance with the results of many recent 
studies, our results confirmed that eTR increased the phosphorylation of AMPK 
in skeletal muscles and furthermore that curcumin co-treatment additive the 
effect of eTR (Figure V-1 and V-2). When the intracellular energy state changes 
because of exercise, an increase in the cellular NAD
+
 concentration and the 
resulting interaction of AMPK and SIRT1 can induce the expression of proteins 





] / [NADH] ratio (Fig . V-3 and V-4), resulting in an increase 
in SIRT1 expression (Figure V-5).  
SIRT1-mediated PGC-1α deacetylation may be essential to activate 
mitochondrial biogenesis in skeletal muscles (Price et al., 2012; Rodgers et al., 
2008). Thus, a number of studies have observed that SIRT1 levels of gene 
expression and protein increase in skeletal muscles in response to acute and 
chronic exercise, in parallel to an up-regulation of mitochondrial content. Our 
result demonstrated that curcumin treatment increased the cytosolic 
NAD
+
/NADH ratio followed by an increase in the expression of SIRT1 protein 
in the nuclear fraction in Gas (Figure V-5). Furthermore, eTR also showed 
increased the NAD
+
/NADH ratio and SIRT1 expression. In addition, some 
polyphenols, including curcumin, have also been shown to activate SIRT1 
directly or indirectly in a variety of models (Chung et al., 2010; Queen et al., 
2010). This has led to great interest in developing polyphenols to target the 
SIRT1-PGC-1α complex or related signaling pathways in order to regulate 
mitochondrial biogenesis in skeletal muscles, and mimic or potentiate the effect 
of eTR. One study has shown that the activation of SIRT1 by curcumin 
attenuates myocardial IR-induced mitochondrial oxidative damage (Yang et al., 
2013). However, the present study is the first, to our knowledge, to demonstrate 
increases in the expression of SIRT1 protein in both skeletal muscle types in 
response to curcumin treatment combined with eTR (Figure IV-5).  
PGC-1α is a coactivator, involved in activating both nuclear and 
mitochondrial transcription, resulting in mitochondrial biogenesis and the up-
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regulation of genes involved in lipid metabolism and oxidative phosphorylation 
(Benton et al., 2008; Lin et al., 2002; Wu et al., 1999). Various transcriptional 
factors including nuclear respiratory factor 1 (NRF-1) and mitochondrial 
transcription factor A (Tfam) may be involved (Kuo et al., 2012b). A previous 
study has shown that PGC-1α knockdown in skeletal muscle cells significantly 
reduced the expression of Tfam and COX-IV (Uguccioni et al., 2011). PGC-1α 
can also be regulated at the posttranslational level, for instance by acetylation 
(Rodgers et al., 2005). It has been reported that polyphenol combined with 
exercise increase deacetylation PGC-1α (Gurd, 2011). We therefore assessed the 
acetylation/deacetylation state of PGC-1α in the muscles of animals treated with 
curcumin with or without eTR. The ratio of acetylated PGC-1α to total PGC-1α 
protein in the nucleus was significantly decreased by curcumin treatment 
combined with eTR in both Gas and Sol (Figure V-7 and V-8) indicating that 
deacetylation of PGC-1α was facilitated by curcumin. Therefore, curcumin 
treatment had a significant impact on the state of PGC-1α and mitochondrial 
biogenesis when skeletal muscles were subjected to the repeated metabolic 
demands of eTR, and may have the potential to exert an additive effect together 
with eTR. 
As discussed above, deacetylation of PGC-1α by SIRT1 is thought to be an 
important step in increasing PGC-1α activity, and SIRT1 protein expression 
increased with eTR and curcumin (Figure V-5). Although the mechanisms 
presently remain unclear, nitric oxide synthase (NOS) may be involved in this 
effect. Recent studies have shown that curcumin treatment increases NOS 
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enzyme activity in rat endothelium and increases the expression of eNOS and 
nNOS genes (Abdel et al., 2012; Nisoli et al., 2005). Another candidate is 
AMPK, since endurance exercise increases AMPK activity in skeletal muscles 
(Sakamoto et al., 2005; Stein et al., 2000). The results reported here regarding 
the increase in SIRT1 expression and NAD
+
/NADH ratio in skeletal muscles 
following eTR in combination with curcumin treatment, may help explain the 
synergistic effects of the combined treatment in vivo. Our findings demonstrate 
the therapeutic potential of curcumin in the induction of mitochondrial 
biogenesis and function, which may be dependent on the presence of SIRT1 as 
well as on a cellular environment created by the continuous energy demands of 
repeated exercise. Similarly, the beneficial effects of both calorie restriction and 
the polyphenol resveratrol have been suggested to involve activation of SIRT1 
and AMPK (Boily et al., 2009; Boily et al., 2008; Um et al., 2010). Thus, there is 
a dynamic interaction between these two pathways with AMPK activating 
SIRT1, probably through an indirect increase in cellular NAD
+
 concentration 
(Canto et al., 2009). According to the above results, the present study suggests 
that the effects of phosphorylation and activation of AMPK (caused by exercise 
and curcumin treatment) trigger an increase in the cellular NAD
+
/NADH ratio, 
which activates SIRT1. In addition, AMPK also phosphorylates PGC-1α and 
primes it for subsequent deacetylation by SIRT1. The effect of AMPK and 
SIRT1 on the acetylation status of PGC-1α, and possibly other transcriptional 





Figure VIII-1.  Molecular pathways involved in the effects of exercise and 
curcumin treatment on the mitochondrial biogenesis. 
Curcumin together with exercise increases cAMP level, which 
activates PKA and increase phosphorylation CREB and LKB-1. 
Phosphorylation and activation of AMPK triggers an increase in 
the cellular NAD
+
/NADH ratio, which activates SIRT1. In 
addition, AMPK phosphorylates PGC-1α and primes it for 
subsequent deacetylation by SIRT1. The effect of AMPK and 
SIRT1 on the acetylation status of PGC-1α, and potentially of 
other transcriptional regulators, subsequently improves 
mitochondrial biogenesis. AMPK, 5' adenosine monophosphate-
activated protein kinase; ATP, adenosine triphosphate; cAMP, 
cyclic adenosine monophosphate; CREB, cAMP response 
element binding protein; eTR, endurance training; LKB-1, liver 
kinase B1; NAD, nicotinamide adenine dinucleotide; NADH, 
nicotinamide adenine dinucleotide hydrogen; PGC-1α, 
peroxisome proliferator-activated receptor gamma coactivator 1; 
PKA, protein kinase A; SIRT1, sirtuin 1. 
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Since this is the first report showing the additive effect of curcumin and eTR on 
the phosphorylation AMPK in skeletal-muscle, the precise mechanism remains 
unknown.  
3.  Curcumin Treatment and Endurance Exercise Increase cAMP Level in 
Skeletal Muscle 
cAMP is a critical, tightly regulated second messenger involved in many 
intracellular processes and degraded by PDE. cAMP activates PKA, which, in 
turn, phosphorylates CREB and LKB-1 thereby regulating mitochondrial 
biogenesis through PGC-1α. Our results indicated that curcumin and exercise 
increased the levels of cAMP in Gas (Fig 7A). This result confirms the results of 
a previous report, which demonstrated the potential of curcumin to increase 
cAMP levels (Abusnina et al., 2009; Rouse et al., 2014). Identification of cAMP 
as a target for curcumin in this present study might explain how curcumin 
mimics some aspects of exercise.  
 
4.  Curcumin Treatment and Exercise Increase Downstream Target of PKA 
To determine whether cAMP is required to regulate mitochondrial 
biogenesis, we used PKA inhibitor H89 and showed that the induced 
phosphorylation of LKB-1 and CREB (Figure VII-1 and VII-2) in Gas was 
abolished (Figure VII-1 and VII-2). This result indicates that cAMP is needed to 
regulate mitochondrial biogenesis in skeletal muscle and is in accordance with 
the results of a previous study, which showed that curcumin increased the 
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phosphorylation of CREB in the brain (Nam et al., 2014) and of LKB-1 in 
skeletal muscle (Na et al., 2011b). Activated CREB and LKB-1 have proven to 
be important regulators of the PGC-1α promoter (Fernandez-Marcos et al., 2011; 
Koh et al, 2008). The expression of PGC-1α was mediated by the activation of 
the transcription factor CREB, which requires phosphorylation by PKA to 
initiate mitochondrial biogenesis (Kelly et al., 2004) while, LKB-1 regulated 
PGC-1α through the AMPK pathway (Koh et al., 2008). Indeed, our result 
showed that curcumin and exercise increase phosphorylation AMPK, decrease 
acetylation of PGC-1α and increase mitochondrial marker COX-IV expression. 
These results suggest that the ability to increase the levels of cAMP plays an 
important role in the adaptation of mitochondrial biogenesis by curcumin either 
alone or combined with exercise (Figure VIII-1). Since this the first study to 
report on the effect of curcumin together with exercise on skeletal muscle, 
further investigation will be necessary to describe the molecular mechanisms and 
identify whether curcumin directly induces AMPK and SIRT1 to regulate 




IX.  Summary 
 
In the present study, we have investigated the mechanisms by which 
curcumin affects mitochondrial biogenesis in rats. We predicted that treatment 
with curcumin may have effects on the induction of mitochondrial biogenesis, 
and combined with endurance training (eTR), curcumin treatment addictively or 
synergistically enhances eTR-induced mitochondrial biogenesis. The primary 
purpose of the present study was to determine the effects of curcumin treatment 
combined with 24 days of eTR on regulation of mitochondrial biogenesis in 
skeletal muscles (m. gastrocnemius [Gas] and m. soleus [Sol]). The main 
findings from each experiment were as follows. 
 
1.  Effect of Curcumin Treatment on Mitochondrial Biogenesis Marker 
(Experiment I) 
These experiment indicate that high-dose curcumin treatment and eTR 
additively increases the expression of mitochondria marker COX-IV and total 
OXPHOS subunit Complex I, II and III in skeletal muscle. Addition this 
experiment also has showed evidence that endurance training and curcumin 
treatment increase the mitochondrial copy number and CS activity in 






2.  Mechanism Pathway How Curcumin Treatment Regulated 
Mitochondrial Biogenesis (Experiment II) 
This result of this experiments suggests that curcumin activates AMPK 
phosphorylation in skeletal muscles and that the effect is in addition to the 
response to eTR. Furthermore, these results also indicate that curcumin increases 
the expression of SIRT1 in skeletal muscles via an increase in the cellular 
NAD
+
/NADH ratio and that this is additive to the effect of eTR. Parallel with 
above result this present result indicating that curcumin induced PGC-1α 
deacetylation in skeletal muscles in an additive manner to the effect produced by 
eTR alone. This result together suggested that curcumin treatment additively 
endurance exercise to induce mitochondrial biogenesis through AMPK-SIRT1-
PGC-1α pathway. 
 
3.  Effect of Curcumin Treatment on cAMP Level in skeletal muscle 
(Experiment III) 
This experiment result suggested that curcumin treatment have ability to 
increase cAMP level in skeletal muscle. 
 
4.  Effect of Curcumin Treatment on cAMP-PKA Pathway (Experiment 
IV) 
These experiment results suggest that curcumin increases the levels of 
cAMP as well as the phosphorylation of LKB-1, CREB and AMPK. Addition, 
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curcumin also decrease acetylation of PGC-1 and increase COX-IV expression 






All praise, honour and glory to my Lord Jesus Christ for His richest grace and 
mercy for the accomplishment of this dissertation. I would never have been able 
to finish my dissertation without the guidance of my supervisor, help from 
friends, and support from my wife Evi Hadiany Isnaneningsih and my children 
(Darryl and Ranviel). 
Over three years I have received support and encouragement from a great 
number of individuals. Prof. Kazumi MASUDA has been a mentor, colleague, 
and friend. His guidance has made this a thoughtful and rewarding journey. I 
would like to thank my collaborators Tatsuya Yamada, Ph.D, Rie Ishizawa, Ph.D, 
Yoko Saito, Ph.D for their support over the past two years as I moved from an 
idea to a completed study. In addition, all member of Kazumi Masuda laboratory  
for always supporting and encouraging me. Special thank for DIKTI who give 
scholarship and give me opportunity to study abroad and get the new experience 






Abdel, A. M. T., Motawi, T., Rezq, A., Mostafa ,T., Fouad, H. H., Ahmed, H. H., 
Rashed, L., Sabry, D., Senbel, A., Al-Malki, A. and El-Shafiey, R. (2012) 
Effects of a water-soluble curcumin protein conjugate vs. pure curcumin in 
a diabetic model of erectile dysfunction. J. Sex. Med. 9: 1815-1833. 
Abusnina, A., Keravis, T. and Lugnier, C. (2009) D020 The polyphenol 
curcumin inhibits in vitro angiogenesis and cyclic nucleotide 
phosphodiesterases (PDEs) activities similarly to PDE inhibitors. Arch. 
Cardiovasc. Dis. 102, Supplement 1: S43. 
Adhihetty, P. J., Uguccioni, G., Leick, L., Hidalgo, J., Pilegaard, H. and Hood, D. 
A. (2009) The role of PGC-1alpha on mitochondrial function and apoptotic 
susceptibility in muscle. Am. J. Physiol. Cell. Physiol. 297: C217-225. 
Aftab, N. and Vieira, A. (2010) Antioxidant activities of curcumin and 
combinations of this curcuminoid with other phytochemicals. Phytother. 
Res. 24: 500-502. 
Akimoto, T., Sorg, B. S. and Yan, Z. (2004) Real-time imaging of peroxisome 
proliferator-activated receptor-γ coactivator-1α promoter activity in 
skeletal muscles of living mice, Am. J. Physiol. Cell. Physiol. 287: 790-
796. 
Alexander, A. and Walker, C. L. (2011) The role of LKB1 and AMPK in cellular 
responses to stress and damage. FEBS Letters 585: 952-957. 
Aquilano, K., Vigilanza, P., Baldelli, S., Pagliei, B., Rotilio, G. and Ciriolo, M. 
R. (2010) Peroxisome proliferator-activated receptor gamma co-activator 
1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: 
possible direct function in mitochondrial biogenesis. J. Biol. Chem. 285: 
21590-21599. 
Baar, K., Wende, A. R., Jones, T. E., Marison, M., Nolte, L. A., Chen, M., Kelly, 
D. P. and Holloszy, J.O (2002) Adaptations of skeletal muscle to exercise: 
rapid increase in the transcriptional coactivator PGC-1. Faseb J 16: 1879-
1886. 
Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., 
Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., 
Wallberg-Henriksson, H., Laville, M., Palacin, M., Vidal, H., Rivera, F., 
Brand, M. and Zorzano, A. (2003) Mitofusin-2 determines mitochondrial 
network architecture and mitochondrial metabolism. A novel regulatory 
mechanism altered in obesity. J. Biol. Chem. 278: 17190-17197. 
-115- 
 
Bai, P., Canto, C., Oudart, H., Brunyanszki, A., Cen, Y., Thomas, C., Yamamoto, 
H., Huber, A., Kiss, B., Houtkooper, R. H., Schoonjans, K., Schreiber, V., 
Sauve, A. A., Menissier-de Murcia, J. and Auwerx, J. (2011) PARP-1 
inhibition increases mitochondrial metabolism through SIRT1 activation. 
Cell. Metab. 13: 461-468. 
Baker, M. J., Frazier, A. E., Gulbis, J. M. and Ryan, M. T. (2007) Mitochondrial 
protein-import machinery: correlating structure with function. Trends. Cell. 
Biol. 17: 456-464. 
Benton, C. R., Nickerson, J. G., Lally, J., Han, X. X., Holloway, G.P., Glatz, J. 
F., Luiken, J. J., Graham,T. E., Heikkila, J. J. and Bonen, A. (2008) 
Modest PGC-1alpha overexpression in muscle in vivo is sufficient to 
increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not 
intermyofibrillar, mitochondria. J. Biol .Chem. 283: 4228-4240. 
Bereiter-Hahn, J. (1990) Behavior of mitochondria in the living cell. Int. Rev. 
Cytol. 122: 1-63. 
Bergeron, R., Ren, J. M., Cadman, K. S., Moore, I. K., Perret, P., Pypaert, M., 
Young, L. H., Semenkovich, C. F. and Shulman ,G. I. (2001) Chronic 
activation of AMP kinase results in NRF-1 activation and mitochondrial 
biogenesis. Am. J. Physiol 281: E1340-1346. 
Blough, E., Dineen, B. and Esser, K. (1999) Extraction of nuclear proteins from 
striated muscle tissue. BioTechniques 26: 202-204, 206. 
Bogacka, I., Ukropcova, B., McNeil, M., Gimble, J. M. and Smith, S. R. (2005) 
Structural and functional consequences of mitochondrial biogenesis in 
human adipocytes in vitro. J. Clin. Endocrinol. Metab. 90: 6650-6656. 
Boily, G., He, X. H., Pearce, B., Jardine, K. and McBurney, M. W. (2009) SirT1-
null mice develop tumors at normal rates but are poorly protected by 
resveratrol. Oncogene 28: 2882-2893. 
Boily, G., Seifert, E. L., Bevilacqua, L., He, X. H., Sabourin, G., Estey, C., 
Moffat, C., Crawford, S., Saliba, S., Jardine, K., Xuan, J., Evans, M., 
Harper, M. E. and McBurney, M. W. (2008) SirT1 regulates energy 
metabolism and response to caloric restriction in mice. PLoS One 3: e1759. 
Cammarota, M., Paratcha, G., Bevilaqua, L. R., Levi de Stein, M., Lopez, M., 
Pellegrino de Iraldi, A., Izquierdo, I. and Medina, J. H. (1999) Cyclic 
AMP-responsive element binding protein in brain mitochondria. J. 
Neurochem. 72: 2272-2277. 
Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., 
Elliott, P. J., Puigserver, P. and Auwerx, J. (2009) AMPK regulates energy 
-116- 
 
expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 
458: 1056-1060. 
Canto, C., Pich, S., Paz, J. C., Sanches, R., Martinez, V., Orpinell, M., Palacin, 
M., Zorzano, A. and Guma, A. (2007) Neuregulins increase mitochondrial 
oxidative capacity and insulin sensitivity in skeletal muscle cells. Diabetes 
56: 2185-2193. 
Carling, D., Zammit, V. A. and Hardie, D. G. (1987) A common bicyclic protein 
kinase cascade inactivates the regulatory enzymes of fatty acid and 
cholesterol biosynthesis. FEBS Letters 223: 217-222. 
Carter, H.N., Chen, C. C. W. and Hood, D. A. (2015) Mitochondria, Muscle 
Health, and Exercise with Advancing Age. Physiol. 30: 208-223. 
Chen, Z. P., Stephens, T. J., Murthy, S., Canny, B. J., Hargreaves, M., Witters, L. 
A., Kemp, B. E. and McConell, G. K. (2003) Effect of exercise intensity 
on skeletal muscle AMPK signaling in humans. Diabetes 52: 2205-2212. 
Cheung, P. C., Salt, I. P., Davies, S. P., Hardie, D. G. and Carling, D. (2000) 
Characterization of AMP-activated protein kinase gamma-subunit isoforms 
and their role in AMP binding. Biochem J 346: 659-669. 
Chin, E. R. (1985) Role of Ca
2+
/calmodulin-dependent kinases in skeletal muscle 
plasticity. J. Appl. Physiol. 99: 414-423. 
Chowanadisai, W., Bauerly, K. A., Tchaparian, E., Wong, A., Cortopassi, G. A. 
and Rucker, R. B. (2010) Pyrroloquinoline quinone stimulates 
mitochondrial biogenesis through cAMP response element-binding protein 
phosphorylation and increased PGC-1alpha expression. J. Biol. Chem. 285: 
142-152. 
Chung, S., Yao, H., Caito, S., Hwang, J. W., Arunachalam, G. and Rahman, I. 
(2010) Regulation of SIRT1 in cellular functions: role of polyphenols. 
Arch. Biochem.  Biophys. 501: 79-90. 
Conkright, M. D., Canettieri, G., Screaton, R., Guzman, E., Miraglia, L., 
Hogenesch, J. B. and Montminy, M. (2003) TORCs: transducers of 
regulated CREB activity. Mol. Cell. 12: 413-423. 
Corton, J. M., Gillespie, J. G., Hawley, S. A. and Hardie, D. G. (1995) 5-
aminoimidazole-4-carboxamide ribonucleoside. A specific method for 
activating AMP-activated protein kinase in intact cells? Eur. J. Biochem. 
229: 558-565. 
Dallas, C., Gerbi, A., Tenca, G., Juchaux, F. and Bernard, F. X. (2008) Lipolytic 
effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange 
-117- 
 
(SINETROL) in human body fat adipocytes. Mechanism of action by 
inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine 15: 783-792. 
Dickinson, A., Yeung, K.Y., Donoghue, J., Baker, M. J., Kelly, R. D., McKenzie.  
M., Johns,  T. G. and St. John, J. C. (2013) The regulation of mitochondrial 
DNA copy number in glioblastoma cells. Cell. Death. Differ. 20: 1644-
1653. 
Dillon, L. M., Rebelo, A. P. and Moraes, C. T. (2012) The role of PGC-1 
coactivators in aging skeletal muscle and heart. IUBMB Life 64: 231-241. 
Diviani, D., Dodge-Kafka, K. L., Li, J., Kapiloff, M. S. (2011) A-kinase 
anchoring proteins: scaffolding proteins in the heart. J. Physiol. Heart. Circ. 
Physiol. 301: 1742-1753. 
Dorta, D. J., Pigoso, A. A., Mingatto, F. E., Rodrigues, T., Prado, I. M., Helena,  
A. F., Uyemura, S. A., Santos, A. C. and Curti, C. (2005) The interaction 
of flavonoids with mitochondria: effects on energetic processes. Chem. 
Biol. Interact. 152: 67-78. 
Eckert, G. P., Schiborr, C, Hagl, S., Abdel-Kader, R., Muller, W. E., Rimbach, G. 
and Frank, J. (2013) Curcumin prevents mitochondrial dysfunction in the 
brain of the senescence-accelerated mouse-prone 8. Neurochemistry 
international 62: 595-602 
Ejaz, A., Wu, D., Kwan, P. and Meydani, M. (2009) Curcumin Inhibits 
Adipogenesis in 3T3-L1 Adipocytes and Angiogenesis and Obesity in 
C57/BL Mice. The. J. Nut. 139: 919-925. 
Fernandez-Marcos, P. J. and Auwerx, J. (2011) Regulation of PGC-1alpha, a 
nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93: 2. 
Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., Rengo, G., 
Rossi, F. and Filippelli, A. (2008) Exercise training promotes SIRT1 
activity in aged rats. Rejuvenation Res. 11: 139-150. 
Fisher, R. P. and Clayton, D. A. (1985) A transcription factor required for 
promoter recognition by human mitochondrial RNA polymerase. Accurate 
initiation at the heavy- and light-strand promoters dissected and 
reconstituted in vitro. J. Biol. Chem. 260: 11330-11338. 
Furuichi, Y., Sugiura, T., Kato, Y., Shimada, Y. and Masuda, K. (2010) OCTN2 
is associated with carnitine transport capacity of rat skeletal muscles. Acta 
Physiol. 200: 57-64. 
Garcia-Roves, P. M., Osler, M. E., Holmstrom, M. H. and Zierath, J. R. (2008) 
Gain-of-function R225Q mutation in AMP-activated protein kinase 
-118- 
 
gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal 
muscle. J. Biol. Chem. 283: 35724-35734. 
Garnier, A., Fortin, D., Zoll, J., N'Guessan, B., Mettauer, B., Lampert, E., 
Veksler, V. and Ventura-Clapier, R. (2005) Coordinated changes in 
mitochondrial function and biogenesis in healthy and diseased human 
skeletal muscle. Faseb. J. 19: 43-52. 
Gerhart-Hines, Z., Rodgers, J. T., Bare, O., Lerin, C., Kim, S. H., Mostoslavsky, 
R., Alt, F. W., Wu, Z. and Puigserver, P. (2007) Metabolic control of 
muscle mitochondrial function and fatty acid oxidation through 
SIRT1/PGC-1alpha. Embo. J. 26: 1913-1923. 
Girija, C. R., Karunakar, P., Poojari C. S., Begum, N. S. and Syed, A. A. 
Molecular Docking Studies of Curcumin Derivatives with Multiple Protein 
Targets for Procarcinogen Activating Enzyme Inhibition. 2010. J 
Proteomics Bioinform 3: 200- 203. 
Gledhill, J. R., Montgomery, M. G., Leslie, A. G. and Walker, J. E. (2007) 
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related 
polyphenols. Proc. Natl. Acad. Sci. U. S. A. 104: 13632-13637. 
Goldberg, D. M., Yan, J. and Soleas, G. J. (2003) Absorption of three wine-
related polyphenols in three different matrices by healthy subjects. Clin. 
Biochem. 36: 79-87. 
Gollnick, P. D., Armstrong, R. B., Saubert, C, W., Piehl, K. and Saltin, B. (1972) 
Enzyme activity and fiber composition in skeletal muscle of untrained and 
trained men. J. Appl. Physiol. 33: 312-319. 
Gouspillou, G., Sgarioto, N., Norris, B., Barbat-Artigas, S., Aubertin-Leheudre, 
M., Morais, J.A., Burelle, Y., Taivassalo, T. and Hepple, R. T. (2014) The 
relationship between muscle fiber type-specific PGC-1alpha content and 
mitochondrial content varies between rodent models and humans. PLoS 
One 9. 
Grubisha, O., Smith, B. C. and Denu, J. M. (2005) Small molecule regulation of 
Sir2 protein deacetylases. Febs. J. 272: 4607-4616. 
Gurd, B. J. (2011) Deacetylation of PGC-1alpha by SIRT1: importance for 
skeletal muscle function and exercise-induced mitochondrial biogenesis. 
Appl. Physiol. Nutr. Metab. 36: 589-597. 
Handschin, C., Rhee, J., Lin, J., Tarr, P. T. and Spiegelman, B. M. (2003) An 
autoregulatory loop controls peroxisome proliferator-activated receptor 
gamma coactivator 1alpha expression in muscle. Proc. Natl. Acad. Sci. U. 
S. A. 100: 7111-7116. 
-119- 
 
Hardie, D. G. (2007) AMP-activated/SNF1 protein kinases: conserved guardians 
of cellular energy. Nat. Rev. Mol. Cell. Biol. 8: 774-785. 
Hardie, D. G., Carling, D. and Carlson, M. (1998) The AMP-activated/SNF1 
protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. 
Rev. Biochem. 67: 821-855. 
Hardie, D. G. and Hawley, S. A. (2001) AMP-activated protein kinase: the 
energy charge hypothesis revisited. BioEssays 23: 1112-1119. 
Hariharan, N., Maejima, Y., Nakae, J., Paik, J., Depinho, R. A. and Sadoshima, J. 
(2010) Deacetylation of FoxO by Sirt1 Plays an Essential Role in 
Mediating Starvation-Induced Autophagy in Cardiac Myocytes. Circ. Res. 
107: 1470-1482. 
Hatcher, H., Planalp, R., Cho, J., Torti, F. M. and Torti, S. V. (2008) Curcumin: 
from ancient medicine to current clinical trials. Cell. Mol. Life. Sci. 65: 
1631-1652. 
Hawley, S. A., Boudeau, J., Reid, J. L., Mustard, K. J., Udd, L., Makela, T. P., 
Alessi, D. R. and Hardie, D. G. (2003) Complexes between the LKB1 
tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream 
kinases in the AMP-activated protein kinase cascade. J. Biol. 2: 24. 
Hodnick, W. F., Bohmont, C. W., Capps, C. and Pardini, R. S. (1987) Inhibition 
of the mitochondrial NADH-oxidase (NADH-coenzyme Q oxido-
reductase) enzyme system by flavonoids: a structure-activity study. 
Biochem. Pharmacol. 36: 2873-2874. 
Hodnick, W. F., Kung, F. S., Roettger, W. J., Bohmont, C. W. and Pardini, R. S. 
(1986) Inhibition of mitochondrial respiration and production of toxic 
oxygen radicals by flavonoids. A structure-activity study. Biochem. 
Pharmacol. 35: 2345-2357. 
Holloszy, J. O. (1967) Biochemical adaptations in muscle. Effects of exercise on 
mitochondrial oxygen uptake and respiratory enzyme activity in skeletal 
muscle. J. Biol. Chem. 242: 2278-2282. 
Holloszy, J. O. (2008) Regulation by exercise of skeletal muscle content of 
mitochondria and GLUT4. J. Physiol. Pharmacol. 59 Suppl 7: 5-18. 
Holloszy, J. O, Oscai, L. B., Don, I. J. and Molé, P. A. (1970) Mitochondrial 
citric acid cycle and related enzymes: Adaptive response to exercise. 
Biochem. Biophysic. Res. Com. 40: 1368-1373. 
Hood, D. A. (1985) Invited Review: contractile activity-induced mitochondrial 
biogenesis in skeletal muscle. J. Appl. Physiol. 90: 1137-1157. 
-120- 
 
Hood, D. A., Adhihetty, P. J., Colavecchia, M., Gordon, J. W., Irrcher, I., Joseph, 
A. M., Lowe, S. T. and Rungi, A. A. (2003) Mitochondrial biogenesis and 
the role of the protein import pathway. Med. Sci. Sports. Exerc. 35: 86-94. 
Hood, D. A., Saleem, A. (2007) Exercise-induced mitochondrial biogenesis in 
skeletal muscle. Nutr. Metab. Cardiovasc. Dis. 17: 332-337. 
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., 
Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., 
Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., 
Nakamura, T., Yamashita, S., Hanafusa, T. and Matsuzawa, Y. (2000) 
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in 
type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20: 1595-1599. 
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W, Lavu, S., Wood, 
J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B. 
and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend 
Saccharomyces cerevisiae lifespan. Nature 425: 191-196. 
Irrcher, I., Adhihetty, P. J., Sheehan, T., Joseph, A. M. and Hood, D. A. (2003) 
PPARgamma coactivator-1alpha expression during thyroid hormone- and 
contractile activity-induced mitochondrial adaptations. Am. J. Physiol. Cell. 
Physiol. 284: C1669-1677. 
Jeppesen, J., Maarbjerg, S. J., Jordy, A. B., Fritzen, A. M., Pehmoller, C., Sylow, 
L., Serup, A. K., Jessen, N., Thorsen, K., Prats, C., Qvortrup, K., Dyck, J. 
R., Hunter, R. W., Sakamoto, K., Thomson, D. M., Schjerling, P., 
Wojtaszewski, J. F., Richter, E. A. and Kiens, B. (2013) LKB1 regulates 
lipid oxidation during exercise independently of AMPK. Diabetes 62: 
1490-1499. 
Jorgensen, S. B, Treebak, J. T, Viollet, B., Schjerling, P., Vaulont, S., 
Wojtaszewski, J. F. and Richter, E. A. (2007) Role of AMPKalpha2 in 
basal, training-, and AICAR-induced GLUT4, hexokinase II, and 
mitochondrial protein expression in mouse muscle. Am. J. Physiol. 292: 
331-339,. 
Joseph, A. M., Joanisse, D. R., Baillot, R. G. and Hood, D. A. (2012) 
Mitochondrial dysregulation in the pathogenesis of diabetes: potential for 
mitochondrial biogenesis-mediated interventions. Exp. Diabetes. Res. 
2012: 642038. 
Jornayvaz, F. R. and Shulman, G. I. Regulation of mitochondrial biogenesis. 
(2010). Essays Biochem. 2010: 47:69-84. 
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., 
Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., 
-121- 
 
Bedalov, A. and Kennedy, B. K. (2005) Substrate-specific activation of 
sirtuins by resveratrol. J. Biol. Chem. 280: 17038-17045. 
Kawanaka, K., Tabata, I., Katsuta, S. and Higuchi, M. (1985) Changes in 
insulin-stimulated glucose transport and GLUT-4 protein in rat skeletal 
muscle after training. J. Appl. Physiol. 83: 2043-2047. 
Kelly, D. P. and Scarpulla, R. C. (2004) Transcriptional regulatory circuits 
controlling mitochondrial biogenesis and function. Genes. Dev. 18: 357-
368. 
Kidd, P. M. (2009) Bioavailability and activity of phytosome complexes from 
botanical polyphenols: the silymarin, curcumin, green tea, and grape seed 
extracts. Altern. Med. Rev. 14: 226-246. 
Kim, C., Xuong, N. H. and Taylor, S. S. (2005) Crystal structure of a complex 
between the catalytic and regulatory (RI alpha) subunits of PKA. Science 
307: 690-696. 
Koh, H. J., Brandauer, J. and Goodyear, L. J. (2008) LKB1 and AMPK and the 
regulation of skeletal muscle metabolism. Curr. Opin. Clin. Nutr. Metab. 
Care. 11: 227-232. 
Kuo, J. J., Chang, H. H., Tsai, T. H. and Lee, T. Y. (2012a) Curcumin 
ameliorates mitochondrial dysfunction associated with inhibition of 
gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. Int. J. 
Mol. Med. 30: 643-649. 
Kuo, J. J., Chang, H. H., Tsai, T. H. and Lee, T. Y. (2012b) Positive effect of 
curcumin on inflammation and mitochondrial dysfunction in obese mice 
with liver steatosis. Int. J. Mol. Med. 30: 673-679. 
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, 
F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., 
Puigserver, P. and Auwerx, J. (2006) Resveratrol improves mitochondrial 
function and protects against metabolic disease by activating SIRT1 and 
PGC-1alpha. Cell 127: 1109-1122. 
Larsson, N. G., Oldfors, A., Holme, E. and Clayton, D. A. (1994) Low levels of 
mitochondrial transcription factor A in mitochondrial DNA depletion. 
Biochem. Biophysc. Res. Com. 200: 1374-1381. 
Larsson, N. G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, 
M., Barsh, G. S., Clayton, D. A. (1998) Mitochondrial transcription factor 
A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. 
Genet. 18: 231-236. 
-122- 
 
Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., 
Tsokos, M., Alt, F. W. and Finkel, T. (2008) A role for the NAD-
dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. 
Acad. Sci. U. S. A. 105: 3374-3379. 
Lee, J., Kim, C. H., Simon, D. K., Aminova, L. R., Andreyev, A. Y., Kushnareva, 
Y. E., Murphy, A. N, Lonze, B. E, Kim, K. S., Ginty, D. D., Ferrante, R. J., 
Ryu, H. and Ratan, R. R. (2005) Mitochondrial cyclic AMP response 
element-binding protein (CREB) mediates mitochondrial gene expression 
and neuronal survival. J. Biol. Chem. 280: 40398-40401. 
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M. and 
Kelly, D. P. (2000) Peroxisome proliferator-activated receptor gamma 
coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 
106: 847-856. 
Leick, L., Hellsten, Y., Fentz, J., Lyngby, S. S., Wojtaszewski, J. F., Hidalgo, J. 
and Pilegaard, H. (2009) PGC-1alpha mediates exercise-induced skeletal 
muscle VEGF expression in mice. Am. J. Physiology. 297: 92-103. 
Li, L., Pan, R., Li, R., Niemann, B., Aurich, A. C., Chen, Y. and Rohrbach, S. 
(2011) Mitochondrial biogenesis and peroxisome proliferator-activated 
receptor-gamma coactivator-1alpha (PGC-1alpha) deacetylation by 
physical activity: intact adipocytokine signaling is required. Diabetes 60: 
157-167. 
Lin, J., Wu, H., Tarr, P. T., Zhang, C. Y., Wu, Z., Boss, O., Michael, L. F, 
Puigserver, P., Isotani, E., Olson, E. N., Lowell, B. B, Bassel-Duby, R. and 
Spiegelman, B. M. (2002) Transcriptional co-activator PGC-1 alpha drives 
the formation of slow-twitch muscle fibres. Nature 418: 797-801. 
Liu, L., Zhang, W., Wang, L., Li, Y., Tan, B., Lu, X., Deng, Y., Zhang, Y., Guo, 
X., Mu, J. and Yu, G. (2014) Curcumin prevents cerebral ischemia 
reperfusion injury via increase of mitochondrial biogenesis. Neurochem. 
Res. 39: 1322-1331. 
Ljubicic, V., Joseph, A. M., Saleem, A., Uguccioni, G., Collu, Marchese. M. and 
Lai, R. Y. J. (2010). Transcriptional and post-transcriptional regulation of 
mitochondrial biogenesis in skeletal muscle: Effects of exercise and aging. 
Biochimica et Biophysica Acta (BBA) - General Subjects. 1800: 223-34. 
Manach, C., Scalbert, A., Morand, C., Remesy, C. and Jimenez, L. (2004) 
Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79: 727-
747. 




Meirhaeghe, A., Crowley, V., Lenaghan, C., Lelliott, C., Green, K., Stewart, A., 
Hart, K., Schinner, S., Sethi, J. K., Yeo, G., Brand, M. D., Cortright, R. N., 
O'Rahilly, S., Montague, C. and Vidal-Puig, A. J. (2003) Characterization 
of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated 
receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem. J. 
373: 155-165. 
Menzies, K. J., Singh, K., Saleem, A. and Hood, D. A. (2013) Sirtuin 1-mediated 
effects of exercise and resveratrol on mitochondrial biogenesis. J. Biol. 
Chem. 288: 6968-6979. 
Middleton, E., Jr., Kandaswami, C. and Theoharides, T. C. (2000) The effects of 
plant flavonoids on mammalian cells: implications for inflammation, heart 
disease, and cancer. Pharmacol. Rev. 52: 673-751. 
Na, L. X., Zhang, Y. L., Li, Y., Liu, L. Y., Li, R., Kong, T. and Sun, C. H. 
(2011) Curcumin improves insulin resistance in skeletal muscle of rats. 
Nutr. Metab. Cardiovasc. Dis. 21: 526-533. 
Nam, S. M., Choi, J. H., Yoo, D. Y., Kim, W., Jung, H. Y., Kim, J. W., Yoo, M., 
Lee, S., Kim, C. J., Yoon, Y. S. and Hwang, I. K. (2014) Effects of 
curcumin (Curcuma longa) on learning and spatial memory as well as cell 
proliferation and neuroblast differentiation in adult and aged mice by 
upregulating brain-derived neurotrophic factor and CREB signaling. J. 
Med. Food. 17: 641-649. 
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., 
Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, 
R. J. and Evans, R. M. (2008) AMPK and PPARdelta agonists are exercise 
mimetics. Cell 134: 405-415. 
Nemoto, S., Fergusson, M. M. and Finkel, T. (2005) SIRT1 functionally interacts 
with the metabolic regulator and transcriptional coactivator PGC-1alpha. J. 
Biol. Chem. 280: 16456-16460. 
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., 
Bracale, R., Valerio, A., Francolini, M., Moncada, S. and Carruba, M. O. 
(2003) Mitochondrial biogenesis in mammals: the role of endogenous 
nitric oxide. Science 299: 896-899. 
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, 
S., Valerio, A., Cantoni, O., Clementi, E., Moncada, S. and Carruba, M. O. 
(2005) Calorie restriction promotes mitochondrial biogenesis by inducing 
the expression of eNOS. Science 310: 314-317. 
Ohyama, K., Nogusa, Y., Suzuki, K., Shinoda, K., Kajimura, S. and Bannai, M. 
(2015) A combination of exercise and capsinoid supplementation 
-124- 
 
additively suppresses diet-induced obesity by increasing energy 
expenditure in mice. Am. J. Physiol. Endocrinol. Metab. 308: 315-23. 
O'Neill, H. M., Holloway, G. P. and Steinberg, G. R. (2013) AMPK regulation 
of fatty acid metabolism and mitochondrial biogenesis: implications for 
obesity. Mol. Cell. Endocrinol. 366: 135-151. 
O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jorgensen, S. B., 
Schertzer, J. D., Shyroka, O., Kiens, B., Van-Denderen., B. J, Tarnopolsky., 
M. A., Kemp, B. E., Richter, E. A. and Steinberg, G. R. (2011) AMP-
activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an 
essential role for AMPK in maintaining mitochondrial content and glucose 
uptake during exercise. Proc. Natl. Acad. Sci. 108: 16092-16097. 
Palmer, W. K. (1988) Effect of exercise on cardiac cyclic AMP. Med. Sci. Sports. 
Exerc. 20: 525-530. 
Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., 
Rehmann, H., Taussig, R., Brown, A. L., Kim, M. K., Beaven, M. A., 
Burgin, A. B., Manganiello, V. and Chung, J. H. (2012) Resveratrol 
Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP 
Phosphodiesterases. Cell 148: 421-433. 
Patti, M, E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., 
Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., 
Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R. and 
Mandarino, L. J. (2003) Coordinated reduction of genes of oxidative 
metabolism in humans with insulin resistance and diabetes: Potential role 
of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 100: 8466-8471. 
Payton, F., Sandusky, P. and Alworth, W. L. (2007) NMR Study of the Solution 
Structure of Curcumin. J. Nat. Prod. 70: 143-146. 
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. and Shulman, G. I. (2004) 
Impaired mitochondrial activity in the insulin-resistant offspring of patients 
with type 2 diabetes. N. Engl. J. Med. 350: 664-671. 
Philp, A., Chen, A., Lan, D., Meyer, G. A., Murphy, A. N., Knapp, A. E., Olfert, 
IM, McCurdy, C. E, Marcotte, G. R., Hogan, M. C., Baar, K. and Schenk, 
S. (2011) Sirtuin 1 (SIRT1) deacetylase activity is not required for 
mitochondrial biogenesis or peroxisome proliferator-activated receptor-
gamma coactivator-1alpha (PGC-1alpha) deacetylation following 
endurance exercise. J. Biol. Chem. 286: 30561-30570. 
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V, Martin, M. A., North, B. 
J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., Hubbard, B. P., 
Varela, A. T., Davis, J. G., Varamini, B., Hafner, A., Moaddel, R., Rolo, 
A. P., Coppari, R., Palmeira, C. M., de Cabo, R., Baur, J. A. and Sinclair, 
-125- 
 
D. A. (2012) SIRT1 Is Required for AMPK Activation and the Beneficial 
Effects of Resveratrol on Mitochondrial Function. Cell. Metabolism. 15: 
675-690. 
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M. and Spiegelman, B. 
M. (1998) A cold-inducible coactivator of nuclear receptors linked to 
adaptive thermogenesis. Cell 92: 829-839. 
Queen, B. L. and Tollefsbol, T. O. (2010) Polyphenols and aging. Curr. Aging. 
Sci. 3: 34-42 
Revollo, J. R., Korner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., 
Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., Milbrandt, J., 
Kiess, W. and Imai, S. (2007) Nampt/PBEF/Visfatin regulates insulin 
secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 
6: 363-375. 
Rodgers, J. T., Lerin, C., Gerhart, H, Z., Puigserver, P. (2008) Metabolic 
adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS. Lett. 
582: 46-53. 
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M. and 
Puigserver, P. (2005) Nutrient control of glucose homeostasis through a 
complex of PGC-1alpha and SIRT1. Nature 434: 113-118. 
Rouse, M., Younes, A. and Egan, J. M. (2014) Resveratrol and curcumin 
enhance pancreatic beta-cell function by inhibiting phosphodiesterase 
activity. J. Endocrinol. 223: 107-117. 
Roy, R. R., Hutchison, D. L., Pierotti, D. J., Hodgson, J. A., Edgerton, V. R. 
(1985) EMG patterns of rat ankle extensors and flexors during treadmill 
locomotion and swimming. J. Appl. Physiol. 70: 2522-2529. 
Russell, A. P., Feilchenfeldt, J., Schreiber, S., Praz, M., Crettenand, A., Gobelet, 
C., Meier, C. A., Bell, D. R., Kralli, A., Giacobino, J. P. and Deriaz, O. 
(2003) Endurance training in humans leads to fiber type-specific increases 
in levels of peroxisome proliferator-activated receptor-gamma coactivator-
1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. 
Diabetes 52: 2874-2881. 
Russell, L. K., Mansfield, C. M., Lehman, J. J., Kovacs, A., Courtois, M., Saffitz, 
J. E., Medeiros, D. M., Valencik, M. L., McDonald, J. A. and Kelly, D. P. 
(2004) Cardiac-specific induction of the transcriptional coactivator 
peroxisome proliferator-activated receptor gamma coactivator-1alpha 
promotes mitochondrial biogenesis and reversible cardiomyopathy in a 
developmental stage-dependent manner. Circ. Res. 94: 525-533. 
-126- 
 
Ryu, H., Lee, J., Impey, S., Ratan, R. R. and Ferrante, R. J. (2005) Antioxidants 
modulate mitochondrial PKA and increase CREB binding to D-loop DNA 
of the mitochondrial genome in neurons. Proc. Natl. Acad. Sci. 102: 
13915-13920. 
Sack, M. N. and Finkel, T. (2012) Mitochondrial metabolism, sirtuins, and aging. 
Cold Spring Harb. Perspect. Biol. 4: a013102 
Sakamoto, K., McCarthy, A., Smith, D., Green, K. A., Grahame, H. D., 
Ashworth, A. and Alessi, D. R. (2005) Deficiency of LKB1 in skeletal 
muscle prevents AMPK activation and glucose uptake during contraction. 
Embo. J. 24: 1810-1820. 
Santos, A. C., Uyemura, S. A., Lopes, J. L., Bazon, J. N., Mingatto, F. E. and 
Curti, C. (1998) Effect of naturally occurring flavonoids on lipid 
peroxidation and membrane permeability transition in mitochondria. Free. 
Radic. Biol. Med. 24: 1455-1461. 
Scapagnini, G., Foresti, R., Calabrese, V., Giuffrida, S. A. M., Green, C. J. and 
Motterlini, R. (2002) Caffeic acid phenethyl ester and curcumin: a novel 
class of heme oxygenase-1 inducers. Mol. Pharmacol. 61: 554-561. 
Scarpulla, R. C. (2011) Metabolic control of mitochondrial biogenesis through 
the PGC-1 family regulatory network. Biochimica et Biophysica Acta. 
(BBA) - Mol. Cell. Res. 1813: 1269-1278. 
Sheng, B., Wang, X., Su, B., Lee, H. G., Casadesus, G., Perry, G. and Zhu, X. 
(2012) Impaired mitochondrial biogenesis contributes to mitochondrial 
dysfunction in Alzheimer's disease. J. Neurochem. 120: 419-429. 
Sherratt, H. S. (1991) Mitochondria: structure and function. Rev. Neurol. 147: 
417-430. 
Shetty, D., Kim, Y., Shim, H. and Snyder, J. (2014) Eliminating the Heart from 
the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs). 
Molecules 20: 249. 
Soriano, F. X., Liesa, M., Bach, D., Chan, D. C., Palacin, M. and Zorzano, A. 
(2006) Evidence for a mitochondrial regulatory pathway defined by 
peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, 
estrogen-related receptor-alpha, and mitofusin 2. Diabetes 55: 1783-1791. 
Srere, P. A. (1969) [1] Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase 
(CoA-acetylating)]. In Methods in Enzymology, John ML (ed) 13: 3-11. 
Academic Press. 
St-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B. and 
Spiegelman, B. M. (2003) Bioenergetic analysis of peroxisome 
-127- 
 
proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-
1alpha and PGC-1beta) in muscle cells. J. Biol. Chem. 278: 26597-26603. 
Stapleton, D., Woollatt, E., Mitchelhill, K. I., Nicholl, J. K., Fernandez, C. S., 
Michell, B. J., Witters, L. A., Power, D. A., Sutherland, G. R. and Kemp, B. 
E. (1997) AMP-activated protein kinase isoenzyme family: subunit 
structure and chromosomal location. FEBS. Letters 409: 452-456. 
Stein, S. C., Woods, A., Jones, N. A., Davison, M. D. and Carling, D. (2000) The 
regulation of AMP-activated protein kinase by phosphorylation. Biochem. 
J. 3: 437-443. 
Suwa, M., Nakano, H., Radak, Z. and Kumagai, S. (2008) Endurance exercise 
increases the SIRT1 and peroxisome proliferator-activated receptor γ 
coactivator-1α protein expressions in rat skeletal muscle. Metabolism 57: 
986-998. 
Tanner, C. B., Madsen, S. R., Hallowell, D. M., Goring, D. M., Moore, T. M., 
Hardman, S. E., Heninger, M. R., Atwood, D. R. and Thomson, D. M. 
(2013) Mitochondrial and performance adaptations to exercise training in 
mice lacking skeletal muscle LKB1. Am. J. Physiol. Endocrinol. 
Metab.305: 27. 
Taylor, E. B., Lamb, J. D., Hurst, R. W., Chesser, D. G., Ellingson, W. J., 
Greenwood, L. J., Porter, B. B., Herway, S. T. and Winder, W. W. (2005) 
Endurance training increases skeletal muscle LKB1 and PGC-1alpha 
protein abundance: effects of time and intensity. Am. J. Physiol. 
Endocrinol. Metab. 289: E960-968. 
Terada, S., Goto, M., Kato, M., Kawanaka, K., Shimokawa, T. and Tabata, I. 
(2002) Effects of low-intensity prolonged exercise on PGC-1 mRNA 
expression in rat epitrochlearis muscle. Biochem. Biophys. Res. Commun. 
296: 350-354. 
Than, T. A., Lou, H., Ji, C., Win, S. and Kaplowitz, N. (2011) Role of cAMP-
responsive element-binding protein (CREB)-regulated transcription 
coactivator 3 (CRTC3) in the initiation of mitochondrial biogenesis and 
stress response in liver cells. J. Biol. Chem. 286: 22047-22054. 
Uguccioni, G., Hood, D. A. (2011) The importance of PGC-1alpha in contractile 
activity-induced mitochondrial adaptations. Am J Physiology Endocrinol. 
Metab. 300: 361-371. 
Um, J. H., Park, S. J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, 
M. K., Viollet, B. and Chung, J. H. (2010) AMP-activated protein kinase-




Veeranki, S., Hwang, S. H., Sun, T., Kim, B. and Kim, L. (2011) LKB1 
regulates development and the stress response in Dictyostelium. Dev. Biol.  
360: 351-357. 
Ventura, C. R., Garnier, A. and Veksler, V. (2008) Transcriptional control of 
mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc. Res. 
79: 208-217. 
Viña, J., Gomez, C. M. C., Borras, C., Froio, T., Sanchis, G. F., Martinez, B. V. 
E. and Pallardo, F. V. (2009) Mitochondrial biogenesis in exercise and in 
ageing. Adv. Drug. Deliv. Rev. 61: 1369-1374. 
Wang, Y., Vera, L., Fischer, W. H. and Montminy, M. (2009) The CREB 
coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. 
Nature 460: 534-537. 
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M. and Moraes, C. T. 
(2009) Increased muscle PGC-1alpha expression protects from sarcopenia 
and metabolic disease during aging. Proc. Natl. Acad. Sci. 106: 20405-
20410. 
Wiesner, R. (1997) Adaptation of Mitochondrial Gene Expression to Changing 
Cellular Energy Demands. Physiol. 12: 178-184. 
Williams, R. S., Salmons, S., Newsholme, E. A., Kaufman, R. E. and Mellor, J. 
(1986) Regulation of nuclear and mitochondrial gene expression by 
contractile activity in skeletal muscle. J. Biol. Chem. 261: 376-380. 
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M. and 
Holloszy, J. O. (1985) Activation of AMP-activated protein kinase 
increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88: 
2219-2226 
Wu, H., Kanatous, S. B., Thurmond, F. A., Gallardo, T., Isotani, E., Bassel, D. 
and R., Williams, R. S. (2002) Regulation of mitochondrial biogenesis in 
skeletal muscle by CaMK. Science 296: 349-352. 
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., 
Troy, A., Cinti, S., Lowel, B., Scarpulla, R. C. and Spiegelman, B. M. 
(1999) Mechanisms controlling mitochondrial biogenesis and respiration 
through the thermogenic coactivator PGC-1. Cell 98: 115-124. 
Yang, H., Baur, J. A., Chen, A., Miller, C., Adams, J. K., Kisielewski, A., 
Howitz, K. T., Zipkin, R. E. and Sinclair, D. A. (2007) Design and 




Yang, Y., Duan, W., Lin, Y., Yi, W., Liang, Z., Yan, J., Wang, N., Deng, C., 
Zhang, S., Li, Y., Chen, W., Yu, S., Yi, D. and Jin, Z. (2013) SIRT1 
activation by curcumin pretreatment attenuates mitochondrial oxidative 
damage induced by myocardial ischemia reperfusion injury. Free. Radic. 
Biol. Med. 65: 667-679. 
Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J. and 
Shulman, G. I. (2002) AMP kinase is required for mitochondrial 
biogenesis in skeletal muscle in response to chronic energy deprivation. 
Proc. Natl. Acad. Sci. 99: 15983-15987. 
 
 Paper Reference 
 
 
(1)  Hamidie, R. D. R., Yamada, T., Ishizawa, R., Saito, Y. and Masuda, K. (2015) Curcumin 
treatment enhances the effect of exercise on mitochondrial biogenesis in skeletal muscle 
by increasing cAMP levels. Metabolism. 64: 1334-1347  
 
M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L 6 4 ( 2 0 1 5 ) 1 3 3 4 – 1 3 4 7
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
Metabolism
www.metabo l i sm jou rna l . comTranslational
Curcumin treatment enhances the effect of exercise
on mitochondrial biogenesis in skeletal muscle by
increasing cAMP levelsRonaldD. RayHamidiea,b, TatsuyaYamadaa, Rie Ishizawaa, Yoko Saitoc, KazumiMasudaa,d,⁎
a Graduate School of Natural Science and Technology, Kanazawa University, Ishikawa 920-1192, Japan
b Faculty of Sport and Health Education, Indonesia University of Education, West Java 40154, Indonesia
c Faculty of Human Sciences, Kanazawa Seiryo University, Ishikawa 920-8620, Japan
d Faculty of Human Sciences, Kanazawa University, Ishikawa 920-1192, JapanA R T I C L E I N F OAbbreviations: AMPK, 5′ adenosine monoph
CREB, cAMP response element binding protein;
deoxyribonucleic acid; eTR, endurance training
adenine dinucleotide; NADH, nicotinamide
proliferator-activated receptor gamma coactiv
GLUT4, Glucose transporter 4; NRF1/2, nuclea
ribonucleid acid; ADP, adenosine diphosphate;
species; NOS, nitric oxide synthase.
⁎ Corresponding author at: Faculty of Human
Tel.: +81 76 264 5568; fax: +81 76 234 4100.
E-mail address: masudak@staff.kanazawa
http://dx.doi.org/10.1016/j.metabol.2015.07.0
0026-0495/© 2015 Elsevier Inc. All rights resA B S T R A C TArticle history:
Received 16 December 2014
Accepted 15 July 2015Background. In response to physiologic stressors, skeletal muscle has the potential to
elicit wide variety of adaptive responses, such as biogenesis of mitochondria and clearance
of damaged mitochondria to promote healthy muscle. The polyphenol curcumin, derived
from the rhizome Curcuma longa L., is a natural antioxidant that exhibits various
pharmacological activities and therapeutic properties. However, the effect of curcumin on
the regulation of mitochondrial biogenesis in skeletal muscle remains unknown. The
present study aimed to examine the effects of combination of endurance training (eTR) and
curcumin treatment on the expression of AMPK, SIRT1, PGC-1α, and OXPHOS subunits,
mitochondrial DNA copy number, and CS activity in rat skeletal muscle. Furthermore, the
present study also examined the effect of exercise and curcumin treatment on the levels of
cAMP and downstream targets of PKA including phosphorylated CREB and LKB-1.
Methods. Ten-week-old male Wistar rats were randomly divided into non-eTR and eTR
groups. Low doses (50mg/kg-BW/day) or high doses (100mg/kg-BW/day) of curcumin dissolved
in dimethyl sulfoxide (DMSO) were injected intraperitoneally in all animals for 28 days to
investigate the effect of curcumin alone and the combined effect of curcuminwith eTR.Western
blotting (WB) and immunoprecipitation (IP) were performed to detect the presence of proteins.
Results. Our results demonstrated that combination of curcumin treatment and eTR
increased the expression of COX-IV, OXPHOS subunits, mitochondrial DNA copy number
and CS activity in the gastrocnemius (Gas) and soleus (Sol) muscles. In addition, this
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levels of cAMP and downstream target of PKA including phosphorylation CREB and LKB-1
which are involved in the regulation of mitochondrial biogenesis.
Conclusion. Taken together, these results suggest that the combination of curcumin
treatment and eTR has the potential to accelerate mitochondrial biogenesis in skeletal
muscle by increasing cAMP levels.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Skeletal muscle represents one of the largest organs in the body,
with a wide variety of adaptive responses to physiological
stressors. The biogenesis of mitochondria and the clearance of
damaged mitochondria promote healthy muscle and this
turnover can preventmetabolic imbalances, which could predis-
pose individuals to the development of obesity, diabetes,
cardiovascular disease, and accelerated aging [1,2]. Muscle
adaptation occurs in the mitochondria following exercise train-
ing. Endurance exercise training has the potential to enhance
metabolic characteristics in the skeletal muscle, including
mitochondrial biogenesis and the expression of glucose trans-
porter 4 (GLUT4) [3]. Although such adaptations have been
investigated for several decades, their underlying mechanisms
remain to be elucidated. Peroxisome proliferator-activated re-
ceptor gamma coactivator 1 alpha (PGC-1α) has been implicated
as a master regulator of mitochondrial biogenesis by interacting
with nuclear respiratory factor 1 (NRF1) and nuclear respiratory
factor 2 (NRF-2/GA-binding protein-A). Both PGC-1α and NRF-1
activate themitochondrial transcription factor A (Tfam), which is
responsible for transcribing nuclear-encoded mitochondrial
genes, as well as the transcription, translation, and repair of
proteins involved in mitochondrial DNA (mtDNA) [4,5]. The
expression levels of PGC-1α, (both mRNA and protein) increase
following acute endurance exercise [6–9] and endurance exercise
training [10,11], thus suggesting that PGC-1α is a potential
regulator of metabolic adaptations after endurance exercise.
Mammalian sirtuins, such as sirtuin 1 (SIRT1), are mem-
bers of a conserved family of NAD+-dependent deacetylases
and ADP-ribosyltransferases, which are involved in numerous
fundamental cellular processes, including gene silencing,
DNA repair, and metabolic regulation [12,13]. SIRT1 promotes
mitochondrial biogenesis via the deacetylation of PGC-1α.
Another important metabolic sensor, AMP-activated protein
kinase (AMPK), also activates PGC-1α. Both SIRT1 expression
[14] and activity [15] increase after endurance exercise. SIRT1
is also activated by acute endurance exercise [16] and it has
been proposed that AMPK activates SIRT1 indirectly by
increasing the intracellular levels of its co-substrate, NAD+.
Similar to AMPK, SIRT1 is widely associated with energy
metabolism, suggesting that activators of these enzymes
could enhance mitochondrial biogenesis and function and
thereby enhance the endurance capacity. Collectively, these
findings suggest that metabolic adaptations resulting from
endurance exercise training could result, at least in part, from
an AMPK-mediated increase in the expression of PGC-1α.
In both mammalian cells and yeast, the regulation of
mitochondrial biogenesis clearly involves the cyclic adenosine
monophosphate (cAMP) signaling pathway. Indeed, it has beenshown that treatment of human preadipocytes with forskolin,
which leads to an over-activation of the cAMP pathway,
increased the copy number of mtDNA [17]. Protein kinase A
(PKA), also known as cAMP-dependent enzyme, is a well
studied, downstream effector of cAMP and is activated only in
the presence of cAMP. Activated PKA phosphorylates a number
of other proteins including cAMP response element binding
protein (CREB) and liver kinase B1 (LKB-1), which induces PGC-
1α to regulatemitochondria biogenesis ([18,19]. Previous studies
have provided evidence that exercise, including swimming and
running increase cAMP levels in skeletal muscle and myocar-
dium [20] and the mitochondrial biogenesis seen after exercise
may be attributable to this increase.
Several polyphenols have been shown to activate cAMP, and
are currently under intense investigation as potential inducers
ofmitochondrial biogenesis [21,22]. Curcumin, a compoundwith
medicinal properties found in Curcuma longa L, and turmeric, a
popular culinary spice used in both vegetarian and non-
vegetarian foods are examples of polyphenols. The anti-oxidant
activities of curcumin have been reported to be more potent
than those of another well-studied polyphenol, resveratrol [23]
and the long-term effects of dietary curcumin on various
markers of mitochondrial biogenesis have been investigated.
Five months of curcumin as a dietary supplement in senes-
cence-accelerated mouse-prone 8 (SAMP8), a fast-aging mouse
strain, up-regulated PGC-1α protein expression thereby improv-
ing the mitochondrial membrane potential (MMP) and ATP
levels and restoring mitochondrial fusion in the brain [24]. The
effects of curcumin on the regulation of mitochondrial biogen-
esis in skeletal muscle however, have yet to be elucidated.
In the present study, we investigated the mechanisms by
which curcumin affects mitochondrial biogenesis in rats as
reflected by the levels of cAMP and downstream targets of PKA
including phosphorylated CREB and LKB-1. The primary pur-
pose of the present study was to determine the combined
effects of curcumin treatment together with 24 days of
endurance training (eTR) on the regulation of mitochondrial
biogenesis in skeletal muscles (Gas and Sol). We predicted that
treatment with curcumin combinedwith eTRmay additively or
synergistically enhance the effect of exercise. The results
showed that curcumin treatment and eTR have additive effect
on increasing mitochondrial biogenesis in skeletal muscle.2. Material and Methods
2.1. Animals Experiments
All procedures performed in the present study were approved
by the Ethics Committee on Animal Experimentation of
1336 M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L 6 4 ( 2 0 1 5 ) 1 3 3 4 – 1 3 4 7Kanazawa University (Protocol: AP-10187). Thirty six ten-
weeks-old male Wistar rats (body weight, 282–390 g) were
used (six rats in every group). The animals were housed in an
air-conditioned room and exposed to a 12-h light-dark
photoperiod. A standard diet (Oriental Yeast, Tokyo, Japan)
andwaterwereprovidedad libitum. The animalswere randomly
divided into six groups: control without eTR, curcumin
50 mg/kg-BW/day without eTR, curcumin 100 mg/kg-BW/day
without eTR, control with eTR, curcumin 50 mg/kg-BW/day
with eTR, and curcumin 100 mg/kg-BW/day with eTR. All
animals were injected intraperitoneally (I.P), once a day for
twenty-eight days with curcumin (50 or 100 mg/kg-BW/day)
dissolved in dimethyl sulfoxide (DMSO) or the same volume of
DMSO (vehicle alone). The endurance exercise training (eTR)
group rats swam2h/day in four 30-min bouts separated by 5min
of rest. After the first 30-min bout, a weight equal to 2% of body
weight was tied to the body of the rat. The rats swam with the
weight attached for the remaining three exercise bouts. All rats
swam in a barrel filled to a depth of 50 cm with a swimming
area of 190 cm2/rat [25]. The rats performed the above
swimming protocol once a day for 24 days (6 days/week × 4
weeks). For studies involving the effect of curcumin on the
levels of cAMP and PKA, ten-weeks-old male Wistar rats (n = 6
in each group) and the same swimming protocolwere used for 3
days of treatment and H89 (a PKA inhibitor) was injected I.P
(20 mg/kg-BW/day) for 3 days.
2.2. Nuclear Fraction Preparation
Animals were anesthetized with 50 mg of pentobarbital
sodium per 100 g of body weight, one hour after the last
endurance exercise session. For biochemical studies, two calf
muscles (Gas and Sol) were isolated; the tissues were washed
in ice-cold saline, separated from the connective tissues and
nerves, and then frozen rapidly in liquid nitrogen. Nuclear
proteins were isolated using a modified version of the
protocol established by Blough [26] and divided into 1-ml
PBS aliquots.
2.3. Immunoprecipitation and Western Blotting
Lysis buffer (20 mM Tris-HCl [pH 7.4], 50 mM NaCl, 250 mM
sucrose, 50 mM NaF, 5 mM sodium pyrophosphate, 1 mM
DTT, 4 mg/l leupeptin, 50 mg/l trypsin inhibitor, 0.1 mM
benzamidine, and 0.5 mM PMSF) was used for immunopre-
cipitation. Dynabeads (Invitrogen, CA, USA) were added to the
samples of nuclear proteins, and incubated at 4 °C for 1 h. The
Dynabeads were then collected using magnets, and normal
mouse immunoglobulin G (nIgG; Santa Cruz Biotechnology,
CA, USA) was added to the supernatants and incubated at 4 °C
overnight. Samples were centrifuged for 30 s × 7000×g at 4 °C,
and aliquots of this supernatant were reacted with primary
antibodies against PGC-1α and mouse nIgG at 4 °C overnight.
Dynabeads were then added and incubated at 4 °C for 2 h. The
pellets were collected using magnets and washed with PBS.
The final pellet from the immunoprecipitation (IP) was
visualized and the expression of proteins was compared by
western blotting. Western blotting analysis was performed as
previously described [27]. Briefly, equal protein amounts of
samples were loaded onto SDS-PAGE gels 7.5% (SIRT1, PGC-1α,and acetylated lysine), 10% (phospho-AMPKα, AMPKα, phospho-
CREB, CREB + CREM, phospho-LKB-1 and LKB-1), and 12.5% (COX-
IV, Total OXPHOS), and the proteins were transferred onto a
polyvinylidene fluoride (PVDF) membrane. The membrane was
then incubated in blocking buffer, and subsequentlywith PGC-1α
(1:500 dilution, #: KP9803-D00151286, Calbiochem, San Diego, CA,
USA), acetylated–lysine (1:1000 dilution, #: 94415-11, Cell Signal-
ing Technology, Danvers, MA, USA). Phospho-AMPKα (Thr 172)
(1:1000 dilution, #: 2535S-16, Cell Signaling Technology, Danvers,
MA, USA), AMPKα (1:1000 dilution, #: 26035-6, Cell Signaling
Technology, Danvers, MA, USA), SIRT1 (1:1000 dilution, #: 13181-
1-AP-00014457, Proteintech, Chicago, IL, USA), COX-IV (1:1000
dilution, #: ab14744-GR125134-4, Abcam, Cambridge, England),
Total OXPHOS (1:1500 dilution, #: MS604-G2830, Abcam,
Cambridge, England), Phospho LKB-1 (S 428) (1:500 dilution, #:
ab63473-GR91843-2, Abcam, Cambridge, England), LKB-1 (1:500
dilution, #: ab58786-GR146310-3, Abcam, Cambridge, England),
Phospho CREB (Ser 133) (1:500 dilution, #: ab173780-GR316230-2,
Abcam, Cambridge, England), CREB + CREM (1:500 dilution, #:
ab5803-GR156230-3, Abcam, Cambridge, England), anti-β-actin
(1:1000 dilution, #: ab8226-GR110198-3, Abcam, Cambridge,
England), GAPDH (1:1000 dilution, #: ab8245-GR168547-1, Abcam,
Cambridge, England), and lamin (1:1000 dilution, #: SC-20681-
D0142, Santa Cruz Biotechnology, CA, USA). The signal intensity
was quantified using imaging software (Image J, version 1.46,
NIH, Maryland, USA).
2.4. NAD+/NADH Ratio
The intracellular NAD+/NADH ratio was assessed using an
NAD+/NADH assay kit (Biovision, CA, USA) according to the
manufacturer’s instructions. The absorbance (OD450 nm) was
read 1 h after addition of the NADH developer, and the
concentration of NAD+ was calculated by subtracting the
NADH concentration from the total value of NAD.
2.5. Citrate Synthase Activity
Skeletal muscle (20 mg) was homogenized on ice in 0.1 M Tris
buffer containing 0.1% Triton X-100, pH 8.0. Citrate synthase
(CS) activity was determined spectrophotometrically accord-
ing to the method described by Srere [28]. The homogenates
were frozen and thawed three times to disrupt the mitochon-
dria to expose the CS and the assay was performed in a total
volume of 900 μl: 100 mM Tris buffer (pH 8.0), 1 mM 5,5-
dithiobis (2-nitrobenzoate) (DTNB), 3 mM acetyl-CoA, 5 mM
oxaloacetate (OAA), and 100 μl of muscle homogenate. The
principle of the assay is to initiate the reaction of acetyl-CoA
with OAA and link the release of free CoA-SH to a colorimetric
reagent, DTNB. All measurements were performed in dupli-
cate at 30 °C. CS activity was normalized to the total protein
content and was expressed as micromoles per gram protein
per minute.
2.6. Mitochondrial DNA Copy Number
Genomic DNA was extracted using a spin column. Briefly,
muscle tissue was treated with proteinase K (20 μl, Qiagen
Inc., Valencia, CA), followed by addition of SDS (200 μl) to
lysed the cells. The homogenized solution was incubated at







DMSO 352.3 ± 9.6 399.2 ± 13.6 46.8 ± 5.8
CD 50 341.5 ± 32.3 380.8 ± 31.2 39.3 ± 32.8
CD 100 387.3 ± 14.2 420.2 ± 13.6 32.8 ± 5.2
DMSO + eTR 330 ± 35.6 359.3 ± 35.7 29.3 ± 4.5
CD 50 + eTR 331.2 ± 26,6 364.7 ± 26.1 33.5 ± 5.5
CD 100 + eTR 335.8 ± 18.7 359.3 ± 13.2 21.5 ± 6.1
Value are mean ± SD (n = 6 in each group), DMSO = control without
endurance exercise. CD 50 = curcumin 50 mg/kg-BW/day in DMSO.
CD 100 = curcumin 100 mg/kg-BW/day in DMSO. DMSO + eTR =
controlwith endurance exercise. CD50= curcumin 50mg/kg-BW/day
in DMSO + endurance exercise. CD 100 = curcumin 100 mg/kg-BW/
day in DMSO + endurance exercise. Two-way ANOVA revealed main
effect for eTR (P < 0.001) and curcumin treatment (P < 0.001) with no
interaction between two factors (n.s.). Post-hoc analysis revealed
that compared to DMSO group, only high doses curcumin was
significantly decreased body weight (P < 0.05).
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DNA. The mixture was applied to a QIAamp spin column, and
after two washes with buffer (500 μl), genomic DNA was
eluted with elution buffer (200 μl). The final DNA concentra-
tion was determined by UV spectrophotometry at 260 and 280
nm. The mitochondrial (mt) copy number was estimated by
quantitative real-time PCR (ABI 7300 Real Time PCR System;
Foster City, CA) from the relative amounts of nuclear and
mtDNA. (mt:nuclear DNA) which reflects the concentration of
mitochondria per cell in the tissue. Themt.DNA forward primer
used was (5′–3′) CCCTAAAACCCGCC ACATCT and the reverse
primer was GAGCGATGGTGAGAGC TAAGGT. For nuclear DNA,
the forward primer was CGAGTCGTCTTT CTCCTGATGAT and
the reverse primer was TTCTGGATTCCAA TGCTTCGA. Quanti-
fication was performed in a total reaction volume of 20 μl
containing: 2X SYBRTli RNaseH Plus (10 μl), each primer (0.8 μl),
50X ROX Reference Dye II (0.4 μl) sample DNA (2 μl), and water
(6 μl). Amplification and detection were performed in a real
time PCR system (7300 real time PCR system, Applied
Biosystems). The PCR was initiated with 95 °C denaturation
followed by an enzyme activation step for 30 s followed by 40
cycles of 95 °C denaturation for 5 s, and annealing and
elongation for 30 s at 60 °C. Samples were assayed in duplicate.
Data analysis was based on measurement of the cycle
threshold (CT), and the difference in CT values was used as a
measure of relative abundance: CT (nDNA) – CT (mtDNA) or
ΔCT, a quantitative measure of the mitochondrial genome.
Results were expressed as the copy number of mtDNA per
cell, 2 × 2−ΔCT, which is a unitless ratio.
2.7. cAMP Level
Levels of cAMP in cell extracts were measured with the
cAMP Direct Immunoassay Kit from Abcam (ab65355),
following the manufacturer's instructions. Briefly, add
50 μl of the acetylated Standard cAMP and test samples
from to the Protein G coated 96-well plate. This step
following by added 10 μl of the reconstituted cAMP antibody
per well to the standard cAMP and sample wells. Incubate
for 1 hour at room temperature with gentle agitation. Wash
5 times with 200 μl 1X Assay Buffer each wash. Completely
empty the wells by tapping the plate on a new paper towel
after each wash. After making sure there is no liquid left
behind, add 100 μl of HRP developer and develop for 1 hour
at room temperature with agitation. Finally, stop the
reaction by adding 100 μl of 1M HCl (not provided) to each
well (sample color should change from blue to yellow) and
read the plate at OD450 nm by spectrophotometry (Infinite
200 PRO, Tecan, USA).
2.8. Statistical Analysis
Two-way analysis of variance (ANOVA) as used to assess the
main effect of exercise (non-eTR vs. eTR groups) and curcumin
(non-curcumin vs. curcumin groups) and the exercise ×
curcumin interaction. The Tukey-Kramer post-hoc test was
used for analysis to identify of difference between low dose and
high dose curcumin groups. All data were expressed asmean ±
standard deviation (SD). The level of significance was
established at P < 0.05.3. Results
3.1. Effect of Curcumin Treatment on Body Weight
Descriptive data for body weight are presented in Table 1.
Two-way ANOVA indicated that eTR decreased body weight
compared to non-eTR (F = 45.91, P < 0.001). Furthermore rats
with curcumin treatment also decreased body weight com-
pare to non-curcumin group (F = 15.85, P < 0.001) with no
interaction between two factors (F = 3.90, P > 0.05). Post-hoc
test analysis indicated that only high dose curcumin treat-
ment was significantly different than DMSO (P < 0.05). These
results indicated that curcumin and eTR have additive effect
to reducing body weight.
3.2. Curcumin Treatment with eTR Enhances Expression
of the Mitochondrial Markers COX-IV and OXPHOS Subunit
We assessed the mitochondrial content in skeletal muscle by
measuring the expression level of cytochrome c oxidase
subunit IV (COX-IV). Figs. 1A and 2A show the change in the
COX IV protein expression in skeletal muscle after 28 days of
treatment with eTR or curcumin treatment. Two-way ANOVA
showed significantly different effect for eTR in Gas and Sol
(F = 173.03 for Gas, 150.75 for Sol, P < 0.001) and curcumin
treatment (F = 36.94 for Gas, 20.77 for Sol, P < 0.001) with no
interaction between two factors (n.s.). Furthermore, post-hoc
test analysis indicated that both doses of curcumin were
significantly different than DMSO (P < 0.05) and high dose and
low dose were significantly different (P < 0.05). The results of
four representative oxidative phosphorylation (OXPHOS) sub-
units by two-way ANOVA analysis demonstrated that eTR
upregulated the protein levels, in both Gas and Sol (Figs. 1B
and C, 2B and C, P < 0.001) but was not showed for Complex V:
ATP synthase subunit-α (Figs. 1D and 2D, n.s.). Furthermore, in
both Gas and Sol, curcumin treatment increased Complex I

































eTR: P < 0.001 (non-eTR < eTR)
































































eTR: P < 0.001 (non-eTR <eTR)
CD: P < 0.001 (DMSO < CD50 < CD100)
Interaction: n.s.






































DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
Fig. 1 – COX-IV protein expression (A), OXPHOS subunits expression (B) and intensity OXPHOS subunits relative to DMSO (C
and D) in gastrocnemius.Value are mean ± SD (n = 6 in each group) DMSO = control without endurance exercise. CD 50 =
curcumin 50 mg/kg-BW/day in DMSO. CD 100 = curcumin 100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-way
ANOVA revealed the main effect for eTR (P < 0.001) and curcumin treatment (P < 0.001) for COX-IV and OXPHOS subunit
expression in Gas with no interaction between two factors (n.s.). Post-hoc analysis revealed that compared to DMSO group,
both doses of curcumin increased COX IV (A) and OXPHOS subunit Complex I, II, and III expression (B and C, P < 0.05) in Gas.
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subunit 30 kDa (F = 10.59 for Gas, 13.68 for Sol, P < 0.001) with no
interaction between two factors (n.s.), and Complex III subunit
Core 2 (F = 35.33 for Gas, 60.229 for Sol, P < 0.001) with no
interaction between two factors (n.s.), whereas levels of
Complex V: ATP synthase subunit-α was not increased in Gas
and Sol (Figs. 1D and 2D, n.s.). Additionally, post-hoc analysis
indicated that high dose curcumin was significantly different
than low dose (P < 0.05) for increasing OXPHOS subunit
Complex I, II, III and COX-IV in Gas and Sol (P < 0.05). In
conclusion, these results indicated that curcumin treatment in
conjunction with eTR increased the expression of COX-IV and
OXPHOS subunits in skeletal muscle and curcumin and eTR
were found to act additively.
3.3. Curcumin Treatment Together with eTR Enhances the
Mitochondrial DNA Copy Number and CS Activity
An increase in mtDNA copy number relative to nuclear DNA is
one of the best molecular markers of mitochondrial biogenesis[22]. Two way ANOVA demonstrated that eTR significantly
increased the mtDNA copy number in both Gas and Sol
compared to non eTR (Fig. 3A, F = 593.82 for Gas, 145.94 for Sol,
P < 0.001), curcumin treatment increased mtDNA copy number
compared to that by the control onlyDMSO (Fig. 3A, F = 43.46 for
Gas, 14.05 for Sol, P < 0.001) with no interaction between two
factors (n.s.). Furthermore, post-hoc test analysis indicated that
both doses of curcumin were significantly different than DMSO
group (P < 0.05) in Gas but in Sol only high dose significantly
different than DMSO (P < 0.05). In addition, eTR increased CS
enzyme activity in Gas and Sol (Fig. 3B, F = 652.69 for Gas, 152.09
for Sol, P < 0.001) and this was observed also with curcumin
treatment where the CS activity increased in both Gas and
Sol (Fig. 3B, F = 42.34 for Gas, 38.04 for Sol, P < 0.001) with no
interaction between two factors (n.s.). Post-hoc analysis
indicated that only high dose curcumin was significantly
different than DMSO (P < 0.05) to enhance CS activity in Gas and
Sol (P < 0.05). These results indicate that high-dose curcumin
treatment and eTR additively increases themitochondrial copy




















































































































eTR: P < 0.001 (non-eTR < eTR)




eTR: P < 0.001 (non-eTR < eTR)













DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
Fig. 2 – COX-IV protein expression (A), OXPHOS subunits expression (B) and intensity OXPHOS subunits relative to DMSO (C
and D) in soleus.Value are mean ± SD (n = 6 in each group) DMSO = control without endurance exercise. CD 50 = curcumin 50
mg/kg-BW/day in DMSO. CD 100 = curcumin 100 mg/kg-BW/day in DMSO. eTR = endurance training. Two-way ANOVA
revealed the main effect for eTR (P < 0.001) and curcumin treatment (P < 0.001) for COX-IV (A) and OXPHOS subunit (B and C)
expression in Sol with no interaction between two factors (n.s.). Post-hoc analysis revealed that compared to DMSO group,
both doses of curcumin increased COX IV (A) and OXPHOS subunit Complex I, II, and III expression (B and C, P < 0.05) in Sol.
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AMPK
AMPK is a critical regulator of mitochondrial biogenesis in
response to energy deprivation and previous studies have
reported that its expression increases after exercise [29,30].
Furthermore, previous studies found that curcumin increases
the phosphorylation of AMPK in skeletal muscle [31]. In
accordance with previous study reports, two way ANOVA
demonstrated that administration of curcumin enhanced the
phosphorylation of the Thr172 residue of the AMPKα catalytic
subunit in Gas and Sol (Fig. 4A and B, F = 100.51 for Gas, 17.99
for Sol, P < 0.001). In both Gas and Sol, eTR treatment
increased phosphorylation of AMPK (Fig. 4A and B, F = 383.29
for Gas, 125.96 for Sol, P < 0.001) with no interactions between
two factors (n.s.). Meanwhile, post-hoc analysis showed that
both doses curcumin were significantly different than DMSO
(Fig. 4A and B, P < 0.05) and low dose was different than high
dose (P < 0.05) to increase phosphorylation AMPK inGas and Sol
(Fig. 4A and B, P < 0.05). This result suggests that curcuminactivates AMPK phosphorylation in skeletal muscles and that
the effect is in addition to the response to eTR.
3.5. Curcumin Treatment with eTR Increases NAD+/NADH
Ratio and SIRT1 Expression
NAD+ and NADH, are coenzymes required for the generation
of ATP by mitochondria. SIRT1 is dependent on NAD+ as a
substrate and has therefore been proposed as a key regulator
of the adaptation to acute and chronic exercise in the
mitochondria of skeletal muscle [32]. In accordance with this
approach, two way ANOVA demonstrated that eTR increased
the cellular NAD+/NADH ratio in Gas and Sol (Fig. 5A and B, F =
243.73 for Gas, 587.07 for Sol, P < 0.001). Furthermore,
curcumin treatment increased the cellular NAD+/NADH ratio
in Gas and Sol (Fig. 5A and B, F = 39.74 for Gas, 50.97 for Sol, P <
0.001) with no interaction between two factors (n.s.).
However, curcumin treatment increased the expression of
the SIRT1 protein only in Gas (Fig. 5C, F = 14.32, P < 0.001) but































m. gastrocnemius m. soleusm. gastrocnemius m. soleus
30 eTR: P < 0.001 (non-eTR < eTR)
CD: Gas, P < 0.001 (DMSO & CD50 < CD100)































































eTR: P < 0.001 (non-eTR < eTR)
CD: Gas,  P < 0.001 (DMSO < CD50 < CD100)
Sol, P < 0.001 (DMSO & CD50 < CD100)
Interaction: n.s.
Fig. 3 – Mitochondria DNA copy number (A) and CS activity (B) in skeletal muscle.Value are mean ± SD (n = 6 in each group)
DMSO = control without endurance exercise. CD 50 = curcumin 50mg/kg-BW/day in DMSO. CD 100 = curcumin 100mg/kg-BW/
day in DMSO. eTR = endurance training. (A) Two-way ANOVA revealed the main effect for eTR (P < 0.001) and curcumin
treatment (P < 0.001) for mitochondrial DNA copy number in Gas and Sol with no interaction between two factors (n.s.).
Post-hoc analysis revealed that compared to DMSO group, both doses of curcumin increased mitochondrial copy number in
Gas (P < 0.05) but in Sol only for high dose curcumin. (B) Two-way ANOVA revealedmain effect for eTR (P < 0.001) and curcumin
treatment (P < 0.001) for CS activity in Gas and Sol and no interaction between two factors (n.s.). Post-hoc analysis revealed that
compared to DMSO group, high dose of curcumin increased CS activity in Gas and Sol (P < 0.05).
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75.97 for Gas, 53.65 for Sol, P < 0.001) with no interaction
between the two factors (n.s.). Meanwhile, post-hoc analysis

































DMSO CD50 CD100 DMSO CD50 CD100
eTR
eTR: P < 0.001 (non-eTR< eTR)
CD: P < 0.001 (DMSO < CD50 < CD100)
Interaction: n.s.
Fig. 4 –AMPK phosphorylation in skeletal muscle.Value aremean
exercise. CD 50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 =
with endurance exercise. eTR = endurance training. Two-way A
curcumin treatment (P < 0.001) for phosphorylation of AMPK in G
(n.s.). Post-hoc analysis revealed that compared to DMSO group,
in skeletal muscle (P < 0.05).different than DMSO to increase NAD+/NADH ratio in both
skeletalmuscles (Fig. 5A andB, P < 0.05). On theother hand, only
high dose curcuminwas different than DMSO to increase SIRT1

































eTR: P < 0.001 (non-eTR< eTR)
CD: P < 0.001 (DMSO < CD50 < CD100)
Interaction: n.s.
DMSO CD50 CD100 DMSO CD50 CD100
eTR
± SD (n = 6 in each group) DMSO = control without endurance
curcumin 100mg/kg-BW/day in DMSO. DMSO + eTR = control
NOVA revealed the main effect for eTR (P < 0.001) and
as (A) and Sol (B) with no interaction between two factors
both doses of curcumin increased phosphorylation of AMPK
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SIRT1 in skeletal muscle via an increase in the cellular NAD+/
NADH ratio and that this is additive to the effect of eTR.
3.6. Curcumin Treatment with eTR Enhances Deacetylation
of PGC-1α
Activation of PGC-1α is important both for the determination
of mitochondrial content and the induction of mitochondrial
biogenesis in skeletal muscle. Previous research has demon-
strated that deacetylation of PGC-1α by SIRT1 is important for
skeletal muscle function and the induction of mitochondrial
biogenesis in response to exercise [32]. We therefore exam-
ined the deacetylation of PGC-1α in skeletal muscle. As shown
in Fig. 6A and B, two way ANOVA determined that curcumin
treatment, decreased the acetylation of PGC-1α in Gas and Sol




























eTR: P < 0.05 (non-eTR < eTR)



























eTR: P < 0.001 (non-eTR < eTR)
CD: P < 0.001 (DMSO & CD50 < CD100)
Interaction: n.s.
DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
Fig. 5 – NAD+/NADH ratio and SIRT1 protein expression in skelet
control without endurance exercise. CD 50 = curcumin 50 mg/kg
DMSO. Two-way ANOVA revealed themain effect for eTR (P < 0.00
Gas and Sol (A and B) with no interaction between two factors (n.
both doses of curcumin increased NAD+/NADH ratio in Gas and S
main effect for eTR (P < 0.001) for SIRT1 expression in Gas and S
curcumin treatment only in Gas (C, P < 0.001) but not in Sol (D, naddition, eTR decreased the acetylation of PGC-1α in both Gas
and Sol (Fig. 6A and B, F = 148.82 for Gas, 217.923 for Sol, P <
0.001) with no interaction between the two factors (n.s.).
Furthermore, post-hoc analysis showed that low dose and
high dose curcumin were significantly different than DMSO in
Gas and Sol (Fig. 6A and B, P < 0.05) but there was no different
between low dose and high dose treatment (n.s.). These
results together indicate that curcumin induced PGC-1α
deacetylation in skeletal muscles in an additive manner to
the effect produced by eTR alone.
3.7. Curcumin Treatment Increases cAMP Level
It is well known that exercise increases the levels of cAMP [33]
and curcumin has also been reported to have this effect as
measured by inhibition of endothelial cell phosphodiesterase




























eTR: P < 0.05 (non-eTR < eTR)



























eTR: P < 0.001 (non-eTR < eTR)
CD: n.s
Interaction: n.s.
DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
al muscle.Value are mean ± SD (n = 6 in each group) DMSO =
-BW/day in DMSO. CD 100 = curcumin 100 mg/kg-BW/day in
1) and curcumin treatment (P < 0.001) for NAD+/NADH ratio in
s.). Post-hoc analysis revealed that compared to DMSO group,
ol (A and B, P < 0.05). Additionally, two-way ANOVA revealed
ol (C and D). On the other hand, there was a main effect of
.s.).
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in Gas compared to non exercise (Fig. 7A, F = 211.26, P < 0.001)
with no interaction between the two factors (F = 0.29, n.s.). We
determined the downstream target proteins of cAMP-
dependent protein kinase (PKA) by using the PKA inhibitor
H89. Our results showed that curcumin increased the phos-
phorylation of CREB and LKB-1 inGas (Fig. 7B andC, F = 64.12 for
p-CREB and 16.21 for p-LKB-1, P < 0.001) and H89 abolished this
effect (Fig. 7B and C, F = 101.38 for p-CREB and 41.35 for p-LKB-
1, P < 0.001). These results suggested that curcumin increases
the levels of cAMP as well as the phosphorylation of CREB and
LKB-1 in skeletal muscle in addition to the effect of exercise.4. Discussion
The physiological significance of mitochondrial biogenesis is
enhancement of cellular oxidative phosphorylation, which
improves the endurance of the organism. Pathways that
regulate mitochondrial biogenesis have recently emerged as
potential metabolic targets. Previous studies presented evi-
dence that curcumin could induce mitochondrial biogenesis
in the liver and brain [35,36]. Our data support the finding that
curcumin upregulates the expression ofmitochondrialmarkers
COX-IV (Figs. 1A and 2A), and OXPHOS sub unit (Figs. 1B and C,
2B and C) aswell as increases themtDNA copy number (Fig. 3A)
and CS activity (Fig. 3B). Furthermore, we demonstrated that
eTR increases in the expression of COX-IV (Figs. 1A and 2A),




































eTR: P < 0.001 (non-eTR < eTR)
CD: P < 0.001 (DMSO < CD50 & CD100)
Interaction: n.s.
DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
Fig. 6 – Acetylation of PGC-1α. In skeletal muscle.Value are mean
exercise. CD 50 = curcumin 50 mg/kg-BW/day in DMSO. CD 100 =
revealed the main effect for eTR (P < 0.001) and curcumin treatm
with no interaction between two factors (n.s.). Post-hoc analysis
curcumin decreased acetylation of PGC-1α in Gas and Sol (P < 0.number (Fig. 3A), and CS activity (Fig. 3B) as predicted. To our
knowledge, this study is the first to demonstrate increased
mitochondrial biogenesis in rat skeletal muscle stimulated by a
combination of curcumin and exercise. The effect of curcumin
appeared less in Sol than that in Gas and this could be owing to
differences in the recruitment pattern of lower limb muscles
during rat swimming [37]. This evidence was strengthened by
the previous study which showed that swimming exercise did
not increase PGC-1α which is involved in regulation of mito-
chondrial biogenesis in soleusmuscle [6]. The previous research
suggested that the polyphenol resveratrol combined with
exercise could regulated mitochondrial biogenesis through its
antioxidant activity [38]. In fact, the increased mitochondrial
capacity stimulated by physical exercise was actually ROS-
dependent, and ROS generated in muscles during exhaustive
activity was the stimulus that triggered mitochondrial biogen-
esis [39]. Curcumin, however, is a more powerful antioxidant
than other polyphenols including resveratrol [23] and biomed-
ical investigations of curcumin have provided evidence for a
wide range ofmolecular and cellular activities, mostly related to
redox reactions and signal transduction [40]. We therefore
speculated that the bioactivity of curcumin in skeletal muscles
would be superior to that of resveratrol and directed through the
regulation of mitochondrial biogenesis. In this study, curcumin
treatment increased the levels of markers of mitochondrial
biogenesis in skeletalmuscle in a similar fashion to combination
treatment with endurance training, suggesting that curcumin
treatment together with exercise plays a role in the regulation of





































eTR: P < 0.001 (non-eTR < eTR)
CD: P < 0.001 (DMSO < CD50 & CD100)
Interaction: n.s.
DMSO DMSO CD50 CD100CD50 CD100
DMSO DMSO CD50 CD100CD50 CD100
± SD (n = 6 in each group) DMSO = control without endurance
curcumin 100 mg/kg-BW/day in DMSO. Two-way ANOVA
ent (P < 0.001) for acetylation of PGC-1α in Gas (A) and Sol (B)
































40 Ex: P < 0.001 (non-Ex < Ex)
















































Ex: P < 0.001 (non-Ex < Ex)
CD: P < 0.001 (DMSO < CD100)
Interaction: n.s.
3.0
4.0 Ex: P < 0.001 (non-Ex < Ex)










































































Fig. 7 – cAMP level (A) and CREB (B) and LKB-1 (C) phosphorylation in gastrocnemius skeletal muscle.Value aremean ± SD (n = 6
in each group) DMSO = control without exercise. CD 100 = curcumin 100 mg/kg-BW/day in DMSO. Ex = exercise. (A) Two-way
ANOVA revealed themain effect for exercise (P < 0.001) and curcumin treatment (P < 0.001) for increased cAMP level in Gaswith
no interaction between two factors (n.s.). Post-hoc analysis revealed that compared to DMSO group, curcumin increased cAMP
level in Gas (P < 0.05). (B) Two-way ANOVA revealed main effect for exercise (P < 0.001) and curcumin treatment (P < 0.001) for
phosphorylation of CREB in Gas and H89 abolished this effect (P < 0.001). (C) Two-way ANOVA revealedmain effect for exercise
(P < 0.001) and curcumin treatment (P < 0.001) for phosphorylation of LKB-1 in Gas and H89 abolished this effect (P < 0.001).
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skeletal muscles and improve performance by increasing
oxidative capacity [41,42] for which the enzyme AMPK serves
as a metabolic sensor. Structurally, mammalian AMPK is a
heterotrimer of three subunits: one catalytic (α) and two
regulatory (β and γ) subunits [43,44]. In skeletal muscles,
exercise can elevate the cellular [AMP]/[ATP] ratio in cells [45],
thereby activating AMPK [46–48], which is a critical regulator
of mitochondrial biogenesis in response to energy depriva-
tion. A previous study demonstrated that curcumin treatment
could increase the phosphorylation of AMPK and alleviate
insulin resistance in skeletal muscles [31]. In adipocytes of
C57/BL6 mice fed a high-fat diet, curcumin was shown toincrease the phosphorylation of AMPK [49] suggesting that the
AMPK pathway might be a target for curcumin in regulating
mitochondrial biogenesis in skeletal muscles. Indeed, our
results demonstrated that high doses of curcumin induced
the phosphorylation of AMPK in Gas and Sol (Fig. 4A and B). In
addition, in accordance with the results of many recent
studies, our results confirmed that eTR increased the
phosphorylation of AMPK in skeletal muscles and further-
more that curcumin co-treatment was additive to the effect of
eTR (Fig. 4A and B). When the intracellular energy state
changes because of exercise, an increase in the cellular NAD+
concentration and the resulting interaction of AMPK and
SIRT1 can induce the expression of proteins involved in
1344 M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L 6 4 ( 2 0 1 5 ) 1 3 3 4 – 1 3 4 7mitochondria biogenesis. In this study, curcumin was shown
to increase the NAD+/NADH ratio, resulting in an increase in
SIRT1 expression (Fig. 5).
SIRT1-mediated PGC-1α deacetylation may be essential to
activate mitochondrial biogenesis in skeletal muscles [50,51].
Thus, a number of studies have observed that SIRT1 levels of
gene expression and protein increase in skeletal muscles in
response to acute and chronic exercise, in parallel to an up-
regulation of mitochondrial content. Our results demon-
strated that curcumin treatment increased the cytosol
NAD+/NADH ratio followed by an increase in the expression
of SIRT1 protein in the nuclear fraction in Gas (Fig. 5A and
C). Furthermore, eTR also increased the NAD+/NADH ratio
and SIRT1 expression (Fig. 5). In addition, some polyphe-
nols, including curcumin, have also been shown to activate
SIRT1 directly or indirectly in a variety of models [52,53].
This has led to great interest in developing polyphenols to
target the SIRT1-PGC-1α complex or related signaling
pathways in order to regulate mitochondrial biogenesis in
skeletal muscles, and mimic or potentiate the effect of eTR.
One study has shown that the activation of SIRT1 by
curcumin attenuates myocardial IR-induced mitochondrial
oxidative damage [54]. However, the present study is the
first, to our knowledge, to demonstrate increases in the
expression of SIRT1 protein in both skeletal muscle types in
response to curcumin treatment combined with eTR (Fig. 5C
and D).
PGC-1α is a coactivator, involved in activating both nuclear
and mitochondrial transcription, resulting in mitochondrial
biogenesis and the up-regulation of genes involved in lipid
metabolism and oxidative phosphorylation [55–57]. Various
transcriptional factors including nuclear respiratory factor 1
(NRF-1) and mitochondrial transcription factor A (Tfam) may
be involved [58]. A previous study has shown that PGC-1α
knockdown in skeletal muscle cells significantly reduced the
expression of Tfam and COX-IV [59]. PGC-1α can also be
regulated at the posttranslational level, for instance by
acetylation [60]. It has been reported that polyphenol com-
bined with exercise increase deacetylation PGC-1α [32]. We
therefore assessed the acetylation/deacetylation state of PGC-
1α in the muscles of animals treated with curcumin with or
without eTR. The ratio of acetylated PGC-1α to total PGC-1α
protein in the nucleus was significantly decreased by
curcumin treatment combined with eTR in both Gas and Sol
(Fig. 6) indicating that deacetylation of PGC-1α was facilitated
by curcumin. Therefore, curcumin treatment had a significant
impact on the state of PGC-1α and mitochondrial biogenesis
when skeletal muscles were subjected to the repeated
metabolic demands of eTR, and may have the potential to
exert an additive effect together with eTR.
As discussed above, deacetylation of PGC-1α by SIRT1 is
thought to be an important step in increasing PGC-1α activity,
and SIRT1 protein expression increased with eTR and
curcumin (Fig. 5C and D). Although themechanisms presently
remain unclear, nitric oxide synthase (NOS) may be involved
in this effect. Recent studies have shown that curcumin
treatment increases NOS enzyme activity in rat endothelium
and increases the expression of eNOS and nNOS genes [61,62].
Another candidate is AMPK, since endurance exercise in-
creases AMPK activity in skeletal muscles [29,30]. The resultsreported here regarding the increase in SIRT1 expression and
NAD+/NADH ratio in skeletal muscles following eTR in
combination with curcumin treatment, may help explain the
additive effects of the combined treatment in vivo. Our
findings demonstrate the therapeutic potential of curcumin
in the induction of mitochondrial biogenesis and function,
which may be dependent on the presence of SIRT1 as well as
on a cellular environment created by the continuous energy
demands of repeated exercise. Similarly, the beneficial effects
of both calorie restriction and the polyphenol resveratrol have
been suggested to involve activation of SIRT1 and AMPK [63–
65]. Thus, there is a dynamic interaction between these two
pathways with AMPK activating SIRT1, probably through an
indirect increase in cellular NAD+ concentration [66]. Accord-
ing to the above results, the present study suggests that the
effects of phosphorylation and activation of AMPK (caused by
exercise and curcumin treatment) trigger an increase in the
cellular NAD+/NADH ratio, which activates SIRT1. In addition,
AMPK also phosphorylates PGC-1α and primes it for subse-
quent deacetylation by SIRT1. The effect of AMPK and SIRT1
on the acetylation status of PGC-1α, and possibly other
transcriptional regulators, subsequently improves mitochon-
drial biogenesis (Fig. 8). Since this is the first report showing
the additive effect of curcumin and eTR on the phosphoryla-
tion of AMPK skeletal muscle, the precise mechanism
remains unknown.
cAMP is a critical, tightly regulated second messenger
involved in many intracellular processes and degraded by
PDE. cAMP activates PKA, which, in turn, phosphorylates
CREB and LKB-1 thereby regulating mitochondrial biogenesis
through PGC-1α. Our results indicated that curcumin and
exercise increased the levels of cAMP in Gas (Fig. 7A). This
result confirms the results of a previous report, which
demonstrated the potential of curcumin to increase cAMP
levels [34,67]. Identification of cAMP as a target for curcumin
in this present study might explain how curcumin mimics
some aspects of exercise. To determine whether cAMP is
required to regulate mitochondrial biogenesis, we used PKA
inhibitor H89 and showed that the induced phosphorylation
of CREB and LKB-1 (Fig. 7B and C) in Gas was abolished (Fig. 7B
and C). This result indicates that cAMP is needed to regulate
mitochondrial biogenesis in skeletal muscle and is in accor-
dance with the results of a previous study, which showed that
curcumin increased the phosphorylation of CREB in the
brain [68] and of LKB-1 in skeletal muscle [31]. Activated
CREB and LKB-1 have proven to be important regulators of
the PGC-1α promoter [69,70]. The expression of PGC-1α was
mediated by the activation of the transcription factor CREB,
which requires phosphorylation by PKA to initiate mito-
chondrial biogenesis [71] while, LKB-1 regulated PGC-1α
through the AMPK pathway [70]. These results suggest that
the ability to increase the levels of cAMP plays an important
role in the adaptation of mitochondrial biogenesis by
curcumin either alone or combined with exercise (Fig. 8).
Since this the first study to report on the effect of curcumin
together with exercise on skeletal muscle, further investi-
gation will be necessary to describe the molecular mecha-
nisms and identify whether curcumin directly induces



















Fig. 8 – Molecular pathways involved in the effects of
exercise and curcumin treatment on the mitochondrial
biogenesis.Curcumin together with exercise increases cAMP
level, which activates PKA and increase phosphorylation
CREB and LKB-1. Phosphorylation and activation of AMPK
triggers an increase in the cellular NAD+/NADH ratio, which
activates SIRT1. In addition, AMPK phosphorylates PGC-1α
and primes it for subsequent deacetylation by SIRT1. The
effect of AMPK and SIRT1 on the acetylation status of
PGC-1α, and potentially of other transcriptional regulators,
subsequently improves mitochondrial biogenesis. AMPK,
5′ adenosine monophosphate-activated protein kinase; ATP,
adenosine triphosphate; cAMP, cyclic adenosine
monophosphate; CREB, cAMP response element binding
protein; eTR, endurance training; LKB-1, liver kinase B1;
NAD, nicotinamide adenine dinucleotide; NADH,
nicotinamide adenine dinucleotide hydrogen; PGC-1α,
peroxisome proliferator-activated receptor gamma
coactivator 1; PKA, protein kinase A; SIRT1, sirtuin 1.
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In conclusion, curcumin treatment combined with eTR
activated AMPK and increased the NAD+/NADH ratio in
skeletal muscle to induce SIRT1 activation. Activation of
AMPK and SIRT1 promoted the deacetylation of PGC-1α and
enhanced the expression of themitochondrial marker COX IV,
CS enzyme activity, OXPHOS sub unit expression, and mtDNA
copy number. Furthermore, curcumin increased the levels of
cAMP and phosphorylation of CREB and LKB-1, which are
involved in the regulation of mitochondrial biogenesis. Taken
together, our data suggest that curcumin treatment enhances
the effect of eTR on the regulation of mitochondrial biogenesis
in skeletal muscles through an increase in the level of cAMP.Author Contribution
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